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ABSTRACT OF THE DISSERTATION
COMPARISON OF CORONARY HEART DISEASE RISK FACTORS IN FOREIGN-
BORN AND UNITED STATES-BORN AFRO CARIBBEAN AMERICANS AND
AFRICAN AMERICANS IN SOUTH FLORIDA
by
Errol Earl Davis
Florida International University, 2004
Miami, Florida
Professor Fatma G. Huffman, Major Professor
In a cross-sectional study design, risk factors for coronary heart disease (CHD)
were evaluated in three groups: 66 Afro Caribbeans (FBCA) living in the US for less than
10 years, 62 US-born Afro Caribbean (USBCA) and 61 African American (AA) adults
(18-40 years), with equal numbers of males and females in each group. Socio-
demographic, dietary, anthropometric and blood pressure data were collected. Fasting
blood glucose, blood lipids and high-sensitivity C-reactive protein (hs-CRP) were
determined.
The USBCA and AA participants compared to the FBCA participants consumed
significantly (p< 0.05) more mean total fat (g) (66.3 41.7 and 73.0 47.8 vs. 52.8
32.3), saturated fat (g) (23.1 14.9 and 24.9 15.8 vs. 18.6 11.5), percent energy from
fat (%) (33.1 6.5 and 31.4 6.4 vs. 29.3 6.8), fat servings (1.8 1.2 and 1.5 1.0 vs.
1.2 0.9), dietary cholesterol (mg) (220.4 161.9 and 244.1 155.0 vs. 168.8 114.0)
and sodium (mg) (2245.2 1238.3 and 2402.6 1359.3 vs.1838.0 983.4) and less than
2 servings of fruits per day (%) (86.9 and 94.9 vs. 78.5). These differences were more
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pronounced in males compared to females and remained after correcting for age. Also,
the percentages of USBCA and AA participants who were obese (17.1% and 23.0%,
respectively) were significantly (p< 0.05) higher compared to FBCA (7.6%) participants.
More USBCA and AA than FBCA individuals smoked cigarettes (4.8% and 6.6% vs.
0.0%) and consumed alcoholic beverages (29.0% and 50.8% vs. 24.2%). The mean hs-
CRP level of the AA participants (2.2 2.7 mg/L) was significantly (p< 0.01) higher
compared to the FBCA (1.1 1.3 mg/L) and USBCA (1.3 1.6 mg/L) participants.
The FBCA participants had a better CHD risk profile than the USBCA and AA
participants. Focus should be placed on the ethnic and cultural differences in a population
to better understand the variations in health indicators among different ethnic groups of
the same race. This focus can provide healthcare professionals and policy planners with
the opportunity to develop culturally sensitive programs and strategies for the
improvement of health outcomes.
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CHAPTER I
INTRODUCTION
Cardiovascular disease (CVD) is a serious public health concern affecting more
than 64 million Americans in 2001 (American Heart Association [AHA] Statistical
Update, 2004). Since more than 55% of all CVD deaths are due to coronary heart disease
(CHD), modification of the risk factors for CHD is important in the prevention of CUD
(AHA Statistical Update, 2004). Evidence shows a decreasing trend in mortality due to
CVD over the past 20 years (Braunwald, 1997; AHA Statistical Update, 2004; Rifai and
Ridker, 2002). However, despite behavior/lifestyle changes and the use of new
pharmacological drug therapies to decrease blood cholesterol (Shepard et al., 1995) and
blood pressure levels (Kostis et al., 1997) CVD remains the leading cause of death in the
United States (US) (Braunwald, 1997). Cardiovascular disease accounted for nearly 1
million deaths and over 6 million hospital discharges in 2001 and exacted a heavy burden
on Black males and females (AHA Statistical Update, 2004). The incidence and
prevalence of CVD will continue to increase as the population ages and, together may
become one of the leading causes of disability-adjusted life years (DALYs) lost among
working adults (Beaglehole et al., 2001; AHA Statistical Update, 2002). Nationally, the
annual estimated direct and indirect cost of CVD in 2004 was over $368 billion (AHA
Statistical Update, 2004).
The current approach to the prevention of CUD is predicated on identification of
risk factors and the quantitative assessment of short-term cardiovascular risk (Linton and
Fazio, 2003). The Multiple Risk Factor Intervention Trial (MRFIT) (Stamler et al., 1986)
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and the Nurses' Health Study (Stampfer et al., 2000) have shown that the major risk
factors for CHD (advancing age, cigarette smoking, elevated blood pressure [BP], total
cholesterol [TC], low-density lipoprotein cholesterol [LDL-C], low levels of high-density
lipoprotein cholesterol [HDL-C]) account for more than 70% of the excess risk for
premature CHD. High fat diets, obesity and physical inactivity are now also considered
major risk factors for CHD (National Cholesterol Education Program [NCEP]: Adult
Treatment Panel [ATP] III, 2001). The measurement of serum lipids, especially LDL-C
has been predictive of CHD (AHA, 2002; NCEP: ATP III, 2001).
Research indicates that 50% of males and 63% of females who died suddenly of
CHD and had no previous symptoms of this disease (AHA Statistical Update, 2003), had
normal or only slightly elevated lipid levels but, elevated high-sensitivity C-reactive
protein (hs-CRP) levels, a marker of low-grade inflammation (Yu and Rifai, 2000; Rifai
and Ridker, 2001). This is an indication that atherothrombosis can occur in the absence of
hyperlipidemia (Ross, 1999; Ridker et al., 2002). Thus, in addition to the measurement of
lipid parameters, measurements of hs-CRP have been shown to significantly improve the
clinical prediction value in apparently healthy males and females, of first myocardial
infarction (Ridker et al., 1998c; Ridker et al., 2000). This is important since apparently
healthy young adults with normal lipid levels may have elevated hs-CRP levels and may
be at risk for CHD.
Statement of the problem
The non-Hispanic Black (interchangeable with African American) population,
now the second largest ethnic group in the US (US Census Bureau, 2000), is a composite
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of blacks born inside and outside the US, including groups such as foreign- and US-born
Afro Caribbean Americans, a growing population in South Florida. In the year 2000,
there were over 2.8 million foreign-born Caribbean Nationals in the US (US Census
Bureau: Current Population Reports [P23-206], 2001). In March 2002, this population
increased to over 3.1 million, with 55% living in South Florida (US Census Bureau:
Current Population Report [P20-539], 2003; US Census Bureau: Current Population
Survey [CENBR], 2002). As this population increases it is important for healthcare
professionals and health policy planners to monitor the health status of this and other
foreign-born population. This is because their health care needs and access to quality
health care may differ from that of US-born individuals (Stephen et al., 1994).
There is evidence showing lower all-cause mortality due to CHD in foreign-born
Blacks compared to US-born Blacks and US-born Whites (Fang et al., 1997; Singh and
Siahpush, 2002). In these studies, blacks included both non-Hispanic Blacks and
Hispanic Blacks. Fang et al (1996) also showed that Caribbean Americans in New York
City had substantially lower all-cause and cardiovascular mortality rates compared to
Blacks born in the southern and northeastern US. However, risk factors for CHD were
not investigated in this study.
Most of the studies investigating risk factors for CHD (including hs-CRP levels
and TC/HDL-C ratio) have been done with adults aged between 40 years and older.
There is a dearth of information on socio-demographic (educational attainment,
household income, perceived stress, knowledge of risk factors for CHD, family history of
CHD, medical insurance coverage, visitations to healthcare professionals),
behavioral/environmental (atherogenic diet, physical inactivity, elevated body mass
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index, cigarette smoking and alcohol consumption,), physiological (elevated blood
pressures, blood glucose, TC, LDL-C, TG and low HDL-C) and emerging (elevated hs-
CRP, TC/HDL-C ratio) risk factors for CHD in foreign-born and US-born Caribbean
Americans, especially younger adults (18-40 years).
Although national health data on African-Americans have been collected since the
1980s, the data is of a composite nature and may have included foreign-born Afro
Caribbeans, Also, it is being suggested that studies which compare minority populations
with the majority 'White' population may give the impression that the latter group
represented some kind of a health "norm" and that ethnic differences may represent some
sort of a 'deviant' health state (Curtis and Lawson, 2000). Thus, it is suggested that we
interpret these comparative studies with care.
Significance
Despite guidelines for the management of individual risk factors for CHD
(National High Blood Pressure Education Program [JNC, VI, 1997], American Diabetes
Association, 2002, NCEP: ATP III, 2001), CHD remains the number one killer of
Americans (Braunwald, 1997; Beaglehole et al., 2001), thus the search for other
(emerging) risk factors for CHD. Early detection of risk factors is important in reducing
the severity and age of onset of CHD. The Healthy People 2010 Heart disease and Stroke
Goal is to improve cardiovascular health and quality of life through the prevention,
detection and treatment of risk factors; early identification and treatment of heart attacks
and strokes; and prevention of recurrent cardiovascular events (HP 2010). The prevalence
of risk factors for CHD is higher in non-Hispanic Blacks and other ethnic groups
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compared to non-Hispanic Whites (Gillum, 1988) and, in the absence of these risk
factors, death from CHD is rare (Beaglehole et al., 2001).
Ethnic populations' beliefs and practices can influence the interactions between
healthcare provider and individuals of this population. However, insufficient attention is
paid to the area of ethno-medicine (Bronner, 1994). Information about an individual
ethnic group is important for the identification, tracking and investigation of the reasons
for ethnic differences in the prevalence and severity of disease and in the response of
diseases to treatment (Burchard et al., 2003). Also, information about a person's ethnic
group is important in identifying different risk factor profiles even when a disease does
not occur with dramatically different frequencies in the different ethnic groups (Burchard
et al., 2003). It is suggested that by focusing on the ethnic and cultural differences in a
population we can better understand the variations within and between different ethnic
and cultural groups and, the influence of birth origin on the prevalence of risk factors for
and, severity of diseases (Burchard et al., 2003). This focus can provide the opportunity
for healthcare professionals to develop culturally sensitive programs and strategies for the
improvement of health outcomes.
No study has been done to evaluate the socio-demographic,
behavioral/enviro ental, physiological and emerging risk factors of CHD in foreign-
born and US-born Caribbean Americans, especially in South Florida, where there is a
growing population. Foreign-born Afro Caribbeans may have different health
perceptions, beliefs, behaviors, dietary habits and propensities to report health/nutritional
conditions compared to US-born Caribbean Americans and African Americans. Also,
there may be differences in socio-economic status, perception of stress, exposure to
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knowledge about CHD, eating habits, physical activity, obesity status, cigarette smoking
and alcohol consumption. These differences may be distinguishing features of these
groups and may influence risk factors for cardiovascular disease in this population of
African ancestry (Curtis and Lawson, 2000). Designing effective prevention programs to
reduce the risk of CHD requires responding to the needs of different ethnic groups
(Dundas et al., 2001).
This research determined and compared socio-demographic (educational
attainment, household income, perceived stress, knowledge of risk factors for CHD,
family history of CHD, medical insurance coverage, visitations to healthcare
professionals), behavioral/environmental (atherogenic diet, physical inactivity, elevated
body mass index, cigarette smoking and alcohol consumption), physiological (elevated
BP, fasting BG, serum TC, LDL-C, triglyceride (TG), low HDL-C) and emerging
(elevated hs-CRP and TC/HDL-C ratio) risk factors for CHD in apparently healthy
foreign-bom Afro Caribbean (FBCA), US-born Afro Caribbean American (USBCA) and
African American (AA) adults (18-40 years old). Data from this study may prove useful
to healthcare professionals managing CHD risk factors reduction among this
heterogeneous population.
Research Questions
1. Are the socio-demographic profiles of FBCA, USBCA and AA adults similar?
2. Are FBCA adults less likely to have behavioral risk/environmental risk factors
of CHD as compared to USBCA and AA adults?
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3. Are FBCA adults less likely to have physiological risk factors of CHD as
compared to USBCA and AA adults?
4. Are FBCA adults less likely to have emerging risk factors of CHD as
compared to USBCA and AA adults?
Purpose and Specific Objectives
Ethnicity is a construct that encompasses both genetic and cultural differences
(Anand, 1999; Yusuf et al., 2001). Thus, the purpose of the proposed research was: to
determine and compare socio-demographic, behavioral/environmental, bio-physiological
and emerging risk factors for CHD in apparently healthy FBCA, USBCA and AA adults
(18-40 years old) in South Florida.
The following risk factors were included in the study:
1. Socio-demographic risk for CHD such as:
(a) Educational Attainment: was self-reported using the self-administered socio-
demographic questionnaire (SDQ) as levels of educational attainment.
(b) Household income: was self-reported using the self-administered SDQ as levels
of household income.
(c) Perceived Stress: was self-administered using the Cohen Perceived Stress scale
(PSS). It contains 14 items and uses a five-point Likert scale (never, almost never,
sometimes, fairly often, very often) to assess perceived stress levels.
(d) Knowledge of CHD risk factors: was self-administered using the "Knowledge
of CHD Risk Factors" questionnaire. Subjects answered a set of questions that
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measured knowledge of CUD risks. The questionnaire contains 25 'T' or 'F'
responses.
(e) Family history of CHD: was self-reported using the self-administered SDQ as
knowing or not knowing their family history of CHD.
(f) Medical insurance coverage: was self-reported using the self-administered SDQ
as no coverage and type of insurance coverage.
(g) Visitations to healthcare professionals: was self-reported using the self-
administered SDQ as number of visits during the past year.
Behavioral and environmental risks for CHD such as:
(a) Dietary Intakes: was self-administered using the validated food frequency
questionnaire (FFQ). Dietary intakes of carbohydrate, total fat, saturated fat,
monounsaturated and polyunsaturated fats, fiber, fruits, vegetables and sodium
were determined.
(b) Physical Activity: (PA) was self-administered using the Baecke questionnaire.
This questionnaire assesses leisure time and occupational activities.
(c) Anthropometry: body mass index (weight (kilograms, kg) divided by height
(meters, m2 ), was calculated using weight and height measurements of the
subjects taken at the Nutrition Laboratory at Florida International University.
(d) Smoking status: was self-reported on the self-administered validated FFQ, as
current smoker (number of cigarettes smoked per day) or not currently smoking.
(e) Alcohol Consumption: was self-reported on the self-administered validated FFQ
as frequency of alcohol consumption per year/month/week/day.
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3. Bio-physiological risk factors for CHD such as:
(a) Blood pressure: (BP) was measured by a trained technician.
(b) Fasting blood glucose levels were measured by automated standard laboratory
procedures.
(c) Total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), and
triglyceride (TG) levels were measured by automated standard laboratory
procedures. Serum LDL-C was calculated by the Friedwald equation.
4. Emerging markers of CHD risk such as:
(a) Fasting high-sensitivity C-reactive protein (hs-CRP) levels were measured by
the Food and Drug Administration (FDA) approved latex-enhanced high-
sensitivity immunoephelometric assays on a BN II analyzer (Dade Be hng, US).
(b) TC/HDL-C ratio was calculated by dividing TC concentration (mg/dL) by HDL-
C concentration (mg/dL).
Other cardiovascular diseases with significant public health impact include stroke,
valvular heart disease, Chagas disease and heart failure (Yusuf et al., 2001). However, for
the purpose of this study, the review of literature was limited to:
(a) Socio-demographic risk factors such as: socio-economic status (SES), perceived
stress, knowledge of risk factors for CHD, family history of CHD,
(b) Behavioral/Environmental risk factors for CHD such as: atherogenic diet,
physical inactivity, elevated body mass index (BMI), cigarette smoking and
alcohol consumption,
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(c) Bio-physiological risk factors for CHD such as: elevated blood pressure, fasting
blood glucose, TC, LDL-C, TG and low HDL-C levels and,
(d) Emerging risk factors for CHD such as: elevated hs-CRP and TC/HDL-C ratio.
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CHAPTER II
LITERATURE REVIEW
Cardiovascular Disease and Coronary Heart Disease
Total cardiovascular disease (CVD) comprises all "diseases of the circulatory
system" (International Classification of Diseases, 1 0 th revision [ICD/10] codes 100-199),
and includes rheumatic fever/rheumatic heart disease (codes 100-109); hypertensive
diseases (codes 110-115); ischemic (coronary) heart disease (codes 120-125); pulmonary
heart disease and diseases of pulmonary circulation (codes 126-128); other forms of heart
disease (codes 130-152); cerebrovascular disease (stroke) (codes 160-169);
atherosclerosis (code 170); other diseases of the arteries, arterioles and capillaries (codes
171-179); diseases of the veins, lymphatic and lymph nodes, not classified elsewhere
(codes 180-189); and other and unspecified disorders of the circulatory system (codes
195-199). Depending upon availability, data for congenital cardiovascular defects (codes
Q20-Q28) are also included (American Heart Association [AHA] Statistical Update,
2003).
There is a decrease in mortality due to cardiovascular diseases (CVD) over the
past 20 years. Indeed, during 1989-1999 the death rate from CVD declined by 15.6%
(Braunwald, 1997; AHA Statistical Update, 2002; Rifai and Ridker, 2002) and continues
to decline (AHA Statistical Update, 2004). However, despite lifestyle behavior changes
and the use of new pharmacological drug therapies to decrease blood cholesterol
(Shepard et al., 1995) and blood pressure levels (Kostis et al., 1997) CVD remains the
leading cause of death among Americans of all race/ethnic groups and accounts for over
12 million deaths (7 million to coronary heart disease [CHD] and 5 million to stroke)
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annually, worldwide (Beaglehole et al, 2001). It is estimated that over 2,600 Americans
die each day from CVD, an average of 1 death every 34 seconds (AHA Statistical
Update, 2004). The incidence and prevalence of CVD will continue to increase as the
population ages and, may become one of the leading causes of disability-adjusted life
years (DALYs) lost among working adults (Beaglehole et al., 2001; AHA Statistical
Update, 2002). Nationally, the annual estimated cost of CVD in 2004 is expected to be
over $368.4 billion, $226.7 billion in direct costs and $141.7 due to indirect costs (AHA
Statistical Update, 2004).
In 2001, the age-adjusted prevalence of CVD in the US among non-Hispanic
White males (30.0%) and females (23.8%) was lower compared to non-Hispanic Black
males (40.5%) and females (39.6%). The age-adjusted prevalence for Mexican-American
males (28.8%) and females (26.6%) was similar to the values seen in non-Hispanic
Whites (AHA Statistical Update, 2004; NHANES III, 1988-94). Although more White
males (374,280) and females (433,867) died from CVD compared to Black males
(48,939) and females (56,821), the overall CVD mortality for 2001 was lower in White
males (384.3/100,000) and females (273.6/100,000) compared to Black males
(510.5/100,000) and females (376.6/100,000) (AHA Statistical Update, 2004; NHANES
III, 1988-94). Also, higher numbers of CVD risk factors were seen among non-Hispanic
Black and Mexican-American females than among non-Hispanic White females of
comparable socio-economic status (NHANES III, 1988-94).
In the year 2000, Florida was ranked 19$x in age-adjusted CVD deaths with a
death rate of 309.4/100,000 population, a 16.3% decrease since 1990, compared to the
national average of 345.3/100,000 population, a 16.5% decrease since 1990 (AHA
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Statistical Update, 2004). In Florida during the year 2000, there were more than 64, 000
deaths due to CVD (39,000 due to coronary heart disease and 10,000 due to stroke) and,
229,900 hospital discharges due to CHD and stroke (Florida Department of Health
[FLDH], 2001). Cardiovascular disease is not just a disease of the elderly. In Florida
during the year 2000, there were nearly 5,000 heart attack deaths and more than 1,100
stroke deaths in individuals under the age of 65 years. Also, there were more than 71,000
hospital discharges for heart disease and stroke among individuals under the age of 65
years (FLDH, 2001).
The major cardiovascular event is CHD and is defined as symptomatic ischemic
heart disease including myocardial infarction (ICD/10 codes 121-122), stable or unstable
angina (ICD/10 code 120), atherosclerotic cardiovascular disease (ICD/10 code 125.0),
demonstrated myocardial ischemia by non-invasive testing and history of coronary artery
procedures, and all other forms of chronic ischemic heart disease (ICD/10 codes 125.1-
125.9) (National Cholesterol Education Program [NCEP]: Adult Treatment Program
[ATP] III, 2001; AHA Statistical Update, 2002). Coronary heart disease occurs when the
coronary vessels (blood vessels that carry oxygen and nutrients to the heart) are clogged
or blocked. If enough oxygen-carrying blood cannot reach the heart, the individual will
feel pain in the chest or left arm or shoulder, called angina pectoris. If the blood supply is
cut off completely, the individual will suffer a heart attack (AHA Statistical Update,
2002; Healthy People [HP], 2010). Coronary heart disease and stroke combined account
for 72% of the total cardiovascular events in the US (Figure 1).
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Figure 1 - Percentage Breakdown of Deaths from Cardiovascular Diseases: United
States, 2001.
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In the year 2001, over 13 million persons in the US (6.4% of the population) had
CUD whereas 4.8 million persons (2.0% of the population) had cerebrovascular disease,
ischemic stroke being the major cerebrovascular event (AHA Statistical Update, 2004).
Individuals with CHD often suffer from stroke and those with stroke often suffer from
CUD (Assmann et aL., 1999). In the US, a coronary event occurs every 26 seconds and
every minute someone will die from one. Someone suffers a stroke every 53 seconds and
every 3 minutes someone will die from one (AHA Statistical Update, 2004). Coronary
heart disease is also the leading cause of premature, permanent disability in the US labor
force, accounting for 19% of disability allowances paid by the Social Security
Administration (AHA Statistical Update, 2002). In 1998, $10.6 billion was paid to
Medicare beneficiaries for CUD ($10,428 per discharge for acute myocardial infarction;
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$11,399 per discharge for coronary atherosclerosis and $3,617 per discharge for other
CHD) (Health Care Financing Administration [HCFA] Statistical Supplement, 2000). In
the year 2001, the overall mortality rate for CHD was lower in White males
(228.4/100,000) and females (137.4/100,000) compared to Black males (260.0/100,000)
and females (176.7/100,000) (AHA Statistical Update, 2004).
In the year 2000, Florida was ranked 3 5 th in age-adjusted CHD deaths with a
death rate of 191.3/100,000 population compared to the national average of
188.9/100,000 population (AHA Statistical Update, 2004). In Florida during 2000, more
men (20,317) died from CHD than women (19,381) (FLDH, 2001). Counties with the
highest CHD rates for males and females were found in the rural northern region of the
state, including Tallahassee. The lowest CHD rates for males were found in the southern
region of the state, including the cities of Miami, Fort Lauderdale and Fort Myers,
whereas females in the city of Miami experienced intermediate rates of CHD deaths
(Center of Disease Control [CDC] Fact sheets, 2002).
Culture, Migration, Ethnicity and CHD
The beliefs, traditions and practices by a community of individuals are classified
as culture. These behavioral patterns are reinforced when the community is isolated by
geography or segregated by socioeconomic status. This set of behavioral patterns is
learned, not inherited, and is passed from one generation to the next through a process
called enculturation (Plawecki, 1992). Cultural membership is defined by the term
ethnicity (Brookins, 1993; Kittler and Sucher, 2001) which is a much broader construct
that takes into account cultural traditions, common history and shared genetic heritage
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(Burchard et al., 2001). When individuals from one ethnic group migrate to an area with
different cultural norms, these individuals will start to adapt to the cultural norms of the
major society through a process known as acculturation. This occurs through a continuum
of behavioral patterns (Kittler and Sucher, 2001). Some individuals become bicultural
(practicing both cultures) whereas, others, especially second and third generation
migrants may shed their ethnic identity and fully merge into the cultural norms of the
majority culture, a process known as assimilation (Brookins, 1993; Kittler and Sucher,
2001). Although Bronner (1994) has suggested that individuals from a given culture may
have similar health beliefs, attitudes, traditions and practices, the population may by no
means be homogenous. Individuals may differ by socio-economic status, behavioral
attitudes, exposure to stress, biophysical and biochemical parameters, country of origin
and length of time in the US.
Individuals who migrate to other countries often carry patterns of disease and
behavioral habits from their countries of origin to their countries of adoption. This has
been shown in studies investigating risk for CHD in migrating Japanese (Robertson et al.,
1977), Chinese (Gerber and Madhaven, 1980) and Filipinos (Gerber, 1980). However, as
these individuals assimilate into the dominant society they may reflect the disease
patterns of this society. This was seen in Southern-born Blacks who migrated to other
regions in the US having higher mortality rates compared to Blacks native to their
adopted region but below those of the south (Greenberg and Schneider, 1992). There are
reports documenting this geographical transition of CHD risks. For example, in the Ni-
Hon-San study of Japanese migrants, low total cholesterol (TC) levels and CHD rates
were seen in Japanese men in Japan whereas intermediate and high TC levels and CHD
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rates were seen in Honolulu and San Francisco, respectively (Kagan et al., 1974).
Additionally, in investigating the rates of non-insulin dependent diabetes mellitus
(NIiDDM) among the population of the African Diaspora in Nigeria, Barbados, Jamaica,
St. Lucia, the United States (US) and the United Kingdom (UK), Cooper et al (1997)
showed that the age-adjusted prevalence rates for NIDDM was 2% in Nigeria, 9% in the
Caribbean and 11% in the US and UK, respectively. In investigating the distribution of
blood pressures in seven populations of African origin (West Africa, Nigeria, Cameroon),
the Caribbean (Barbados, Jamaica, St. Lucia), the US (metropolitan Chicago, Illinois),
Cooper et al (1997a) observed a consistent gradient of hypertension prevalence from 16%
in West Africa to 26% in the Caribbean and 33% in the US. They suggested that
environmental factors such as dietary intakes of sodium and potassium and obesity may
be important determinants of this gradient.
Individuals living in the same environment have been evaluated with respect to
morbidity and mortality differentials. Singh and Siahpush (2002) analyzed data from the
1979-1989 National Longitudinal Mortality Study (NLMS) (longitudinal data set for
examining socioeconomic status, occupational and demographic factors associated with
all-cause and cause-specific mortality in the US) and, the 1993-1994 National Health
Interview Survey (household survey in which data on socioeconomic status,
demographic, behavioral [smoking, alcohol use, diet, physical activity], morbidity, health
care are collected). The NLMS sample consisted of 240,738 US-born non-Hispanic
Whites; 25,655 US-born non-Hispanic Blacks; 2,189 US-born Asians and Pacific
Islanders; 6,686 US-born Hispanics; 2,095 American Indians and, 13,073 foreign-born
non-Hispanic Whites; 777 foreign-born Blacks; 3,520 foreign-born Asian and Pacific
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Islanders and 6,177 foreign-born Hispanics. They found that immigrants tended to have
more favorable health-enhancing behavioral habits than their US-born counterparts. They
also showed that Black migrants compared to their US-born counterparts were less likely
to smoke cigarettes (10.4% vs. 29.3%), less likely to be overweight (25.2% vs. 38.4%),
and less likely to be hypertensive (16.8% vs. 25.5%) but more likely to have no medical
insurance (40.2% vs. 34.5%). In this study (Singh and Siahpush, 2002), Blacks consisted
of a composite group comprising African Americans, Nigerian Americans, Black Puerto
Ricans, Jamaican Americans, West Indian Americans and Haitian Americans.
A similar study by Fang et al. (1997) showed 46%-5 1% lower mortality among
Black migrants compared to US-born counterparts in New York City. In this study,
Blacks were also a composite of African Americans, Black Puerto Ricans, Jamaicans,
Nigerians, West Indians and Haitians. an earlier study, Fang et al. (1996) showed that
Caribbean-born Blacks in New York City had substantially lower all-cause and
cardiovascular mortality rates compared to Blacks born in the southern and northern
region of the US. In this study Fang et al (1996) linked mortality data from 1988 through
1992 with 1990 US Census data for New York City. Mortality data for African
Americans born in the southern US (Alabama, Arkansas, Delaware, Florida, Georgia,
Kentucky, Louisiana, Maryland, Mississippi, North Carolina, Oklahoma, South Carolina,
Tennessee, Texas, Virginia, West Virginia, District of Columbia), Northeastern US
(Connecticut, Maine, Massachusetts, New Hampshire, New Jersey, New York,
Pennsylvania, Rhode Island, Vermont) and the Caribbean (mostly from Barbados [86%],
Grenada, Haiti, Jamaica, Trinidad and Tobago) were compared with those for non-
Hispanic Whites born in the Northeastern US. They found that the age-adjusted death rate
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from CHD in Caribbean Americans 25 to 44 years of age was lower (7.4/100,000
population) compared to non-Hispanic Whites born in the Northeast (16.8/100,000
population) and, African Americans from the Northeast (23.1/100,000 population) and
South (30.1/100,000 population). Also, higher educational and employment levels were
seen in Whites compared to African-Americans. More Caribbean Americans compared to
African Americans born in the South were high school graduates and their average length
of stay in the US was 13.9 years. This study did not evaluate the risk factors for CHD and
stroke.
A study from the National Academy of Sciences (Hernandez, 1999) has reported
on the protective effect of immigrant status. This report demonstrated that foreign-born
young adults experienced more favorable physical and emotional health and less
involvement in risky behaviors than US-born young adults of foreign-born parents and
US-born young adults of US-born parents. The report also stated that the protective
quality of immigrant status was not related to the family or neighborhood context of
immigrant children. Thus, it is suggested that future research should concentrate on
uncovering the mechanism(s) behind the health protective effect(s) of foreign birth.
Race/Ethnic Disparities in Cardiovascular Health
Ethnicity is an important risk factor for CHD. In general, members of minority
groups are at higher risk of CHD, have greater prevalence of risk factors for CHD and
have greater death rates from CHD compared to non-Hispanic Whites (FLDH, 2001).
African Americans have the highest overall mortality from CHD of any ethnic group in
the US, particularly at younger ages (Clark et al., 2001; Gillum, 1997; NCEP: ATP III,
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2001). In 1995, the age-adjusted death rate for heart disease was 42% higher in African
American males than in White males and 65% higher in African American females than
in White females and almost twice as high in males than females (HP, 2010). Disparities
also exist in treatment outcomes for individuals who have heart attacks. Females (44 % of
those who experienced heart attacks) have poorer outcomes following a heart attack
compared to males (27%) who experienced heart attacks (Gillum et al., 1997). These
differences can be explained, partially by the presence of high blood pressure, diabetes,
elevated serum lipids and, possibly congestive heart failure (Zoratti, 1998; AHA
Statistical Update, 2002). Other factors such as age, gender, low socio-economic status,
and prior medical conditions have been associated with longer pre-hospital delays in
seeking medical care for symptoms of a heart attack (AHA statistical Update, 2002).
It is important to monitor the health status of ethnic groups. The US population
profile is changing and, by the year 2010, the percentages of African Americans,
Hispanics and other minority groups are expected to increase (HP 2010). However,
race/ethnic gaps in health care and inadequate access to health care assistance will remain
if appropriate intervention programs are not instituted (HP, 2010).
African Americans, Foreign-born and US-born Afro Caribbean Americans
The non-Hispanic Black population of over 35 million persons is the nation's
second largest ethnic group, comprising 12.3% of the entire United States (US)
population (US Census, 2000). This population is heterogeneous and includes several
groups with different cultural backgrounds such as African Americans, Afro Caribbean
Americans (US-bom Afro Caribbeans), Afro Caribbean migrants and other foreign-born
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individuals of African ancestry (US Census, 2000). The estimated foreign-born
population of the US, in March 2000, was 28.4 million with over 2.8 million foreign-born
Caribbean Nationals (US Census Bureau: Current Population Reports [P23-206], 2001).
In March 2002, the population of foreign-born Caribbean Nationals was estimated to be
over 3.1 million with 55% living in South Florida (US Census Bureau: Current
Population Report [P20-539], 2003).
Caribbean migrants are a diverse group of individuals from the Caribbean region,
which stretches from Florida to Venezuela. This region includes independent states such
as Antigua/ Barbuda, the Bahamas, Barbados, Belize, Cuba, Dominica, Dominican
Republic, Grenada, Guyana, Jamaica, Montserrat, St. Christopher/Nevis, St. Lucia, St.
Vincent/Grenadines, Trinidad & Tobago, Haiti and the US territory of Puerto Rico. Some
of the islands, such as the Cayman Islands (Britain), Turks and Caicos Islands (US), the
Virgin Islands (US) and, Martinique (France) are still under foreign control. Most of
these islands are south of the State of Florida, between longitudes 85W and 59W and
latitudes 1ON and 25N. Belize and Guyana are on the mainland of Central and South
America, respectively. Jamaican and Haitians are the two major groups contributing to
the Afro Caribbean population in the US. Jamaicans are concentrated in Fort Lauderdale
(46%), New York (40%), Nassau-Suffolk (39%), Washington DC (49%) and Atlanta
(53%), whereas Haitians are more populous in Miami (61%), West Palm Beach (62%),
Boston (57%) and Newark (50%) (Logan and Deane, 2003).
Of the estimated 3.1 million foreign-born Caribbean Nationals living in the US,
over 1.5 million are classified as Afro Caribbean and, since 1990, the Afro Caribbean
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population has increased by over 60% from 924,697 in 1990 to 1,542,895 in 2000 with
60% being foreign-born (Table 1) (US Census, 2000; Logan and Deane, 2003).
Table 1 - Composition and Growth of the non-Hispanic Black Populations of the
US, 1990 - 2000
Population (000) Percent of Black Percent of Total Growth
Population (%) Population (%) (%)
1990 2000 1990 2000 1990 2000 1990/2000
AA 28,034 33,048 96.0 93.9 11.3 11.7 17.9
AC 924 1,542 3.2 4.4 0.4 0.5 66.9
African 229 612 0.8 1.7 0.1 0.2 166.9
NHB 29,188 35,203 11.7 12.5 20.6
Total US 248,709 281,421 100.0 100.0 13.2
Source: US Census, 2000; Logan and Deane, 2003 (Adapted)
AA= African Americans
AC= Afro Caribbean
NHB= Non-Hispanic Black
In Florida, Miami has the highest proportion of foreign-born individuals. This
population will increase in the future as migrants form families. One indication of this is
the increase in the proportion of births to foreign-born women residing in the US from
6% in 1970 to over 20% in 1999 (US Census Bureau: Current Population Survey
[CENBR], 2002). Individuals from the Caribbean Region are the fastest growing ancestry
group in Broward, Palm Beach and Miami-Dade Counties in South Florida (US Census,
2000). For the year 1990 to 2000, the Caribbean population grew by 173% (from 55,197
to 150,476) in Broward County, 142% (from 20,441 to 49,402) in Palm Beach County
and 45% (from 105,477 to 153,255) in Miami-Date County (US Census, 2000). In spite
of this increase in the foreign-born population of the US, there are relatively few studies
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investigating differentials in nutrition/health and mortality patterns between foreign-born
and US-born individuals (Singh and Siahpush, 2002), especially Caribbean Americans.
In 2000, the average African American had a lower median household income
($35,679 versus $41,321) and educational attainment (17.5% college education versus
20.3% college education) compared to Afro Caribbeans. Also, more African Americans
were unemployed (11.2% versus 8.7%) and below the poverty threshold (30.4% versus
18.8%) compared to Afro Caribbeans. However, more African Americans owned their
homes (53.1% versus 49.8%) compared to Afro Caribbeans (Table 2) (Logan and Deane,
2003).
Table 2 - Socio-economic Characteristics of the Non-Hispanic Black Populations in
Comparison with Other US Racial and Ethnic Groups, 1990 - 2000
Population Foreign- Years of Median Unemploye Below
(000) born (%) Education Household d (%) Poverty
Income (%)
1990
AA 28,034 1.8 11.7 $29,251 12.5 32.8
AC 924 72.4 12.1 $42,927 9.4 17.8
African 229 72.1 14.3 $35,041 8.5 24.7
NHB 29,188 4.7 11.7 $29,850 12.3 32.3
2000
AA 33,048 2.2 12.4 $33,790 11.2 30.4
AC 1,542 68.3 12.6 $43,650 8.7 18.8
African 612 78.5 14.0 $42,900 7.3 22.1
NHB 35,203 6.4 12.5 $34,300 11.0 29.7
Source: Logan and Deane, 2003 (Adapted)
AA= African Americans
AC= Afro Caribbean
NHB= Non-Hispanic Black
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Genetics, cultural patterns and behavioral/environmental factors may influence
differences in morbidity and mortality from diet-related diseases in this population
(Kumanyika, 1993; Department of Health and Human Services [DHHS], 1991). Also,
subgroups within this Black population may have different cultural and lifestyle habits
that may influence the direction of risks and risk factors for CHD.
During the past two decades, changes in dietary, nutrition and health behaviors
(Popkin, 1994) have occurred in the Caribbean, reflective of the close ties with the US
and the introduction of American dietary and behavioral habits in the region. The
consequences of these transitions have been an increase in chronic degenerative
conditions, such as cardiovascular disease, diabetes mellitus and obesity, now the main
causes of death (Sinha, 1995; Jackson, 2001; Henry, 2001).
Most of the studies investigating risk factors for CHD (including CRP levels and
TC/HDL-C ratio) have been done with adults aged between 40 and 84 years. There is a
dearth of information on CHD risk factors (such as obesity, cigarette smoking, blood
pressure values, blood glucose and lipids levels) in foreign-born and US-born Caribbean
Americans. Also, the influence of diet, physical activity, perceived stress and knowledge
of CHD on traditional risk factors for CHD is unknown in this population. In addition,
there is no information on CRP levels and TC/HDL-C ratio in this population.
Nutritional and health information on African Americans may not be applicable to
Caribbean migrants and Caribbean Americans. Caribbean migrants may have different
health perceptions, beliefs, behaviors, dietary habits and propensities to influence
nutritional/health conditions compared to African Americans and possibly Caribbean
Americans. Also, there may be differences in exposure to knowledge about CHD,
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physical activity and stress. These differences may be distinguishing features among the
groups and, may influence risk factors for cardiovascular disease between the population
groups (Curtis and Lawson, 2000).
Thus, the Healthy People 2010 Heart Disease and Stroke (HP 2010: Priority 12)
goal is to improve cardiovascular health and quality of life through the prevention,
detection, and treatment of risk factors; early identification and treatment of heart attacks
and strokes, and prevention of recurrent cardiovascular events in the US (HP 2010).
Risk Factors for CHD
Risk factors are characteristics, attributes or behaviors that increase an
individual's risk or chances of developing or dying from a disease. There are several
well-known modifiable and non-modifiable risk factors for CHD. Modifiable risk factors
are those attributes or behaviors that increase our risk of developing or dying from CHD.
These include an atherogenic diet (poor nutrition), physical inactivity, overweight and
obesity, stress, tobacco use, elevated blood pressure, blood glucose and lipids. Each of
these behaviors or conditions can be changed with appropriate intervention (AHA
Statistical Update, 2002; NCEP: ATP III, 2001). In the absence of these risk factors death
from CHD is non-existent (Beaglehole et al., 2001). Non-modifiable risk factors for CHD
are those that cannot be changed and include advancing age, gender (males are at higher
risk of CHD compared to females), and family history of CHD (AHA Statistical Update,
2002; NCEP: ATP III, 2001). Additionally, the population attributable risk percent
(PAR%) represents the percentage of all CHD deaths that could be avoided if a particular
risk factor was eliminated from the population. For example, in Florida during 2001,
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elevated cholesterol and physical inactivity were responsible for an estimated 43% and
35% of all CHD deaths, respectively (Table 3) (FLDH, 2001).
Table 3 - Population Attributable Risk Percent for CHD and Stroke
Population Attributable Risk CHD Stroke
Physical inactivity 35% *
Obesity 17% 20%
Cigarette use 22% 12%
High blood pressure 25% 26%
Diabetes 8% 3%
Elevated cholesterol 43% 10%
*Data not available
Source: FLDH, 2001
Socio-demographic Variables
Age
As individuals age there is a progressive accumulation of coronary plaque due to
cumulative exposure to CHD risk factors, both known and unknown. The plaque can
rupture, causing acute coronary events such as unstable angina or myocardial infarction,
and/or increase in size causing coronary obstructive symptoms, such as angina pectoris
(NCEP: ATP III, 2001).
Gender
At any given age males have a greater risk for CUD and stroke than females
(Wilson et al., 1998; NCEP: ATP III, 2001; AHA Statistical Update, 2002). The
incidence of CHD in women lags behind men by 10 years for total CHD and by 20 years
for more serious clinical events such as myocardial infarction and sudden death. The
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reasons for a gender difference in risk for CHD are not fully understood. It is suggested
that the amount of sex hormones in the blood may influence the risk of CUD and stroke
(AUA Statistical Update, 2002). There is evidence suggesting that men suffer more CHD
events than women before women reach the age of menopause. If menopause is caused
by surgery to remove the uterus and ovaries, the risk of CHD rises sharply, however, if
menopause occurs naturally, the risk rises more slowly (AUA Statistical Update, 2002).
Socio-economic Status (SES) and Stress
Individuals with lower income and educational levels have a higher risk for stroke
and CHD (AUA Statistical Update, 2002; Kaplan and Keil, 1993). African American and
non-Hispanic White males with lower socio-economic status (SES) have been shown to
have a higher risk of death from CHD than non-Hispanic White males of higher SES
(Tyroler et al., 1984). Inversely, Keil et al (1984) showed that African American males
with high SES had half the CHD of other African-American males and, experienced no
angina pectoris, acute myocardial infarction (AMI) death or sudden death during the
observation period of the study. Obviously, there are marked socio-economic differences
in CHD morbidity and mortality (Wood et al., 1998). This may be partly explained by
socio-economic differences in CHD risk factors such as smoking, blood pressure levels,
blood lipid and glucose levels (Jacobson and Thelle, 1988; Luepker et al., 1993). Another
suggestion is that individuals from lower socio-economic groups may have poorer health
habits and health knowledge (Wood et al., 1998). Other researchers have shown that SES
may be associated with higher cumulative levels of stress and that biological reaction to
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this stress may contribute to hypertension (Kington and Smith, 1997; Williams, 1992),
overeating and/or increase in cigarette smoking (AHA Statistical Update, 2002).
Knowledge of Risk Factors for CHD
Little is known about the attitudes and knowledge of CUD risk factors in
individuals and the factors will motivate individuals to effect changes in their behaviors
in an attempt to reduce the onset of chronic diseases, such as CHD (Shepherd, 1998;
Erhardt and Hobbs, 2002). The Heart European Leaders Panel (HELP) study in 5
European countries (France, Germany, Italy, Sweden, United Kingdom) showed that a
considerable degree of indifference to CHD existed, despite the possession of a
reasonable level of knowledge of CHD risk factors, even among individuals with CHD
(Shepherd, 1998). In a survey (Hyman et al., 1993) conducted to examine cholesterol-
related knowledge, attitudes and behaviors among 547 randomly selected individuals 18
years and older, 76% reported knowledge of high blood or serum cholesterol whereas
30% had never had a cholesterol screening. The individuals consisted of Hispanics
(54%), African-Americans (28%), non-Hispanic Whites (14%), Asians and Native
Americans (4%). From this same study, 30% of Hispanics reported that they never read
food labels, which was approximately double the percentage of African-Americans and
non-Hispanic White individuals who did not. In a study conducted by Levy et al (1993)
consumer knowledge about dietary fat and cholesterol was poor. This suggested a
relatively low level of awareness of risk factors for CHD. In a study by Gates and
McDonald (1997) ethnic differences were found in knowledge, attitudes and nutrient
intakes related to CVD. In this same study, compared to non-Hispanic White females,
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African American females consumed poorer diets, were less aware of the relationship
between nutrient intakes and health and had less knowledge about food sources of fat and
cholesterol. However, these African-American females were more aware of the need to
change their diets and were more likely to report that nutrition was important when they
shop for food than the non-Hispanic White females. Compared to non-Hispanic Whites,
African Americans and other ethnic groups disproportionately have higher prevalence of
poverty, lack of education and lack of access to health care thus, exposing them to greater
risk of chronic diseases (Gates and McDonald, 1997). There is no available data
comparing knowledge of CHD risk factors differentials between foreign-born and US-
born Afro Caribbean Americans.
Family History of Premature CHD
There is evidence to indicate that a family history of premature CHD (definite
myocardial infarction or sudden death before 55 years of age in father or other male first-
degree relative, or before 65 years of age in mother or other female first-degree relative,
is an independent risk factor for coronary events even when other risk factors are absent
(Benson et al., 1999; Li et al., 2000; Williams et al., 2001). The relative risk for CHD in
first-degree relatives has been reported to range from 2 to as high as 12 times that of the
general population (NCEP: ATP III, 2001; Phillips et al., 1974; Rissanen, 1979) and, that
risk increases with the number of primary relatives affected and at younger ages of onset
of the coronary event (Pohjola-Sintonen et al., 1998; Rissanen and Nikkila, 1977).
Children of parents with heart disease are more likely to develop the condition
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themselves, probably due to shared socio-cultural environment, exposures to similar
behavioral habits and genetics (NCEP: ATP III, 2001).
Many prospective cohort and case-control studies, including the recent
Atherosclerosis Risk in Communities Study (ARIC) in four US communities, have shown
family history of CHD to be independent of the traditional risk factors (Benson et al.,
1999; Sharrett et al., 1999). Many risk factors for CHD are under genetic control (such as
blood pressure, serum lipids and obesity), but they account for only a portion of the
aggregation of CHD seen in families (Snowden et al., 1982; Khaw and Barrett-Connor,
1986). A positive family history of CHD captures the underlying complexities of gene-
gene and gene-environment interactions by identifying families with combinations of risk
factors, both measured and unmeasured, that lead to disease expression. Also, a positive
family history of CHD identifies the relatively small subset of families in the population
at highest risk for CVD who may benefit most from targeted screening and intensive
intervention (Hunt et al., 2003). However, the use of family history of CHD in risk
evaluation has created some debate (Gotto et al., 2000). For example, in the US,
guidelines (NCEP: ATP III, 2001) consider family history of CHD to be an important
non-modifiable risk factor for CHD, whereas in Europe, calculations do not generally
adjust for family history of CHD but only note that a positive family history for CHD
increases the predicted risk (Gotto et al., 2000).
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Behavioral/Environmental Risk Factors for CHD
Atherogenic Diet
Poor nutrition and physical inactivity together are the second leading preventable
cause of death in the US. Poor nutrition and physical inactivity are responsible for an
estimated 300,000 deaths each year and are causally related to a variety of chronic
diseases and conditions, including overweight and obesity, high blood pressure,
hyperglycemia and diabetes, hypercholesterolemia, CHD, stroke, osteoarthritis and some
cancers (FLDH, 2001). Dietary habits can modify and/or influence CHD and stroke risk
factors in the population (United States Department of Agriculture [USDA], 2000;
Krauss et aL., 2000). For example, dietary intakes high in saturated fatty acids and
cholesterol can influence LDL and HDL- cholesterol and obesity whereas high salt
intakes can influence blood pressure in high-risk populations (NCEP: ATP III, 2001).
Krauss et al. (2000) have also indicated that populations consuming diets high in fruits,
vegetables, whole grains and unsaturated fatty acids may be at lower risk for many of the
chronic degenerative conditions, such as CHD, obesity, hypertension and diabetes. The
particular nutrients that influence this lower risk have not been adequately defined,
however fiber (both soluble and insoluble) (Pimm et al., 1996a), antioxidant nutrients,
such as carotenoids, flavanoids, Vitamins C and E, B-complex of vitamins, omega-3 fatty
acids and other micronutrients have been implicated (Krauss et al., 2000). Also,
components of antioxidant enzymes, such as selenium and copper can act singly or
jointly to protect the arterial vessels from oxidative damage and, thus may influence CHD
risk (Gey et al., 1993).
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Fatty Acids and Dietary Cholesterol: The American Heart Association recommends a
diet low in saturated fat, trans fat, cholesterol and sodium and high in vegetables, fruits,
whole grains, legumes, fat-free or low-fat dairy products, and dietary fiber (AHA
Statistical Update, 2002). The total fat (saturated, trans, monounsaturated,
polyunsaturated) intake should be less than 30% of total daily calories, saturated fat and
trans fat should not exceed 10% of total daily calories for healthy individuals. There is
evidence from animal experiments, observational studies, clinical trials and metabolic
studies conducted in different populations showing a strong and consistent relationship
between dietary fats and CVD, especially CHD (Kris-Etherton et al., 2001 a). Saturated
fatty acids raise total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-C),
however, individual fatty acids may have different effects (Katan et al., 1996; Mensink et
al., 1992). Monounsaturated fatty acids (MUFA) and n-6 polyunsaturated fatty acids
(PUFA) have been shown to reduce TC and LDL-C levels (Kris-Etherton, 1999). Hu et
al. (1997), using 14-year follow-up data from the Nurses' Health Study, have shown that
intakes of MUFA and PUFA were inversely associated with CHD risk, whereas saturated
and trans fats were positively associated with CHD risk.
Between 1965 and 1991, total fat as a proportion of daily calorie intake and
saturated fat intakes fell from 39.1% to 33.1% and 14.4% and 11.0%, respectively among
US adults 18 years and older. The average daily total fat intake in the US was 81.4 grams
(96.5 g for males and 67.3 g for females). Non-Hispanic Whites had higher total fat
intake (82.7 g) (99.0 g for males and 67.4 g for females) compared to non-Hispanic
Blacks (82.0 g) (94.6 g for males and 71.2 g for females) (NHANES III, [1988-94]). The
average daily saturated fat intake in the US was 27.9 g (33.1 g for males and 23.0 g for
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females). Non-Hispanic Whites also had higher saturated fat intake (28.4 g) (34.1 g for
males and 23.1 g for females) compared to non-Hispanic Blacks (27.5 g) (31.7 g for
males and 23.8 g for females).
Dietary cholesterol elevates plasma cholesterol levels (Hopkins, 1992), however,
its association with CHD is still controversial (Hu et al., 1999). The recommended daily
intake of dietary cholesterol for adults is less than 300 milligrams (mg) (NHANES
III,[1988-1994]). The average daily intake of dietary cholesterol in the US was 269.6 mg
(323.5 mg for males and 218.9 mg for females). Non-Hispanic Blacks consumed more
dietary cholesterol (297.9 mg) (358.8 mg for males and 245.6 mg for females) than non-
Hispanic Whites (259.3 mg) (312.6 mg for males and 209.1 mg for females) (NHANES
III, [1988-94]).
Dietary Fiber: Dietary fiber (soluble fiber-pectins, gums, mucilages, hemicelluloses;
insoluble fiber-cellulose, hemicelluloses) has been shown to reduce TC and LDL-C
(Anderson and Hanna, 1999). Several studies have demonstrated that a high fiber diet
lowers the risk of CHD (Trushwell, 2002; Liu et al., 1999; Pietinen et al., 1996; Rimm et
al., 1996). The recommended daily intake of fiber is 25 g or more while the average daily
consumption of fiber in the US is 15.6 g (17.8 g for males and 13.6 g for females)
(NHANES III,[1988-1994]). Non-Hispanic Blacks (13.4 g) (15.0 g for males and 12.0 g
for females) consumed less fiber non-Hispanic Whites (15.8 g) (18.1 g for males and 13.7
g for females) (NHANES III, [1988-94]).
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African Americans and Afro Caribbeans Eating Habits
The African American diet tends to be low in fruits and vegetables and high in
fats and salt (Kant et al., 1991). Favorite food items of African Americans include fried
chicken, barbecued ribs, corn bread, sweet potato pie, collard greens, and fruit-flavored
drinks and juices (Kitler and Sucher, 2001). In addition, cookies or candies are preferred
snack items (Kitler and Sucher, 2001). African Americans have adopted the traditional
southern cuisine, known as "soul food", as an emblem of identity and recognition of
Black history.
The traditional Caribbean diet is high in fiber and low in saturated fats and high in
salt (Lemic-Stojcevic et al., 2001; Sharma et al., 1999). There are studies indicating that
as individuals migrate from their region of origin to another country or region, they
eventually practice the dietary habits of the dominant society (Sharma et al., 1999;
Robertson et al., 1977; Gerber and Madhaven, 1980; Gerber, 1980). There is also
evidence that as populations become more affluent they will also practice the dietary
habits of more developed countries and experience increases in chronic degenerative
conditions such as CHD, stroke, diabetes, obesity and some types of cancers (Sinha,
1995; Henry, 2001; WHO, 2000; Sharma et al., 1999). Sharma et al (1999) investigated
nutrient intake trends among 102 male and 153 female Afro Caribbeans in Britain of
which 18% were born in England (second generation Afro-Caribbeans), 60% in Jamaica,
6% in Barbados and 14% in other eastern Caribbean islands. They found that Caribbean-
born individuals (mean age 56 years, mean time in Britain 30 years) had significantly
lower percent of energy from total fat (31.3%) and saturated fat (10.9%) than younger
(mean age 29 years) British-born Afro Caribbeans (35% and 12.6%), respectively. The
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Caribbean-born individuals also ate more fruits (an additional 84 g per day) and
vegetables (an additional 26 g per day) compared to British-born Afro Caribbeans. More
than 30% of the adult population in Florida does not consume enough fruits and
vegetables (FLDH, 2001). There is insufficient data on the dietary habits of Afro
Caribbeans/Caribbean Americans living in the US.
Physical Activity/Inactivity
There are studies indicating that physical activity lowers LDL-C and TG levels,
raises HDL-C cholesterol levels, improves insulin sensitivity and lowers blood pressure
(Blair et al., 1983; King and Kriska, 1992; Helmrich et al., 1991; Haskell et al., 1994;
NCEP: ATP III, 2001). Conversely, there is evidence indicating that physical inactivity is
a major risk factor for CHD (NCEP: ATP III, 2001; Fletcher et al., 1994; US Surgeon
General Report, 1996). The relative risk of CHD associated with physical inactivity
ranges from 1.5 to 2.4, an increase in risk comparable to that observed for high blood
pressure, high blood cholesterol or cigarette smoking (AHA Statistical Update, 2004;
Pate et al., 1995). The mechanisms whereby physical inactivity raises the risk for CHD
are not fully understood and may be multi-factorial in nature (NCEP: ATP III, 2001).
Individuals who are physically inactive reduce their caloric expenditure and this may
contribute to obesity and its associated lipid and non-lipid risk factors (Grundy et al.,
1999a) as well as to insulin resistance (Perseghin et al., 1996).
In the US, during the years 1997-1998, 38.3% of adults 18 years and older
reported no physical activity, 61.7% reported some activity but not enough to achieve
recommended levels whereas, only 22.7% were reportedly engaged in light-moderate
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physical activity at least five times per week (AHA Statistical Update, 2004). Physical
inactivity is more prevalent among women than men, among non-Hispanic Black men
(46.0%) and women (57.1%) and, Hispanic men (49.9%) and women (57.1%) than non-
Hispanic White men (33.3%) and women (38.9%), among older than younger adults and
among less affluent than the more affluent (AHA Statistical Update, 2004; USA Surgeon
General's Report, 1996). A recent study of over 72,000 female nurses indicated that
moderate-intensity physical activity, such as walking is associated with substantial
reduction in risk of total and ischemic stroke when compared with physical activity done
at an average or casual pace (Hu et al., 2000). In Florida, the percentage of adults who
have no leisure-time physical activity (70% - 80%) has remained stable over the past 10
years (FLDH, 2001). However, there is no data on the prevalence of physical activity
among the Caribbean Americans living in the US.
Body Weight and Obesity
Overweight is defined as a body mass index (BMI= weight in kg divided by the
square of height in meters) of 25-29.9 kg/i 2 and obesity as BMI ? 30 kg/m 2 (Obesity:
Class I BMI 30.0-34.9 kg/m2; Class II BMI 35.0-39.9 kg/m 2; Class III BMI 40.0
kg/i 2). Over 108 million Americans age 20 years and older are overweight (over 55
million men and over 52 million women), with over 44 million being obese (over 18
million men and over 25 million women) (National Institutes of Health, 1998a,b; AHA
Statistical Update, 2002; NCEP: ATP III, 2001). In addition, over 5 million children
between the ages of 6-17 are overweight (based on the 9 5 th percentile of BMI values:
CDC growth chart for the US, 2000). The annual total cost of obesity-related disorders in
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the US is over $100 billion. As BMI values increase, the average blood pressure and total
cholesterol levels increase, whereas the average HDL-C levels decrease (HP, 2010).
Individuals who are overweight or obese are at increased risk of all-cause
mortality from CHD, stroke (Calle et al., 1999), high blood pressure (Blair et al., 1984),
lipid disorders (Denke et al., 1993), type 2 diabetes mellitus (NCEP: ATP III, 2001; AHA
Statistical Update, 2004), gallbladder disease, osteoarthritis, sleep apnea and other
respiratory disorders and certain cancers (NIH, 1998a,b; HP, 2010; NCEP: ATP III
2001). Evidence from the Framingham Heart Study has indicated that obesity is strongly
predictive of CHD and that risk for cardiovascular disease is increased when abdominal
obesity is present (abdominal obesity defined as waist circumference > 102 cm [> 40
inches] in men and > 88 cm [> 35 inches] in women) (NIH, 1998a,b)- Similarly, Han et al
(1995) have shown that waist circumference, waist-to-hip ratio and BMI were positively
correlated with measures of CHD risks such as blood pressure or blood lipids.
The age-adjusted prevalence of overweight in the US during 2001 increased from
55.9% in NHANES III (1988-1994) to 64.5% in NHANES IV (1999-2000). The
prevalence of obesity also increased during this period from 22.9% to 30.5%, whereas
extreme obesity (Class III obesity) increased from 2.9% to 4.7% (AHA Statistical
Update, 2004; Flegal et al., 2002). During this same period, the age-adjusted prevalence
of overweight in the US was higher in non-Hispanic White men (67.4%) compared to
non-Hispanic Black men (60.7%) but, higher in non-Hispanic Black women (77.3%)
compared to non-Hispanic White women (57.3%). The age-adjusted prevalence of
overweight in Mexican-American males and females was 74.7% and 71.9%, respectively.
The age-adjusted prevalence of obesity in non-Hispanic ite men (27.3%) and women
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(30.1%) was lower compared to non-Hispanic Black men (28.9%) and women (49.7%),
whereas the age-adjusted prevalence of obesity in Mexican-American males and females
was 28.9% and 39.7%, respectively (AHA Statistical Update, 2004; Flegal et al., 2002).
Other developed countries are experiencing similar increases and developing
countries are showing increases in the incidence and prevalence of obesity and
overweight as they become more affluent (Flegal et al., 2002; WHO, 2000b). The
prevalence of obesity in Caribbean males is estimated to be 7-12% whereas the range in
females is estimated to be 20-48% (Henry, 2001). In England, there is evidence showing
higher age-adjusted prevalence of obesity (average 36.3%) in Afro Caribbeans compared
to Whites (average 28.7%) (Dundas et al., 2001; Cappuccio et al., 1997). Singh and
Siahpush (2002) have shown that the percentage of a composite migrant Black population
(25.2%) that was overweight was lower compared to their US-born counterparts (38.4%).
In Florida during the year 2002, more than 57% of the adult population was overweight,
whereas 19.4% was obese (FLDH, 2001). More non-Hispanic Blacks (39.5% and 32.3%)
were overweight and obese compared to non-Hispanic Whites (36.0% and 18.0%),
respectively (FLDH, 2001). However, data relating to overweight and obesity
differentials in foreign-born and US-born Afro Caribbeans in Florida is non-existent.
Cigarette Smoking and Alcohol Consumption
In the US, tobacco use is the leading preventable cause of death (FLDH, 2001).
There is ample evidence to support the claim that cigarette smoking is a contributor to the
risk for CHD and other forms of CVD (Kannel et al., 1980; Colditz et al., 1988; LaCroix,
1991; McBride, 1992; Jonas et al., 1992; Py6rala et al., 1994). This relationship is dose
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related and smoke cessation will reduce the risk for CVD events within months of
quitting (US Surgeon General Report, 1990). According to the American Heart
Association (AHA Statistical Update, 2002), the risk of CHD is reduced up to 50% one
year after smoke cessation and, within 15 years, the relative risk of dying from CHD of
an ex-smoker approaches that of a lifetime non-smoker.
The age-adjusted prevalence of smoking in Americans 18 years and older is
25.2% (25, 600,000) in males and 20.7% (22,600,000) in females putting them at
increased risk for CHD and stroke (Health United States, 2001; AHA Statistical Update,
2004). The use of tobacco products in the year 2001 was higher in non-Hispanic Whites
(31.3%) compared to non-Hispanic Blacks (27.7%) (AHA Statistical Update, 2004). A
similar trend was seen in England where more Whites (31.2%) were current smokers
compared to Afro-Caribbeans (22.6%) (Dundas et al., 2001; Cappuccio et al., 1997).
There is also evidence showing that smoking prevalence is highest among those with 9-
11 years of education (35.4%) compared with those with more than 16 years of education
(11.6%) and is highest among individuals living below the poverty level (33.3%)
compared with other income groups (MMWR, Vol 48, No. 43, 1999; AHA Statistical
Update, 2004). Singh and Siahpush, (2002) reported that the percentage of foreign-born
Blacks who were current smokers was lower (10.4%) compared to US-born Blacks
(29.3%).
Alcohol Consumption
There is a complex relationship (J-shaped) between alcohol consumption and
CHD (Pearson et al., 1996). Individuals who consume three or more alcoholic beverages
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each day, total mortality increases with the total number of drinks per day, whereas the
lowest mortality, a reduction in risk of approximately 30% to 50% occurs in those who
consume one or two drinks per day (Bradley et al., 1993). In Florida, 6.4% of individuals
reported heavy drinking (the consumption of > 2 drinks/day for men and > 1 drink/day
for females during the past month). In the Miami-Miami Beach-Kendall section of
Florida, 3.5% of individuals reported heavy alcoholic beverage consumption (MMWR,
2004). There is limited data on the drinking habits of Afro Caribbean Americans.
Bio-physiological Risk Factors for CHD
Blood Pressure and Hypertension
High blood pressure (HBP) (hypertension) is traditional defined as systolic blood
pressure (SBP) of 140 mmHg or greater and/or diastolic blood pressure (DBP) of 90
mmHg or greater or current use of antihypertensive treatment (6 th Report of the Joint
National Committee on Prevention, Detection, Evaluation and Treatment of High Blood
Pressure [JNC VI], 1997). However, a recent report (JNC VII, 2003) has classified
normal BP as SBP < 120 mm Hg and/or DBP < 80 mm Hg and, has added a new
category, designated pre-hypertension (SBP 120-139 mm Hg OR DBP 80-89 mm Hg)
(Table 4).
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Table 4 - Classification of Blood Pressure for Adults Aged 18 Years and Older
BP Classification Systolic BP, mm Hg* Diastolic BP, mm Hg*
Normal <120 and <80
Pre-hypertension 120-139 or 80-89
Stage 1 Hypertension 140-159 or 90-99
Stage 2 Hypertension 160 or > 100
Adapted from JNC VII, 2003).
*Treatment determined by highest BP category.
Hypertension is a major risk factor for CHD, stroke, kidney failure and heart
failure (JNC VI, 1997). Systolic blood pressure is now being recognized as a more potent
predictor of CHD than DBP, especially in older adults (Kannel et al., 1980; Systolic
Hypertension in the Elderly Program [SHEP], 1991). About 50 million persons, in the
US, age 6 years and older have high blood pressure (AHA Statistical Update, 2002;
NHANES III, 1988-1994). Of those with HBP, 30% are unaware they have it, 34%
controlled with medication, 25% are on medication but do not have it under control and,
11% are not on medication (JNC VII, 2003). High blood pressure is associated with
physical inactivity, high salt and alcohol intakes, and low intakes of potassium and
calcium (FLDH, 2001). Control of HBP through weight loss, dietary, behavior or
medication changes has been shown to be very effective in reducing the risk of CHD
(FLDH, 2001). Individuals with lower educational and income levels tend to have higher
blood pressure compared to those with higher educational and income levels (AHA
Statistical Update, 2002).
The overall death rate from HBP in the US in 2001 was 16.5/100,000 population.
However, death rates for African American males and females were higher (47.8 and
38.9/100,000 population, respectively), compared to White males and females (13.7 and
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13.4/100,000 population, respectively) (AHA Statistical Update, 2004). African
Americans develop HBP earlier in life and their average blood pressures are higher than
Whites. Thus, African Americans have 1.3 times greater rate of non-fatal stroke, 1.8
times greater rate of fatal stroke, 1.5 times greater rate of heart disease death and 4.2
times greater rate of end-stage kidney disease compared to Whites (JNC VI, 1997). The
death rates from hypertensive disease in the Caribbean during 1987-1991 were much
higher than those seen in the US and Canada during the same period (Sinha, 1995).
The age-adjusted prevalence of HBP in individuals 20 years and older in 2001, in
the US, was higher in non-Hispanic Black males (41.6%) and females (44.7%) compared
to non-Hispanic White males (32.2%) and females (29.5%) (AHA Statistical Update,
2004). Data from England also indicate that Afro-Caribbeans have higher blood pressure
values compared to Whites (Lemic-Stojcevic et al., 2001; Cappuccio et al., 1997),
however, data in the US (Singh and Siahpush, 2002) showed the percentage of foreign-
born Blacks who had high blood pressure was lower (16.8%) compared to US-born
Blacks (25.5%). Cooper et al (1997a) investigating hypertension prevalence in
individuals of African Ancestry in the Caribbean and the US also showed the prevalence
of hypertension was lower in the Caribbean (26%) compared to the US (33%). There is
insufficient data on blood pressure differentials in foreign-born and US-born Afro
Caribbean Americans in Florida, however.
Fasting Blood Glucose, Metabolic Syndrome and Diabetes
Impaired fasting blood glucose level (110-125 mg/dL) is an indicator of insulin
resistance and is generally accompanied by other metabolic risk factors (Tripathy et al.,
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2000; NCEP: ATP III, 2001). Some individuals with impaired fasting blood glucose will
eventually develop type 2 diabetes (Lindahl et al., 1999), which further enhances the risk
for CHD. Type 2 diabetes is the epitome of the metabolic syndrome, characterized by
abdominal obesity, atherogenic dyslipidemia (elevated triglyceride, small low-density
particles, low high-density cholesterol), elevated blood pressure, insulin resistance,
prothrombotic and proinflammatory conditions (Table 5) (NCEP: ATP III, 2001). This
disorder is associated with increased risk of CHD and occurs in 24% of the US adult
population (Ford et al., 2002).
Table 5 - Clinical Identification of the Metabolic Syndrome*
Risk Factors Defining Level
Abdominal Obesity Waist circumferencet
Men > 40 in (> 102 cm)
Women >35 in (88 cm)
Triglycerides 150 mg/dL
HDL Cholesterol
Men < 40 mg/dL
Women <50 mg/dL
Blood Pressure 130/85 m Hg
Fasting Blood Glucose 110 mg/dL
* The ATP III panel did not find adequate evidence to recommend routine measurement of
insulin resistance (e.g., plasma insulin), proinflammatory state (e.g., high-sensitivity C-reactive
protein), or prothrombotic state (e.g., fibrinogen or PAI-1) in the diagnosis of the metabolic
syndrome.
t Some male persons can develop multiple metabolic risk factors when the waist circumference
is only marginally increased, e.g., 37-39 in (94-102 cm). Such persons may have a strong genetic
contribution to insulin resistance. They should benefit from changes in lifestyle habits, similarly
to men with categorical increases in waist circumference.
Source: NCEP: ATP III, 2001
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Diabetes Mellitus
A sustained blood glucose level equal to or greater than 126 mg/dL is indicative
of diabetes mellitus (Gavin et al., 1998). Diabetes mellitus (DM) is a multi-factorial
condition caused by inherited and! or deficiency in insulin production, by the p- cells of
the pancreas or, by ineffectiveness of the insulin produced. Sustained elevation of blood
glucose and abnormalities in the metabolism of carbohydrates, fats, and proteins can lead
to tissue and organ dysfunction and damage, especially in eyes, kidneys, nerves, and
blood vessels. Type 1 DM (insulin-dependent DM) (5% of diabetics) is characterized by
absolute lack of insulin whereas, Type 2 DM (non insulin-dependent DM) (90% of
diabetics) is characterized by insulin resistance and defects in insulin action. There are
other types (5%) of DM due to pregnancy, DM secondary to specific genetic syndromes,
drugs, malnutrition, infections and other medical conditions (Gavin et al., 1998; CDC
Diabetes Factsheets, 2000). Individuals with undiagnosed type 2 DM are at increased risk
for stroke, CHD, and peripheral vascular disease compared to the non-diabetic population
(American Diabetes Association [ADA], 2002). Obesity, impaired glucose tolerance,
habitual physical inactivity, stress, race/ethnicity, family history of DM, prior history of
gestational DM, hypertension, high-density lipoprotein cholesterol 35 mg/dL and/or a
triglyceride level >250 mg/dL, and advancing age are recognized risk factors for type 2
DM (CDC Diabetes Factsheets, 2000; ADA, 2002).
The prevalence of DM in adults globally was estimated to be 4.0% (135 million
individuals) in 1995 and, it is predicted to increase to 5.4% (300 million individuals) by
the year 2025 (HP 2010). In 2001, the prevalence of DM in the US was over 11 million
(5.5%) with nearly 6 million (2.9%) of these individuals unaware that they have elevated
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blood glucose (CDC Diabetes Factsheets, 2000; AHA Statistical Update, 2004). Over
600,000 individuals are diagnosed with DM each year. Diabetes accounts for over
200,000 deaths and $18.9 million in ambulatory visits annually (CDC Diabetes Data
Sheet, 2000). In the year 2001, the age-adjusted prevalence of DM in individuals 20 years
and older for non-Hispanic White males (5.5%) and females (4.7%) was lower compared
to non-Hispanic Black males (7.6%) and females (9.5%), with Hispanic males (8.1%) and
females (11.4%) having even higher prevalence (NHANES III, 1988-94; AHA Statistical
Update, 2004). A similar trend has been observed in Afro-Caribbeans in London who had
significantly higher (18.3%) glycosylated hemoglobin (HbAlc) levels compared to
Whites (7.0%) (Lemic-Stojcevic et al., 2001). Also, Cooper et al (1997) investigating
rates of non-insulin dependent diabetes mellitus (NIDDM) in individuals of African
Ancestry in Nigeria, the Caribbean, the US and the UK showed that the rates of NIDDM
were 2%, 9%, 11%, 11%, respectively. The prevalence of DM in the Caribbean is
estimated to range from 10-15% (Sinha, 1995).
In Florida, trends in DM mortality rate, showed an increase from 11.5/100,000
population in 1950 to 13.3/100,000 population in 2000, with DM mortality rates being
much higher in non-Hispanic Blacks (50%) compared to non-Hispanic Whites (18%)
(FLDH, 2001). The annual economic cost of DM in Florida in 2001 was over $6 billion
(FLDH, 2001). There is no published data on the blood glucose levels in Caribbean
Americans.
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Lipid Risk Factors - Serum Lipids
Observations about the role of lipids in cardiovascular disease were documented
as early as the mid to late 1800s. A century later, numerous clinical studies documented
increased amounts of blood cholesterol in atherosclerotic vessels as well as in the blood
of survivors of myocardial infarction. Studies in the 1950s demonstrated that serum
cholesterol levels showed a dose-response relationship to CVD death rates (Criqui and
Beatrice, 1998).
Total Cholesterol
In the US, more than 50 million adults have elevated blood cholesterol levels that
need medical attention (HP 2010; Sempos et al., 1993), whereas over 104 million have
blood cholesterol levels that are higher than desirable (200 mg/dL and higher) (NCEP:
ATP III, 2001; AHA Statistical Update, 2004). As blood cholesterol rises, so does risk for
CHD. In the Multiple Risk Factor Intervention Trial (MRFIT), the age-adjusted death rate
from CHD, in men, increased from 3.5/1,000 at a TC of 140 mg/dL to about 5.0/1,000 at
a TC of 200 mg/dL (Martin et al., 1986). Data from the Seven Countries Study also
supported this by showing an exponential relationship between CHD and higher levels of
TC (Verschuren et al., 1995). When other risk factors such as high blood pressure and
smoking are present, the risk will increase greatly. An individual's blood cholesterol
levels are also affected by age, gender, heredity and diet (AHA Statistical Update, 2004;
NCEP: ATP III, 2001). Mortality from CHD has been shown to begin with a blood
cholesterol level as low as 180 mg/dl, increasing as blood cholesterol increases,
especially above 200 mg/dL (Stamler et al., 1986). Evidence from research, in the 1980s,
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showed for the first time that lowering high blood cholesterol significantly reduces the
risk for heart attacks and heart attack deaths.
In the year 2001, the prevalence of TC (greater than 200 mg/dL) was lower in
non-Hispanic Black males (37.3%) and females (46.4%) compared to non-Hispanic
White males (51.0%) and females (53.6%) (AHA Statistical Update, 2004). There is
now evidence indicating that a 10% decrease in total cholesterol levels may result in an
estimated 30% reduction in the incidence of CHD (MM , 2000).
Similar trends in serum TC and HDL-C levels are seen in Afro-Caribbeans who
live in London (Lemic-Stojcevic et al., 2001). Lemic-Stojcevic et al. (2001) showed that
TC (6.0 mmol/L) and TG (1.77 mmol/L) levels in Whites were significantly (p <0.0001)
higher than in Afro-Caribbeans (5.55 mmol/L and 1.39 respectively). However, HDL-C
levels (1.59 mmol/L) in Afro-Caribbeans were significantly higher than values in Whites
(1.50 mmol/L).
Lifestyle changes that can help prevent or lower high blood cholesterol include
smoking cessation, a diet low in saturated fat and cholesterol, increasing physical activity
and reducing excess weight (HP, 2010; NCEP: ATP III, 2001). The Framingham study
(LaRosa et al., 1990) has shown that a treatment regime that lowers an individual's blood
cholesterol by 1% can be translated into a 2% reduction in CHD risk. It is suggested that
differences in lipid profile may account for some of the ethnic differences in CHD
mortality rates in the US population (Whitty et al., 1999). There is no standardized data
on the serum lipid levels of Caribbean Americans. These values may be different since
Caribbean Americans in the US may have different dietary and behavioral habits
compared to Afro-Caribbeans who live in England.
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The more risk factors one has, the greater the chance of developing CHD and
stroke. Also, the greater the level of each risk factor, the greater the risk. Even though
everyone with a serum cholesterol level greater than 240 mg/dL is considered at high
risk, a person with a TC of 300 mg/dL is at a much greater risk than someone with a total
cholesterol of 240 mg/dL (AHA Statistical Update, 2002). In the absence of these
traditional risk factors, death from cardiovascular causes is relatively rare (Beaglehole et
al., 2001).
Low-density Lipoprotein Cholesterol
High levels of Low-Density Lipoprotein Cholesterol (LDL-C), an atherogenic
lipoprotein that contains most of the body's cholesterol, is a powerful risk factor for CHD
(NCEP: ATP 111, 2001). There is evidence indicating that individuals who have very
low levels of LDL-C throughout life due to familial hyperbetalipoproteinemia have an
extended life span (NCEP: ATP III, 2001; Glueck et al., 1976). In individuals with the
genetic forms of hypercholesterolemia advanced coronary atherosclerosis and premature
CHD occur even in the complete absence of other risk factors (Brown and Goldstein,
1986; Austin et al., 2000a; NCEP: ATP III, 2001). These disorders provide the strongest
evidence that LDL-C is a powerful atherogenic lipoprotein (NCEP: ATP III, 2001). The
Framingham Heart Study (Wilson et al., 1998), the Multiple Risk Factor Intervention
Trial (MRFIT) (Stamler et al., 1986), and the Lipid Research Clinics (LRC) trial (Lipid
Research Clinics Program 1984a,b) have shown a direct relationship between LDL-C (or
TC) and the rate of new onset of CHD in men and women who were initially free of
CHD. Any LDL-C levels above 100 mg/dL appear to be atherogenic (NCEP:ATP III,
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2001). Atherosclerosis proceeds at a significant rate when LDL-C is between 130-159
mg/dL whereas above 160 mg/dL it is markedly elevated. These relationships have been
confirmed by the log-linear relationship between serum cholesterol levels and CHD risk
observed in many populations (Law et al., 1994b; Law, 1999).
In the US, the mean LDL-C level of adults 20 years and older is 127 mg/dL. In
the year 2001, the prevalence of LDL-C 130 mg/dL and higher was higher in non-
Hispanic White males (49.6%) and females (43.7%) compared to non-Hispanic Black
males (46.3%) and females (41.6%) (AHA Statistical Update, 2004). There is no
published data on LDL-C levels in foreign-born and US-born Afro Caribbeans.
Serum Triglycerides
There is evidence, albeit inconsistent indicating a positive relationship between
serum triglyceride (TG) levels and incidence of CHD (Austin et al., 1998; Assmann et al.,
1998a; NCEP: ATP III, 2001). However, the NCEP: ATP III (2001) Guidelines give
increased weight to elevated TG in cholesterol management as a marker for atherogenic
remnant lipoproteins and as a marker for other lipid and non-lipid risk factors in the
metabolic syndrome.
High-density Lipoprotein Cholesterol
There is strong epidemiological evidence indicating that low levels of High-
Density Lipoprotein Cholesterol (HDL-C) increase CHD mortality and morbidity
(Wilson et al., 1998; Gordon et al., 1989; NCEP: ATP III, 2001). Levels of HDL-C above
60 mg/dL are considered desirable and cardio-protective, whereas levels below 40 mg/dL
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are considered a risk factor for CHD and stroke (NCEP: ATP III, 2001; AHA Statistical
Update, 2004). Individuals with HDL-C < 40 mg/dL and TG > 150 mg/dL are at
increased risk of CHD. Indeed, males with HDL-C levels 37 mg/dL or lower and,
females with HDL-C levels 47 mg/dL or lower are at the highest risk regardless of their
TC levels (AHA Statistical Update, 2004). However, males with HDL-C levels 53 mg/dL
or greater and, females with HDL-C levels 67 mg/dL or greater, are at low risk for CHD
even if they have elevated TC levels (AHA Statistical Update, 2004).
In the NHANES III (1988-1994) study, the mean level of HDL-C for adults 20
years and older was 50.7 mg/dL. In the year 2001, the prevalence of low HDL-C (< 40
mg/dL) was higher in males (39.0%) compared to females (14.9%). Also, the prevalence
of low HDL-C was lower in non-Hispanic Black males (24.3%) and females (13.0%)
compared to non-Hispanic White males (40.5%), females (14.5%) and Mexican
American males (40.1%) and females (18.4%) (AHA Statistical Update, 2004).
There is also evidence indicating that a 1% decrease in HDL-C is associated with
a 2-3% increase in CHD risk (Gordon et al., 1989). The mechanism for this association is
suggested to be through a reverse cholesterol transport pathway. Other suggested
mechanisms include inhibition of lipid peroxidation (Mackness and Durrington, 1995),
cellular adhesion (Barter, 1997) and/or platelet activation (Sugatani et al., 1996). In the
US, low levels of HDL-C rather than high LDL-C levels are the most prevalent finding
(Rubins et al., 1995). Blood levels of HDL-C can be influenced by elevated serum TG,
overweight and obesity, physical inactivity, cigarette smoking, very high carbohydrate
intakes (more than 60 % of total energy intake), type 2 diabetes, certain drugs (beta-
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blockers, anabolic steroids, progestational agents) and genetic factors. Table 6 shows the
classification of serum TC, LDL-C, TG and HDL-C levels (NCEP: ATP III, 2001).
Table 6 - NCEP: ATP III Classification of Total Cholesterol, Low-density Lipoprotein
Cholesterol, Triglycide and High-density Lipoprotein Cholesterol
Total Cholesterol LDL Cholesterol Triglycerides HDL Cholesterol
(mg/dL) (mg/dL (mg/dL mg/dL)
< 200 Desirable < 100 Optimal < 150 Normal > 60 Desirable
200-239 Borderline 100-129 Near 150-199 Border
High optimal/ line
above High
optimal
240 High 130-159 Borderline 200-499 High < 40 Undesirable
High
160-189 High 500 Very
High
_ 190 Very High
Source: NCEP: ATP III, 2001
Emerging Biochemical Risk Factors for CHD
The behavioral/environmental and physiological risk factors for CHD (increasing
age, cigarette smoking, elevated blood pressure, blood sugar, LDL-C, TC, low HDL-C),
have been shown to be positively associated with the development of CHD (Greenland et
al., 2003; Ridker, 2003a; Beaglehole et al., 2001; AHA Statistical Update,2002; NCEP:
ATP III, 2001). However, these major risk factors can explain only about 70 % of the
variability in CHD risk in the US population (NCEP: ATP III, 2001; Ridker, 2003a).
Thus, the intensive research to identify new (emerging) risk factors that will enhance
predictive power in individuals with and without CHD is important (ATP III, 2001).
These emerging risk factors are listed in Table 6 (Ross, 1999; NCEP: ATP III, 2001).
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Of the emerging risk factors listed in Table 7, inflammatory markers, such as
high-sensitivity C-reactive protein (hs-CRP) has received the most attention (Ridker,
1999). However, these emerging risk factors must be evaluated against the following
criteria used to identify the major risk factors:
Table 7 - Emerging Risk Factors for Coronary Heart Disease
Lipid Factors Non-Lipid Factors
- TC/HDL-C ratio* Inflammationt
- Lipoprotein (a) Inflammatory markers
- Lipoprotein Remnants - high-sensitivity C-reactive protein (hs-CRP)*
- - Small LDL Particles - serum amyloid A
- Apolipoprotein B - interleukins
- Apolipoprotein Al - Vascular & cellular fibrinogen adhesion molecule
Concentration markers - homocysteine
- tissue-type plasminogen activator
- plasminogen activator inhibitor
Thrombogenic/hemostatic statett
Impaired Fasting Blood Glucose
Ankle-brachial Blood Pressure Index
Tests for Myocardial Ischemia
- Carotid Intimal Medial Thickening
- Coronary Calcium
* Emerging risk factors investigated in the present study.
t Emerging evidence has indicated that chronic arterial inflammation as a risk factor for major
coronary events.
ttThis risk is inferred from observations that antiplatelet drugs and anticoagulants have been
shown to reduce risk for CHD.
Adapted from Ridker, 1997. Association of hemostatic and thrombotic factors with
cardiovascular risk. In: Schafer AI, ed. Molecular Mechanisms of Hypercoagulable States.
Austin, TX: Landes Boiscience; 1997; ATP III, 2001.
1. Laboratory or clinical measurement must be widely available, well
standardized, inexpensive, have accepted population-reference values, and be
relatively stable biologically (Ridker, 1999; NCEP: ATP III, 2001). The efficacy and
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clinical use of other emerging markers of CHD has been inconsistent (Tate et al., 1998;
Ridker, 1999; Angleton et al., 1989; Andreotti and Kiuft, 1991; Ridker, 1999). However,
the testing for hs-CRP has provided consistent and reliable results (Macy et al., 1997;
Ledue et al., 1997), and standards for the assessment of hs-CRP have been set by the
World Health Organization (WHO, 1987).
2. Significant predictive power that is independent of the other major risk
factors. It is not sufficient that a particular marker of risk for CHD has predictive value
in univariate analysis, since it may be confounded by other traditional risk factors
(Ridker, 1999). Information from both the Physician Health Study (Ridker et al., 1998c)
and the Women's Health Study (Ridker et al., 2000) have indicated that the predictive
power of hs-CRP was significantly higher than those associated with the traditional
biochemical markers of risk (TC, HDL-C, LDL-C, Lp(a), homocysteine, apolipoproteins
Al and B) for CHD. In univariate analysis of future cardiovascular events hs-CRP was
the strongest predictor of future risk (relative risk [RR] = 4.4; 95% CI, 2.2-8.9) whereas
the LDL-C (well-established marker for CHD) had a lesser predictive value (RR = 2.4;
95% CI, 1.3-4.6) for future cardiovascular events (Figure 3). However, when other risk
factors for CHD (obesity, hypertension, diabetes, family history of CHD) were accounted
for in multivariate analysis, only hs-CRP and TC/HDL-C ratio had independent
predictive value (Figure 2).
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Figure 2 - Relative Risk of Future Cardiovascular Events
Relative Risk (RR) for future cardiovascular events among apparently healthy women in the
WHS according to base line values of several biochemical markers. For consistency, risk
estimates (M) and 95% CIs (lines) are computed for those in the top compared with the bottom
quartile for each marker. L(a), lipoprotein (a); tHCY, total homocysteine; IL-, interleukin-6
sICAM-1, soluble intercellular adhesion molecule-1; LDLC, low-density lipoprotein cholesterol;
SAA, serum amyloid A; Apo B, apolipoprotein Bi; HDLC, high-density lipoprotein cholesterol.
Source: Ridker et al, 2000, with permission.
High-sensitivity CRP is highly stable over long periods of time and
standardized, reproducible and automated analytical procedures for its measurement are
available thus, it has become the most widely studied inflammatory bio-marker (Rifai and
Ridker, 2002; Rifai et al., 1999). The plasma half--life of hs-CR is approximately 19
hours and, is identical under all conditions (Koenig et al., 1999). Thus, the hepatic
synthesis rate of hs-CR is the sole determinant of its plasma concentration (Vigushin et
al., 1993). Also, the intrinsic biological properties of hs-CRP, as an acute-phase
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substance, are favorable for its use as a sensitive quantitative systemic marker of the
acute-phase response (Pepys and Hirschfield, 2003).
Measurement of CRP is now considered a sensitive marker of chronic low-grade
vascular inflammation, which has been implicated in the pathogenesis of atherosclerosis
(Koenig et al., 1999). A meta-analysis by Danesh et al. (2000) has shown a relative risk
of 2.0 for future atherothrombic event in individuals with a single initial hs-CRP
concentration in the upper third (> 2.4 mg/L) compared with those in the lower third (< 1
mg/L) of the distribution in the general population. Also, data from the Women's Health
Study demonstrated that a single non-fasting measurement of hs-CRP (a) is a stronger
predictor of future cardiovascular event compared to LDL-C, (b) identifies at-risk
individuals with low LDL-C, (c) adds to the prognostic information of the currently used
Framingham risk algorithm and, (d) identifies a higher risk for cardiovascular events in
individuals with the metabolic syndrome (Ridker, 2003; Ridker et al., 2002; Ridker,
2003a). It is suggested that these findings are in strong agreement for screening of hs-
CRP to improve risk assessment in the primary prevention population (Ridker, 2003a).
3. Preferably, but not necessarily, modification of the risk in clinical trials
will have shown reduction in risk. Although there are no currently available therapies
that specifically reduce hs-CRP levels, there is evidence showing a positive association
between baseline hs-CRP levels and BMI, with weight loss lowering hs-CRP levels
(Danish et al., 1999). Weight loss in obese elderly individuals has also been shown to
reduce levels of acute phase proteins, such as hs-CRP (Calles-Escandon et al., 1996; Tisi
et al., 1997). Tisi et al. (1997) investigated 49 individuals with intermittent claudication.
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They found that both serum hs-CRP and amyloid A were significantly reduced after 3 to
6 months of regular physical activity. Physical activity (Ford, 2002) and moderate alcohol
consumption (Imhot et al., 2001) have also been associated with lowering of baseline hs-
CRP levels. There are results from clinical studies indicating that the relative efficacy of
low-dose aspirin and 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors
(statins) may be greater in individuals with evidence of underlying inflammation as
assessed by hs-CRP (Ridker et al., 1997; Ridker et al., 1998). Statins have also been
shown to reduce the risk of future cardiovascular events to the same extent in individuals
with normal and/or elevated LDL-C levels but, with baseline hs-CRP levels above the
median value (Ridker et al., 2001). In the secondary prevention Cholesterol and
Recurrent Events (CARE) trial, the magnitude of preventive benefit associated with
pravastatin treatment was 55% in individuals with high hs-CRP concentrations compared
with 30% in individuals with low hs-CRP concentrations (Ridker et al., 1998; Ridker,
2003a). In the primary prevention large-scale statin trial (Air Force/Texas Coronary
Atherosclerosis Prevention Study), lovastatin treatment reduced the risk of first acute
coronary events by 37% in individuals with average total and LDL-C concentrations and
below average HDL-C concentrations. Also, after one year of lovastatin treatment, hs-
CRP concentrations were reduced by 15% compared to the untreated group. There were
also large reductions in CHD event rates in the lovastatin group with low LDL-C/high hs-
CRP, high LDL-C/low hs-CRP and, high LDL-C/high hs-CRP concentrations compared
to the placebo group, suggesting that apparently healthy individuals with low LDL-C
maybe at increased risk of CHD events based on the measurements of hs-CRP (Ridker et
al., 2001; Ridker, 2003a). It has been suggested that measurement of hs-CRP may thus,
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have important roles in monitoring preventive therapies or an indication for prophylactic
antiatherosclerotic therapy in otherwise apparently healthy individuals (Ridker, 1999;
Rohde et al., 1999; Pepys and Hirschfield, 2003).
High-sensitivity C-reactive Protein and Coronary heart Disease
Numerous prospective epidemiological studies in individuals without a history of
CHD have consistently shown that a single, non-fasting measure of CRP to be a powerful
predictor of future first coronary event (Figure 4) (Kuller et al., 1996; Ridker et al., 1997;
Tracy et al., 1997b; Ridker et al., 1998a,b; Koenig et al., 1999; Ridker et al., 2000;
Roivainen et al., 2000; Mendall et al., 2000; Danesh et al., 2000; Gussekloo et al., 2000;
Packard et al., 2000; Lowe et al., 2001; Ridker et al., 2001; Rost et al., 2001; Pradham et
al., 2002; Albert et al., 2002; Sakkinen et al., 2002). This has been observed across
different populations, such as smokers enrolled in the Multiple Risk Factor Intervention
Trial (MRFIT) (Kuller et al., 1996), elderly individuals in the Cardiovascular Health
Study (Tracy et al., 1997b), postmenopausal women in the Women's Health Study
(Ridker et al., 2000; Ridker et al., 1998b) and in Europe, individuals in the MONItoring
trends and determinants in CArdiovascular disease (MONICA) Augsberg study (Koenig
et al., 1999), the Helsinki Heart Study (Roivainen et al., 2000) and the British Regional
Practice study (Danesh et al., 2000) (Figure 3).
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Figure 3 - Prospective Studies of hs-CRP as a Marker for Future Cardiovascular Events
in Populations of Apparently Healthy Men and Women (Without Known CHD).
Fo ostendy ars tdEnd RinEtiae()an9%Cs(ie)aecauaeds
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For Consistency across Studies, Risk Estimates (U) and 95% CIs (lines) are calculated as
comparison of top versus bottom quartile within each study population. C HD indicates coronary
heart disease; MI, myocardial infarction; PAD, pulmonary artery disease; CV, cardiovascular;
MRFIT, Multiple Risk Factor Intervention Trial; PHS, Physicians' Health Study; CHS,
Cardiovascular Health Study; RHPP, Rural Health Promotion Project; WHS, Women's Health
Study; MONICA, MONItoring trends and determinants In CArdiovascular disease; HELSINKI,
Helsinki Heart Study; CAERPHILLY, Caerphilly Heart Study; BRHS, British Regional Heart
Study; LEIDEN, Leiden Heart Study; SPEEDWELL, Speedwell Heart Study; WOSCOPS, West
of Scotland Coronary Prevention Study; AFCAPS, Air Force Coronary Atherosclerosis
Prevention Study; FHS, Framingham Heart Study; WHI, Women's Health Initiative; and HHS,
Honolulu Heart Study.
Source: Ridker, 2003 with permission.
From these same studies there is evidence indicating that serum hs-CRP levels are
increased many years in advance of the first coronary and cerebrovascular events in
healthy (Ridker et al., 1997; Ridker et al., 1998b; Koenig et al., 1999) and high-risk
individuals (Tracy et al., 1997b; Kuller et al., 1996). In two of these studies (Ridker et al.,
1998a, 2000), hs-CRP was shown to be a powerful indicator of future cardiovascular
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events even among subgroups of women with no history of hyperlipidemia, hypertension,
smoking, diabetes or family history of CHD.
Ridker et al (2000) have shown that it is possible to predict future risk for
cardiovascular events (including MI, stroke, coronary revascularization) even in
individuals with LDL-C values < 130 mg/dL, a level stated by the NCEP: ATP III (2001)
panel to be desirable. Riker et al (2002) evaluated hs-CRP levels in over 29,000 women
(45 years and older) in the Women's Health Study. They showed that women in the high
hs-CRP/low LDL-C group were at higher absolute risk compared to those in the low hs-
CRP/high LDL-C group (Figure 4). They suggested that these individuals (high hs-
CRP/low LDL-C) would normally not be considered at risk for preventive treatment in
the clinical setting, thus, the importance of measuring hs-CRP along with LDL-C levels
(Ridker et al., 2002). Also, hs-CRP levels were found to add substantial prognostic
information to the Framingham risk score and the LDL-C categories of < 130 mg/dL, 130
to 160 mg/dL, and > 160 mg/dL used in the current ATP III guidelines (Figure 5) (NCEP:
ATP III, 2001; Ridker, 2003a).
Ridker et al (2002) have shown that hs-CRP levels can either be interpreted in
terms of population-based quintiles (graph on the left of Figure 6) or clinical cut-points
(graph on right of figure 6). It is suggested that the graph on the right of figure 6 in which
hs-CRP levels of<l, 1-3, and >3 mg/L represent low-, moderate-, and high-risk groups,
respectively, may have more clinical application (Ridker et al. 2002). Both the American
Heart Association and the Centers for Disease Control and Prevention now endorse these
clinical cut points for hs-CRP evaluation (Pearson et al., 2003; Ridker, 2003a).
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Figure 4 - Event-free survival among women with hs-CRP and LDL-C levels above or
below the median for the study population.
Data are shown for the entire cohort (27,939 women) and for women who were not taking
hormone-replacement therapy at baseline (15,745 women). The median values were as follows:
for hs-CRP, 1.52 mg/L; for LDL-C, 123.7 mg/dL (3.20 mmol/L). Note the expanded scale on the
ordinate.
Source: Ridker et al., 2002, with permission.
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Figure 5 - Multivariable-adjusted relative risk of cardiovascular event by Framingham
risk score
Highens vty R ecU r oein (m L) I I Sn iiviy C- eciv Pr in gL
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Percentages of 10-year risk for coronary artery disease [CAD]) and low-density lipoprotein
(LDL) cholesterol level categories according to levels of high-sensitivity C-reactive protein.
Source: Ridker et al., 2002, with permission.
Figure 6 - Cardiovascular event-free survival among apparently healthy
individuals according to baseline hs-CRP levels.
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It is important to recognize that hs-CRP response is non-specific and is triggered
by many disorders unrelated to CVD. Therefore, it is important to establish a true
baseline hs-CRP level not affected by either trivial or serious inter-current pathologies
(Pepys and Hirshfield, 2003). However, in most diseases, the circulating level of hs-CRP
will reflect ongoing inflammation and/or tissue damage more accurately than other
laboratory measures of the acute-phase response (example, plasma viscosity, erythrocyte
sedimentation rate). Also, hs-CRP levels show no diurnal variation and are unaffected by
eating (Pepys and Hirshfield, 2003). The concentration of hs-CRP in the blood is thus a
very useful nonspecific biochemical marker of inflammation. The measurement of this
marker will contribute importantly to (a) screening for organic disease, (b) monitoring of
the response to treatment of inflammation and infection and, (c) detection of inter-current
infection in immuno-compromised people. However, in a few specific cases, such as
systemic lupus erythematosus, ulcerative colitis and leukemia, the hs-CRP response is
either modest or absent (Pepys and Hirshfield, 2003; Pepys et al., 1983).
Factors that can Influence C-reactive Protein Levels
Traditional risk factors for CHD, and hormonal status can influence serum levels
of hs-CRP (Ridker, 2001). Cigarette smoking, which seems to promote arterial
inflammation and predispose to major coronary events, is associated with higher hs-CRP
levels (Tracy et al., 1997b). Increased levels of hs-CRP have been observed in obese
individuals reflecting the fact that adipocytes secrete interleukin-6, a primary hepatic
stimulant of hs-CRP (Visser et al., 1999; Yudkin et al., 1999) and, may also synthesize
and secrete hs-CRP (Pepys And Hirschfield, 2003). There is evidence indicating that
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exercise reduces hs-CRP levels (Smith et al., 1999; Tisi et al., 1997). Individuals with
diabetes (Ford, 1999) and the insulin resistance syndrome (Yudkin et al., 1999; Festa et
al., 2000) have elevated serum hs-CRP suggesting that inflammation may play a role in
these conditions. Similar results, showing hs-CRP levels to be associated with CVD risk
have been demonstrated by Koenig et al (1999). They investigated and followed, for 8.2
years, 936 men between the ages of 45 to 64 years, who participated in the first
Monitoring Trends and Determinants in Cardiovascular Disease (MONICA) Augsburg
study, in Germany, between 1984 and 1985. They demonstrated that hs-CRP levels
varied significantly with age, BMI, TC, smoking status, blood pressure and diabetes and,
slightly with alcohol consumption, education, leisure-time physical activity and work
activity.
Rhode et al (1999) have reported similar results for healthy men in the US. They
investigated 1172 apparently healthy middle-aged (40-84 years) men who participated in
the Physician Health Study. Significant positive associations were found between hs-CRP
levels and age, number of cigarettes smoked each day, BMI, systolic and diastolic blood
pressures, TC and TG. There were also significant inverse associations between hs-CRP
and HDL-C, exercise frequency and apo A-1 and A-II. However, in multivariate analysis
when age, smoking status, serum levels of tissue-type plasminogen activator antigen,
fibrinogen, Lp(a) and total homocysteine and, several traditional risk factors for CHD
were controlled, progressive increases in hs-CRP levels were still observed. These studies
are suggesting significant association between hs-CRP levels and determinants of
cardiovascular risks. However, these studies did not investigate hs-CRP levels and other
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determinants of CHD such as socio-economic status (SES), stress and knowledge of
CHD.
There is limited data on hs-CRP levels in different populations. However, two
large studies (Wener et al., 2000; Wong et al., 2001) using data from the NHANES III
(1988-94) showed variation in hs-CRP levels by age, sex and ethnicity. In one of these
studies (Wong et al., 2001) 4472 men and 5212 women 30-74 years old, without CHD,
were evaluated. In this study, mean ( SD) levels of hs-CRP in males (0.41 0.64 mg/dL)
and females (0.55 0.91 mg/dL) were elevated. The mean hs-CRP levels in men were
lower compared to values in women. This same study found that the hs-CRP levels in
non-Hispanic Black men and Mexican-American women were higher than those in non-
Hispanic Whites. There is no published data for foreign-born and US-born Afro
Caribbean Americans.
Total Cholesterol/High-density Lipoprotein Cholesterol Ratio
Current guidelines recommend using LDL-C levels and other risk factors to
identify individuals at risk of CHD (NCEP: ATP III, 2001). However, there are studies
indicating that almost half of all individuals with CHD have normal LDL-C but elevated
CRP levels (Rifai and Ridker, 2001) and low HDL-C with or without elevated
triglyceride levels (Goldbourt et al., 1997; Rubins et al., 1995; Natarajan et al, 2003).
There is evidence indicating that the total cholesterol/HDL-Cholesterol ratio (TC/HDL-
C) is a powerful predictor for CHD risk (Kinosian et al., 1995; Criqui and Golomb,
1998). The ratio reflects two powerful components of risk: (1) high total cholesterol is a
marker for atherogenic lipoproteins and (2) low HDL-Cholesterol correlates with the
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multiple risk factors of the metabolic syndrome and may impart some independent risk
(NCEP: ATP III, 2001). Low-density lipoprotein cholesterol is now recognized as the
atherogenic component of total cholesterol levels, whereas HDL-C is inversely related to
the atherogenic process (Kannel et al., 2004). It is suggested that the TC/HDL-C ratio
may be a better predictor of the dyslipidemic atherosclerotic process at all ages
(Natarajan et al., 2003; Kannel et al., 2004). There is evidence indicating that changes in
the TC/HDL-C ratio may be superior at predicting individuals who will or will not
develop CHD compared to changes in LDL-C alone (Konosian et al., 1995; Grover et al.,
1995). Konosian et al (1995) and Grover et al (1995), using data from the Framingham
Heart Study and the Lipid Research Clinics Population Prevalence Study, have shown
that the TC/HDL-C ratio is a better predictor of CHD risk, even when compared with
newer risk factors, such as Lp(a), homocysteine, fibrinogen and tissue plasminogen
activator antigen (see also Figure 3, page 68). It is suggested that the readily available
measures such as TC/HDL-C ratio should be incorporated in the current NCEP: ATP III
Guidelines, both for the identification of individuals at very high risk for CHD and for
monitoring cholesterol-lowering therapy (Natarajan et al., 2003). A TC/HDL-C ratio of<
3.5 (males and females) is associated with a lower risk for CHD whereas TC/HDL-C
ratios of 5.0 are associated with higher risk for CHD (Sonnenberg et al., 1996; Kannel,
1983). There is no published data for foreign-born and US-born Afro Caribbean
Americans.
65
Improving the Health of Caribbean Americans
There is evidence showing lower all-cause mortality due to CHD in foreign-born
Blacks compared to US-born Blacks and US-born Whites (Fang et al., 1997; Singh and
Siahpush, 2002). In these studies, Blacks included both non-Hispanic Blacks and
Hispanic Blacks. Fang et al (1996) also, showed that Caribbean Americans in New York
City had substantially lower all-cause and cardiovascular mortality rates compared to
Blacks born in the southern and northeastern USA. However, risk factors for CHD were
not investigated in this study.
Most of the studies investigating risk factors for CHD (including CRP levels)
have been done with adults aged between 40 and 84 years. There is a dearth of
information on CHD risk factors (such as cigarette smoking, blood pressure values,
physical activity, blood glucose and lipids levels) in foreign-born and US-born Caribbean
Americans. Also, the influence of diet, body weight, perceived stress, knowledge of CHD
and CRP levels on risks for CHD is unknown in this population.
Ethnic populations' beliefs and practices can influence the interactions between
healthcare provider and individuals of this population. However, insufficient attention is
paid to the area of etbno-medicine (Bronner, 1994). Information about an individual
ethnic group is important for the identification, tracking and investigation of the reasons
for ethnic differences in the prevalence and severity of disease and in response to
treatment (Burchard et al., 2003). Also, information about a person's ethnic group is
important in identifying different risk factor profiles even when a disease does not occur
with dramatically different frequencies in the different ethnic groups (Burchard et al,
2003). It is suggested that by focusing on the ethnic and cultural differences in a
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population we can better understand the variations among different ethnic and cultural
groups and the influence of migration on the prevalence and severity of diseases
(Burchard et al., 2003). This focus can provide the opportunity for healthcare
professionals and policy planners to develop appropriate programs and strategies for the
improvement of health outcomes.
No study has been done to evaluate lifestyle and biochemical risk factors for CHD
in foreign-born and US-born Caribbean Americans, especially in South Florida, where
there is a growing population. Foreign-born Caribbean Americans may have different
health perceptions, beliefs, behaviors, dietary habits and propensities to report
health/nutritional conditions compared to US-born Caribbean Americans and African
Americans. Also, there may be differences in socio-economic status, exposure to
knowledge about CHD, physical activity and stress. These differences may be
distinguishing features of these groups and may influence risk factors for cardiovascular
disease in this population of African ancestry (Curtis and Lawson, 2000).
Designing effective prevention programs to reduce the risk of CHD requires
responding to the needs of different ethnic groups (Dundas et al., 2001). This research
determined and compared behavioral/enviro ental, bio-physiological and emerging
determinants of CHD in apparently healthy Afro Caribbean American (foreign- and US-
born) and African American adults (18-40 years old) in South Florida. Data from this
study may also prove useful to healthcare professionals with little knowledge of or,
familiarity with Afro Caribbean cultures.
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CHAPTER III
METHODOLOGY
Study Design
A cross sectional survey study design (Newman et al., 2001) using a convenience
sample of individuals 18 to 40 years old from three groups (Foreign-born Afro
Caribbeans, first generation Afro Caribbean Americans [US-born] and African
Americans) was employed. Participants were surveyed only once.
In the published literature, Blacks and/or African Americans are terms used
interchangeably to describe all persons of African ancestry. African Americans and Afro
Caribbeans are participants from the same race but different ethnic and cultural
backgrounds. For the purpose of this study the ethnic groups were defined as follows:
(a) Foreign-born Afro Caribbean Americans (FBCA) were individuals of
African ancestry (non-Hispanic) born in one of the Caribbean Islands
(i.e. Jamaica, Haiti, Trinidad and Tobago, Barbados or other small
Caribbean Islands) and residing in the US for less than 10 years (Fang
et al., 1996 showed mortality differentials due to CVD between
foreign-born [13.9 years being the average length of stay in the US]
and US-born Blacks). Haitians were included in the study if they
understood and spook English.
(b) United States-born (first and subsequent generations) Afro Caribbean
Americans (USBCA) were individuals born in the US to both
Caribbean-born parents.
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(c) African Americans (AA) were individuals of African ancestry born in
the US to both parents who are also born in the US. The place of birth
of participants and their parents was requested at the initial screening
interview.
Study Population
The study participants were recruited from the Miami-Dade and Broward counties
in South Florida. Individuals from the Caribbean, Caribbean American and African
American populations were recruited. There is 85 % power in a 2x3 analysis of variance
(ANO VA) to detect a medium sized (d = 0.25) main effect or interaction with a 0.05
significance level (Cohen, 1988) using sample sizes of 60 respondents for each of the
three ethnic groups. Based on the previous assumptions, the total sample size was 180
individuals (30 males, 30 females) from each of the three ethnic groups: In this study,
risks of coronary heart disease (CHD) for the age range 18-40 years were considered low
(NCEP: ATP III, 2001). Also, risks of CHD for both gender groups were assumed to be
similar (NCEP: ATP III, 2001) and, thus, equal numbers of males and females were
recruited. However, the actual number of subjects recruited for the study is shown in
Table 7. The study was approximately 12 months in duration.
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Table 7 - Actual Sample Size for the Study Population
ETHNIC GROUPS
Foreign-born US-born Caribbean African
GENDER Caribbeans Americans Americans Total
(FBCA) (USBCA) (AA)
Males 31 30 30 91
Females 35 32 31 98
Total 66 62 61 189
Inclusion Criteria
Participants were included in the study if they met the following criteria:
(a) Were from the targeted groups (FBCA & living in the US < 10 years, USBCA; both
parents Afro Caribbean ancestry, AA; both parents AA ancestry).
(b) Between the ages of 18 and 40 years.
(c) Willing to sign an informed consent form.
(d) Not regularly taking anti-inflammatory drugs (aspirin Motrin, Advil)
Exclusion Criteria
(a) Not from the defined ethnic groups.
(b) Less than 18 years and older than 40 years.
(b) Diagnosed with any of the following medical conditions: cancer, cardiomyopathy,
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gout, migraine, peptic ulcer, psychiatric, renal, thyroid and hepatic diseases (self-
reported).
(c) Taking over the counter herbal or prescription medications (anti-inflammatory agents,
Anti-asthmatics, anti-depressants, anti-convulsives).
(d) Pregnant
(e) Chronic alcohol users (three or more drinks per day or per sitting). One drink was
defined as: 12 oz. of 4.5% beer; 4 to 5 oz of 14% wine; 10 oz. wine cooler; 1 to 11/2
oz. distilled liquor (80 % proof whiskey, scotch, rum, vodka).
Pilot Study
Initially, a convenience sample (different from the main population) of 10-15
Afro Caribbeans/Afro Americans from the Florida International University community
was recruited, for validation of the research tools (Block food frequency, Baecke physical
activity, Cohen perceived stress, knowledge of CHD risk factors questionnaires) that
were used in this study. Each participant completed a 24-hour dietary recall at the same
time the Block FFQ was given. For the test-retest reliability of the Baecke physical
activity, Cohen perceived stress and the "knowledge of CHD risk factors" questionnaires,
each participant completed these questionnaires a second time when they returned the
first set of the questionnaires to the investigator. The participants were also asked to
complete an activity log that asked questions about type of activity during the past month.
The data were analyzed (information given in the results section) and the tools adjusted,
if necessary.
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Recruitment of Subjects
Recruitment was based on the following methods: 1) Flyers (Appendix A) with
the study outline and the inclusion criteria, benefits, the investigator's telephone numbers
and e-mail address, were distributed and placed on notice boards at the Florida
International University (FIU) and on notice boards at strategic locations in Miami-Dade
and Broward counties. We also met with Caribbean American and African American
Student Associations at FIU, distributed flyers and discussed the purpose of the study.
Subjects who were interested in the study were asked to contact the investigator
by telephone or electronic mail (e-mail). During the initial telephone interview/e-mail
contact, the investigator explained the purpose, procedures, risks and benefits of the
study, the approximate length of time involved, determined eligibility and willingness to
sign an informed consent form. Individuals who were interested in the study were asked
to report on a specified day, in an overnight fasting state, to the Human Nutrition
Research Laboratory (Health and Life Sciences Building, [HLS] 430), at the College of
Health and Urban Affairs (CHUA) at FIU. When the participants visited our laboratory
they were given an opportunity to review the study materials, ask questions and decide if
they wanted to participate in the study. Those who decided to participate in the study,
after meeting the inclusion criteria, were asked to sign an Informed Consent (IC) form
(Appendix B) approved by the Institutional Review Board (IRB) at FIU (approval #
010803). After the IC form was signed, each participant's blood pressure (taken twice),
weight and height measurements were taken. They were asked to give one tablespoon of
blood and given a packet that included the Socio-demographic Questionnaire (Appendix
C), the Cohen Perceived Stress Questionnaire (Appendix D), the Knowledge of CHD
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Questionnaire (Appendix E), the Food Frequency Questionnaire (Appendix F) and the
Baecke physical activity questionnaire (Appendix G). Only one visit was necessary to
collect all of the required data. The entire process took approximately 60 minutes.
DATA COLLECTION
The following data sets were collected from each subject:
1. Socio-demographic Profile
o Socio-economic data (age, country of origin, education attainment and household
income, family history of CHD, medical insurance coverage, healthcare visits)
Q Cohen Perceived Stress Instrument
Q Knowledge of CHD Risk Factor Instrument
2. Behavioral/environmental Assessment
Q Dietary - Block Food Frequency Questionnaire (included information on
cigarette smoking and alcohol consumption)
o Baecke Physical Activity Assessment Instrument
Q Anthropometry - Body Weight and Height
3. Physiological Assessment
Q Blood Pressure
o Fasting Blood Glucose
o Fasting Total Cholesterol (TC), Low-density Cholesterol (LDL-C),
Triglyceride (TG), High-density Lipoprotein Cholesterol (HDL-C)
4. Emerging Risk Factors Assessment
Q High-sensitivity C-reactive Protein (hs-CRP), TC/HDL-C ratio
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Socio-Demographic Questionnaire (SDQ) (Appendix C)
The Socio-demographic questionnaire (SDQ) included information on age,
gender, ethnic background, education, household income, employment status, marital
status, health insurance, place of birth, frequency of healthcare contact, number of
individuals in the household, personal and family history of CHD, diabetes and length of
residency in the US.
Socio-economic Data: As part of the SDQ, educational level attained and household
income were used to assess SES. Educational attainment was estimated by each
participant indicating on the SDQ the highest year of school completed. Educational
attainment was categorized into those with less than or equal to high school education,
those with college education but without college degree and, those with a college degree.
Participants indicated on the demographic questionnaire the annual household income
bracket in which they belong. The respondents were classified into three income groups
(< $20,000, $20,000 - $39,999, $40,000 per year). An indication of per capita income
was calculated by dividing household income by the number of individuals in the
household. In 2002, a family of five earning < $22,377 per year, a family of four earning
< $18,556 per year, a family of three earning < $14,072 per year, a family of two earning
<$12,047 and an individual earning less than $9,359 were considered below the poverty
line (US Census Bureau, 2002: Poverty).
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Perceived Stress Assessment (Appendix D)
An evaluation of perceived stress level was done using a self-administered 14-
item Perceived Stress Scale (PSS) (Cohen et al., 1983; Cohen and Williamson, 1988)
(Appendix D). The PSS can be administered in a few minutes and, is a better predictor of
health outcomes than a global measure of objective stressors such as life-event scales
(Cohen et al., 1983). It is more sensitive to chronic stress deriving from ongoing life
circumstances, to stress from expectations concerning future events, to stress from events
not listed on a particular life-event scale, and to reactions to the specific events included
on any scale (Cohen et al., 1983). Time reference for PSS measure is the past month. The
areas covered refer to feeling in control, feeling nervous or stress, confidence in handling
personal problems, life hassles and feeling irritated, angry and, upset. A five-point Likert
scale (never, almost never, sometimes, fairly often, very often) was used to assess stress
level. The PSS was obtained by reversing the scores (0=4; 1=3; 2=2; etc) on the seven
positive items (items 4,5,6,7,9,10,13) and then summing across all 14 items. A single
score was generated which represented overall level of stress. One half of the items was
scored positively (i.e. greater stress) and the other half, reverse-scored because they were
phrased to indicate lower stress. The items were general in nature, relatively free of
content specific to any population group and thus, applicable to any population.
Knowledge of CHD Risk Factors Questionnaire (Appendix E)
Assessment of participants' knowledge of CHD risk factors was measured using
the "Check Your Healthy Heart I.Q." (NIH Publication No. 93-2724) and "Check Your
Cholesterol and Heart Disease I.Q." (NIH Publication No. 95-3794) questionnaires,
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developed by the National Heart, Lung and Blood Institute (NHLBI). The "Check Your
Healthy Heart I.Q." (Questions 1-14) and "Check Your Cholesterol and Heart Disease
I.Q." (Questions 15-25) questionnaires contain 14 and 11 "True" and "False" questions,
respectively (Appendix E). Participants received a copy of the right answers and an
explanation after completing the questionnaire. Participants' knowledge of risk factors
for CHD (questions 1-14) and, knowledge and awareness of cholesterol and fat
(questions 15-25) were analyzed and the scores added for analysis. The items are general
in nature, relatively free of content specific to any population group and thus, applicable
to any population.
Dietary Assessment (Appendix F)
Food Frequency Questionnaire (FFQ)
Dietary information was collected using a validated FFQ (Appendix F) (Block et
al., 1986; Block et al., 1990; Subar et al., 2001). The scannable version of this
questionnaire was used. Included with this questionnaire were pictorial representations of
portion sizes to help the participants with portion size selections. Participants were asked
to indicate on a separate form any food they had eaten during the past year that was not
listed on the Block FFQ. The Block FFQ has been substantially revised, based on the
National Health and Nutrition Examination Survey III (NHANES III) food intake data.
This revised FFQ includes foods representing at least 90 percent of the intakes of each of
the nutrients on the NHANES III database (National Center for Health Statistics, DHHS
Publication, 94-1308). The food list was derived separately for African Americans
(inclusive of foreign and US-born Afro Caribbeans), Whites and Hispanics, to ensure that
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major nutrient contributors for each of those groups were included. Nutrient content
database was developed using NHANES III and CSFII survey databases and the United
States Department of Agriculture (USDA) Standard Reference database
(www.nal.usda.gov). The questionnaire consisted of 109 food items, as well as additional
questions to assess use of fat-modified foods, types of milk used, servings of fruits and
vegetables, frequency and type of fat used in cooking, and other nutrient-related
behaviors. We also asked each participant to report any additional foods (local or
international) eaten that were not stated on the FFQ. This FFQ also contained questions
about drinking and cigarette smoking habits. The intakes of selected vitamins, minerals
and supplements such as vitamins A, P-carotene, C, E, B6, B12, folate/folic acid,
selenium, calcium, sodium, iron, zinc and fish oil were assessed. Food models, measuring
utensils, ruler and imperial to metric conversion materials were used to help estimate
portion sizes. Nutrients of interest included those recommended by the American Heart
Association (AHA Statistical Update, 2002) to be important in a heart-healthy diet and
including those that may influence CHD (Willett, 1998). These were: Energy (kilocalorie,
kcal); Protein (grams, g); percent (%) kcal from protein; Carbohydrate (g); percent kcal
from carbohydrate; Dietary Fat (g) (saturated, monounsaturated, polyunsaturated, omega-
3 ((o-3) fatty acid, (mg)); percent kcal from fat; Cholesterol (mg); Dietary Fiber (g)
(soluble and insoluble); selected minerals (Sodium, [mg], Potassium, [mg], Calcium,
[mg], Iron, [mg], Selenium, [mg], Copper, [mg],); vitamins (C, [mg], B, [mg alpha-
tocopherol Equivalent], B6, [mg], B1, [mg], folate, [pg], servings of fruits, vegetables
and legumes, and frequency and type of fat used in cooking.
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A diet score was devised according to whether the participants met recommended
dietary requirements for 7 selected nutrients (percent energy from fat, saturated fat,
dietary cholesterol, fiber, sodium, fruit and vegetable servings) or not. Individuals who
exceeded the dietary recommendations for percent energy from fat, saturated fat,
cholesterol and sodium were assigned a score of 0 and a score of 1 if they met the dietary
requirements. Participants who consumed below the dietary recommendations for dietary
fiber, fruit and vegetable servings were assigned a score of 0 and 1 if they met the dietary
requirements. This score was summed across the selected food items to give a total diet
score. The diet score ranged from 0-7. Higher scores were indicative of better quality
diets.
Food frequency questionnaires (FFQs) are commonly used in epidemiological
studies of chronic disease to evaluate usual and long-term dietary intakes of individuals.
Accurate information about food intake is important because they may be independently
associated with disease outcomes. Compared to diet histories and 24-hour recalls, FFQs
require neither specialized training nor lengthy interviews. Thus, respondent's burden is
light, with subsequent increased participation. The administration of FFQs can be done
by telephone, mail, interviewer to interviewee (face to face) or be self-administered. This
will lead to lower costs, especially in large-scale studies. There is evidence indicating that
the FFQ has adequate test-retest reliability and that measures of reliability were
comparable to those of food records (Willett et al., 1985).
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Dietary Analysis
The FFQ was sent to the Block Dietary Data Systems (Berkeley, CA) for dietary
analysis. The FFQ data was coded, entered and analyzed by using techniques developed
by Block et al., (1986). We also used the Caribbean Food and Nutrition Institute's
(CFNI) Food composition database (Caribbean Food and Nutrition Institute, 1995; 2000)
to aid in the assessment of the food intake of Caribbean Nationals. This database is a
compilation of foods from Britain, the Caribbean and the US.
Physical Activity (Appendix G)
Physical activity was assessed using the validated Baecke physical activity
questionnaire (validated also for blacks or African Americans, inclusive of foreign and
US-born Afro Caribbeans) (Baecke et al., 1982; Kriska and Caspersen, 1997;
Atherosclerosis Risk in Communities Study, 1989). This tool has been validated against
other methods of assessing physical activity (Kriska and Caspersen, 1997) and in studies
assessing CVD risk factors (Rodriquiz et al., 1994; NIH, 1995; Leon et al., 1997;
McMurray et al., 1998). This questionnaire (16 questions) assesses leisure and
occupational activities. It consists of three sections: work activity (questions 1-8), sports
activity (question 9-12) and non-sports leisure activity (questions 13-16). Each section is
scored on a five-point Likert scale, ranging from never to always or very often. For two
of the most frequently reported sports activities, additional questions query the number of
months per year and hours per week of participation. The three sections are further
divided into three levels:
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Occupational physical activity: low level for occupations such as clerical work, driving,
shop-keeping, teaching, studying, housework, medical practice and all other occupations
with a university education; middle level for occupations such as factory work,
plumbing, carpentry, and fanning; and high level for occupations such as dock work,
construction work and sport.
Sports: low level for sports such as billiards, sailing, bowling and golf (average energy
expenditure (ABE) 0.76 MJ/h); middle level for sports such as badminton, cycling,
dancing, swimming and tennis (ABE 1.26 MJ/h); and high level for sports such as
boxing, basketball, football, soccer, rugby and rowing (AEE 1.76 MJ/h). The sport score
was calculated from a combination of the intensity of the sport which was played, the
amount of time spent per week playing that sport and the amount of time during the year
that the sport was played.
The total scores for each of the work, sports and non-sports leisure time activities
were added to give the total score. The scores were then classified into quartiles for
general classification of activity levels. There is evidence that self-assessment of physical
assessment activity parallels the scores of actual physical activity reasonable well (Chave
et al., 1978).
Anthropometry: As part of the SDQ, anthropometric data such as weight (collected as
pounds, [lb], to the nearest half lb, and expressed as kilograms, [kg]), and height,
(collected as inches, [in], to the nearest half in, and expressed as meters, [in], on a beam
balance (calibrated weekly with a reference weight) were collected. These measurements
were taken with the participants in light clothing and in socks. Waist circumference
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(collected as inches, [in] to the nearest half in, and (centimeter, cm) was measured with
each subject standing erect, abdomen relaxed, arms at their sides and feet together. The
measurement was taken using a nonstretchable tape measure at the end of a normal
expiration, without the tape compressing the skin. The tape is placed around the subject,
in a horizontal plane, at the level of the natural waist, which is the narrowest part of the
torso, as seen from the anterior aspect (Callaway et al., 1988). Body Mass Index (BMI),
was calculated as weight (kilograms, kg) divided by height squared (meters, i 2 ). The
BMI is highly correlated with body fat than any other indicator of height and weight and,
was used to assess body fat (overall adiposity). Individuals with BMI less than 18.5 were
considered underweight, between 18.5 and 24.9 normal, between 25.0 and 29.9
overweight and over 30.0 as obese. Waist circumference is positively correlated with
abdominal fat content. Individuals with BMI 25.0 to 34.9 and waist circumference > 102
cm (> 40 in) males and 88 cm (> 35 in) in females are at high to very high risk of
developing obesity-related risk factors for CHD.
Blood Pressure
The blood pressure measurements of the participants were taken in the sitting
position in a quiet, comfortable room following a 10 minutes of rest, by a trained
assistant using a random zero sphygmomanometer (Tycos 5090-02 Welch Allyn Pocket
Aneroid Sphygmomanometer, Arden, NC) and a stethoscope (Littmann Cardiology. 3M,
St. Paul, MN). The appropriate adult-size arm cuff was used in order to record accurate
measures. The appropriate blood pressure cuff was placed approximately one inch above
the antecubital space of the right arm (a natural crease of the elbow), with the center of
81
the bladder applied directly over the brachial artery in the antecubital space. The cuff size
was determined by the width of the inflatable bladder, which was about 40% of the
circumference from the midpoint of the arm. The measurements were read with the
forearm and the manometer at the level of the heart. The cuff was inflated by squeezing
the rubber bulb. The pressure was released at a rate of 2 mm Hg per second after the
monometer indicator exceeded 180 mm Hg. As the pressure fell, systolic blood pressure
was determined at the point where the initial pulse sound was heard; Korotkoff's fifth
phase was used to determine diastolic blood pressure. The cuff was deflated completly at
the end of the measurement.
The first blood pressure reading was taken at the beginning of the study, with the
subject seated after 10 minutes of rest. A total of two blood pressure readings were taken
from each participant at least 10 minutes apart and the average calculated and recorded.
Blood pressure was considered normal if the mean of two measurements was < 120/80
mm Hg; prehypertension if 120-139/80-89 mm Hg; stage 1 hypertension if 140-159/90-
99 mm Hg and stage 2 hypertension if> 160/100 mm Hg (JNC VII, 2003).
Biochemical Data Collection (Blood Glucose, Lipids, hs-CRP)
Fasting blood was collected by a licensed Phlebotomist, using standard
procedures. Blood was collected from each participant after the IC form was signed, at
the first visit to the Human Nutrition Laboratory at the CHUA at FIU. After the blood
was coagulated (30 minutes), it was centrifuged at full speed (1100 RPM) for 15 minutes
and the serum removed, placed in labeled plastic tubes for the determination of serum
lipids (total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C) and
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triglycerides, TG) by the methods of McNamara and Schaefer (1987) using the Beckman
Synchron CX System (Global Chemical, INC., US). Very low-density lipoprotein
cholesterol (VLDL-C) was estimated as TG/5. Low-density lipoprotein cholesterol (LDL-
C) was calculated by the Friedewald formula (Friedewald et al., 1972): LDL-C = TC -
(TG/5 + HDL-C). TC values 200 mg/dL, LDL-C values > 130 mg/dL and TG values >
200 mg/dL were considered elevated whereas, HDL-C < 40 mg/dL was considered
undesirable (NCEP: ATP III, 2001).
Fasting blood glucose was analyzed by enzymatic procedures using the automatic
Chemistry Analyzer (Global Chemical, INC., US). Fasting blood glucose was considered
normal if < 110 mg/dL, glucose intolerant if between 110-126 mg/dL and elevated if>
126 mg/dL.
Serum high-sensitivity CRP (hsCRP) levels were assayed using the Food and
Drug Administration approved latex-enhanced nephelomtric assays (Rifai et al., 1999) on
a BN II analyzer (Dade Behring, USA). Levels of hs-CRP > 3 mg/L will be considered
elevated (Ridker, 2003; Pearson et al., 2003).
Statistical Analysis
The following statistical analyses were done to address the purpose, specific
objectives and research questions of this study. Validation of the Block FFQ for this
population was evaluated by comparing dietary analyses of the Block FFQ and the 24-
hour dietary recall. Test-retest validation of the Baecke Physical Activity, the Cohen
Perceived Stress and the "Knowledge of CHD Risk Factors" questionnaires was
evaluated by comparing the "test" and "retest" scores of these questionnaires from the
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pilot study. Summary statistics using quantitative data from the SDQ, PSS, "Knowledge
of CHD Risk Factors", FFQ, Baecke physical activity questionnaires and, information
from the measured parameters such as weight/height (evaluated as body mass index),
waist circumference, blood pressure, blood glucose, blood lipids, hs-CRP and, categorical
variables from the socio-demographic questionnaire, such as ethnicity, place of birth,
occupation, employment status, education status and household income were calculated
using SPSS for Windows (v. 12.0). The results (socio-demographic,
behavioral/environmental, physiological and emerging determinants of CHD) were
expressed as mean standard deviation, frequencies and percentages and compared by
gender, ethnic groups and gender-ethnic subgroups (Research Questions 1 - 4). One-way
analysis of Variance (ANO VA) and chi-square analysis were performed as appropriate.
Pair-wise comparisons using Bonferroni's posthoc tests were performed to adjust for
multiple comparisons (FBCA vs USBCA, FBCA vs AA, USBCA vs AA). Pearson's
correlations were also performed to evaluate associations between the socio-
demographic, behavioral/environmental, physiological and emerging risk factors for
CHD. Differences were considered significant at p<0.05.
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CHAPTER IV
RESULTS
This study determined and compared socio-demographic,
behavioral/environmental, bio-physiological and emerging risk factors for coronary heart
disease (CHD) in apparently healthy foreign-born Afro Caribbean (FBCA - residence in
the US < 10 years), US-born Afro Caribbean American (USBCA) and African American
(AA) adults aged 18-40 years in South Florida.
The results of this study are organized according to the research questions and are
presented in five sections. Section 1 covers the participants' socio-demographic
information. Sections 2 to 4 cover the participants' behavioral/environmental,
physiological and emerging risk factors for CHD. Reports on the correlations between the
socio-demographics, behavioral/environmental, bio-physiological and emerging risk
factors for CHD are presented in Section 5. The high test/retest correlations of the Baecke
physical activity (r-0.933; p< 0.001), Cohen perceived stress (r=0.986; p< 0.001) and
"knowledge of CHD risk factor" (r=0.927; p< 0.001) questionnaires (Appendices D, E
and G) indicated that the questionnaires were very reliable for this study population.
Section 1 - Research Question 1: Are the socio-demographic profiles of FBCA,
USBCA and AA adults similar?
Over 400 individuals were contacted and/or responded to posted flyers, FIU-wide
email advertisements, classroom presentations and presentations made at churches and
school-based Afro Caribbean/African American Student Organizations. However, only
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those who met the inclusion criteria (N = 189) of the research protocol and signed the IC
form participated in the study.
Country of Birth
The majority of male (n=25, 80.6%) and female (n=27, 77.2%) FBCA
participants were from Jamaica, Haiti, Trinidad and Tobago (Figure 7). The other 19.4%
of the male and 22.8% of the female FBCA were from the Dominican Republic, Antigua,
the Cayman Islands, Dominica, Guyana and St. Lucia. The length of residence in the US
of the male and female FBCA participants, ranged from 1 to 10 years. No significant
difference was seen between the FBCA male and female participants residing in the US
for 1-3 (32.3% vs. 28.6%), 4-5 (19.4% vs. 28.6%) or 6-10 years (45.2% vs. 40.0%). The
majority of male and female USBCA participants were from Florida (n=20, 66.7%; n=22,
68.8%) and New York (n=5, 16.7%; n=5, 15.6%), respectively. The other 16.6% males
and 15.6% females USBCA came from California, Georgia, Massachusetts, New Jersey
and North Carolina (Figure 7). The male and female AA participants were mainly from
Florida (n=22, 73.3%; n=16, 51.6%) and New York (n=4, 13.3%; n=4, 12.9%),
respectively. The other 13.3% of the male and 35.5% of the female AA were from
Chicago, Georgia, Maryland, Tennessee, Virginia and Washington, DC (Figure 7). The
parents of the male and female FBCA participants were mainly from Jamaica (n=16,
51.6%; n=16, 45.7%), Haiti (n=5, 16.1%; n=7, 20.0%) and Trinidad and Tobago (n=4,
12.9%; n=5, 14.3%), respectively (Figure 8). Most of the parents of the males and
females USBCA participants were born in Jamaica (n=17, 56.7%; n=11, 34.4%) and
Haiti (n=10, 33.3%; n=15, 46.9%) (Figure 8).
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The other parents of the males and females USBCA (10.0% and 18.7%),
respectively were born in Barbados, Trinidad and Tobago and Guyana (Figure 8).
Socio-demographic Variables
Significant (p< 0.01) differences in mean ages between USBCA (21.6 3.8) and
AA (24.4 5.1) participants but not the FBCA (24.3 5.8) participants (Table 9) and,
between the USBCA (21.6 3.6) males and AA (25.5 5.4) males but not the FBCA
(24.5 5.8) males (Table 10) were observed. Thus, all analyses were conducted with and
without age-adjustments. However, no differences in results were noted, therefore, only
the unadjusted results are shown.
Males and females differed significantly (p< 0.05) with respect to school
attendance (78.0% vs. 90.8%), visits to healthcare professionals (73.6% vs. 85.7%) and
employment status (74.7% vs. 58.2%), respectively (Table 9). Comparison by ethnic
groups showed school attendance was significantly (p< 0.01) higher in the USBCA
(96.8%) participants compared to the FBCA (83.4%) and AA (73.8%) participants using
Bonferroni's post hoc test (Table 10).
School attendance was significantly (p< 0.05) higher in the USBCA (96.7%)
males compared to AA (60.0%) males but not FBCA (77.4%) males (Table 11). No
significant differences in the socio-demographic variables between the three female
ethnic subgroups were observed (Table 12). No significant differences were observed
between the three ethnic groups or the three male and female ethnic subgroups with
respect to the mean perceived stress or knowledge of CUD risk factors scores (Table 13).
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Table 9- Socio-demographic Factors of Study Participants by Gender
Variable Males Females p
n=91 n=98
Age (mean SD) 23.9 5.3 23.1 5.0 0.305
Attend School (%)
No 22.0 9.2 0.038*
Yes 78.0 90.8
Educational Attainment (%)
High School Graduate 71.4 74.5 0.636
College/Graduate Studies 28.6 25.5
Household Income (%)
<$20,000 41.8 44.7 0.971
$20,000 - $39,999 25.3 24.9
> $40,000 33.0 30.6
Family History of CHD (%)
No 30.8 28.6 0.879
Yes 33.0 31.6
Do not Know 36.3 39.8
Medical Insurance (%)
No 26.4 34.7 0.215
Yes 73.6 65.3
Visits to Health Care
Professional (%)
No/never 26.4 14.3 0.038*
Yes 73.6 85.7
Employment Status (%)
Not Employed 25.3 41.8 0.016*
Employed 74.7 58.2
Individuals in Household (%)
<3 individuals 67.1 68.4 0.739
>3 individuals 32.9 31.6
Family History of Diabetes (%)
No 20.9 8.2 0.069
Yes 56.0 69.4
Do not Know 23.1 22.4
p<0 905
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Table 10 - Socio-demographic Factors of the Participants by Ethnicity
Variables FBCA USBCA AA p
n=66 n=62 n=61
Age (mean SD) 24.3 5.8 ab 21.6 3.8b 24.4 5.1a 0002**
Attend School (%)
No 16.7b 3.2a 26.2b 0.002**
Yes 83.4 96.8 73.8
Educational Attainment (%)
High School Graduate 66.7 82.3 70.5 0.120
College/Graduate Studies 33.3 17.7 29.5
Household Income (%)
<$20,000 45.5 38.7 45.9 0.673
$20,000 - $39,999 19.7 24.2 31.1
> $40,000 34.8 37.1 23.0
Family History of CHD (%)
No 30.3 22.6 36.1 0.083
Yes 39.4 25.8 31.1
Do not Know 30.3 51.6 32.8
Medical Insurance (%)
No 28.8 30.6 32.8 0.888
Yes 71.2 69.4 67.2
Visits to Health Care
Professional (%)
No/never 19.7 14.5 26.2 0.268
Yes 80.3 85.5 73.8
Employment Status (%)
Not Employed 31.8 38.7 31.1 0.614
Employed 68.2 61.3 68.9
Individuals in Household (%)
<3 individuals 71.2 66.2 65.6 0.753
> 3 individuals 28.8 33.9 34.4
Family History of Diabetes (%)
No 15.2 9.7 18.0 0.904
Yes 62.1 64.5 62.3
Do not Know 22.7 25.8 19.7
** p< 0 .0 1
a,b Values in a row with differing superscripts differed significantly at p<0.05 (Bonferroni's test)
FBCA = Foreign-born Afro Caribbeans
USBCA = US-born Afro Caribbean Americans
AA = African Americans
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Table 11 - Socio-demographic Factors of the Male Participants by Ethnicity
Variables FBCA USBCA AA p
n=66 n=62 n=61
Age (mean SD) 24.5 5 .8 a 21.6 3 6 b 25.5 5.4a 0.009*
Attend School
No 22.6ab 3.3a 40.0 0.014*
Yes 77.4 96.7 60.0
Educational Attainment
High School Graduate 61.3 83.3 70.0 0.428
College degree 32.3 13.3 26.7
Graduate Studies 6.5 3.3 3.3
Household Income
<$20,000 51.6 33.3 40.0 0.247
$20,000 - $39,999 16.2 20.0 40.0
> $40,000 32.2 46.7 20.0
Family History of CHD
No 29.0 16.7 46.7 0.163
Yes 35.5 40.0 23.3
Do not Know 35.5 43.3 30.0
Medical Insurance
No 32.3 20.0 26.7 0.241
Yes 67.7 80.0 73.3
Visits to Health Care
Professional
No/never 22.6 16.7 40.0 0.078
Yes 77.4 83.3 60.0
Employment Status
Not Employed 16.1 33.3 26.7 0.296
Employed 83.9 66.7 73.3
Individuals in Household
<3 individuals 74.2 60.0 66.7 0.739
> 3 individuals 25.8 40.0 33.3
Family History of Diabetes
No 19.4 13.3 30.0 0.434
Yes 54.9 63.4 50.0
* p<0.05; ** p<0.01
a,b Values in a row with differing superscripts differed significantly at p<0.05 (Bonferroni's test)
FBCA = Foreign-born Afro Caribbeans
USBCA = US-born Afro Caribbean Americans
AA = African Americans
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Table 12 - Socio-demographic Factors of the Female Participants by Ethnicity
Variables FBCA USBCA AA p
n=35 n=32 n=31
Age (mean SD) 24.2 6.0 21.7 4.0 23.4 4.5 0.107
Attend School (%)
No 11.4 3.1 12.9 0.344
Yes 88.6 96.9 87.1
Educational Attainment (%)
High School Graduate 71.5 81.2 71.0 0.564
College degree 20.0 15.6 19.4
Graduate Studies 8.6 3.1 9.7
Household Income (%)
<$20,000 40.0 43.8 51.7 0.812
$20,000 - $39,999 22.8 28.2 22.6
>$40,000 37.1 28.1 25.8
Family History of CHD (%)
No 31.4 28.1 25.8 0.136
Yes 42.9 12.5 38.7
Do not Know 25.7 59.4 35.5
Medical Insurance (%)
No 25.7 40.6 38.7 0.375
Yes 74.3 59.4 61.3
Visits to Health Care
Professional (%)
No/never 17.1 12.5 12.9 0.237
Yes 82.9 87.5 87.1
Employment Status (%)
Not Employed 45.7 43.8 35.5 0.678
Employed 54.3 56.3 64.5
Individuals in Household (%)
< 3 individuals 68.7 72.0 64.6 0.895
>3 individuals 31.4 28.0 35.4
Family History of Diabetes (%)
No 11.4 6.3 6.5 0.434
Yes 68.6 65.7 74.2
Do not Know 20.0 28.1 19.3
FBCA = Foreign-born Afro Caribbeans
USBCA = US-born Afro Caribbean Americans
AA = African Americans
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Table 13 - Mean Perceived Stress and Knowledge of Coronary Heart Disease Risk
Factor Scores of the Participants by Gender, Ethnicity and Gender-ethnicity Subgroups
Variable Perceived Stress KCIDRF
Score Score
n Mean SD
Gender
Male 91 22.9 7.8 17.8 2.1
Female 98 24.9 7.1 18.3 1.6
Range 7-56 0-25
p-value 0.073 0.055
Ethnicity
FBCA 66 24.3 7.2 17.7 2.4
USBCA 62 23.9 7.5 17.6 2.1
AA 61 23.6 8.0 18.1 1.8
Range 7-56 0-25
p-value 0.846 0.453
Males by Ethnicity
FBCA 31 22.5 7.9 18.0 1.9
USBCA 30 22.4 6.9 18.0 2.0
AA 30 24.0 8.7 18.3 1.8
Range 7-56 0-25
p-value 0.665 0.674
Females by Ethnicity
FBCA 35 26.0 6.1 18.2 1.4
USBCA 32 25.4 7.8 18.3 1.8
AA 31 23.1 7.3 18.6 1.7
Range 7-56 0-25
p-value 0.236 0.580
Perceived Stress, range 7 - 56, where 7 is low stress and 56 is high stress; KCHDRF, Knowledge
of Coronary Heart disease Risk Factors, range 0 - 25, where 0 is low KCHDRF and 25 is high
KCHDRF
FBCA = Foreign-born Afro Caribbeans
USBCA = US-born Afro Caribbean Americans
AA = African Americans
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Section 2 - Research Question 2: Are FBCA adults less likely to have
behavioral/environmental risk factors for CHD as compared to USBCA and AA
adults?
Dietary Intakes
For the dietary analysis, 2 males (2.2%) and 2 females (2.0%) were excluded from the
dietary calculations of the data. These participants reported energy intakes either in
excess of 7,000 kcal or less than 300 kcal per day, which were outside the reported values
by other participants by a large margin in the study.
Energy and Macronutrients
In general, the mean energy and macronutrient intakes of the males were
significantly higher than the females (Table 14). Males consumed more energy (2117.7
1092.0 kcal vs. 1461.3 693.5 kcal; p< 0.001), carbohydrates (263.6 134.5 g vs. 201.8
100.3 g; p< 0.001), protein (84.5 47.0 g vs. 53.6 26.3 g; p< 0.001), total fat (78.6
48.2 g vs. 49.8 28.0 g; p< 0.001), saturated fat (27.3 16.4 g vs. 17.3 9.9 g; p<
0.001), monounsaturated fatty acid (MUFA) (30.4 19.6 g vs. 18.3 10.7 g; p< 0.001),
polyunsaturated fatty acid (PUFA) (13.8 9.3 g vs. 9.8 6.2 g; p< 0.001), cholesterol
(271.4 167.7 mg vs. 152.8 95.0 mg; p< 0.01) and caffeine (25.8 31.5 mg vs. 17.1
23.4 mg; p< 0.05) than the females.
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Table 14 - Mean Energy and Nutrient Intakes of the Participants by Gender
Variables Males Females p
Mean SD
n=89 n=96
Calories (Kcal) 2117.7 1092.0 1461.3 693.5 0.0001***
CHO (g) 263.6 134.5 201.8 100.3 0.0001***
Protein (g) 84.5 47.0 53.6 26.3 0.0001***
Total Fat (g) 78.6 48.2 49.8 28.0 0.0001***
SF 2 (g) 27.3 16.4 17.3 9.9 0.0001***
MUFA 3 (g) 30.4 19.6 18.3 10.7 0.0001***
PUFA 4 (g) 13.8 9.3 9.8 6.2 0.001**
Cholesterol (mg) 271.4 167.7 152.8 95.0 0.0001***
Kcal CHO' (%) 51.3 11.3 55.3 8.2 0.006**
Kcal Prot (%) 16.1 4.1 14.9 3.4 0.034*
Kcal Fat (%) 32.2 7.2 30.3 6.2 0.050*
Kcal Alcohol (%) 2.7 4.3 1.9 4.7 0.234
Kcal Sweet (%) 11.4 8.9 11.3 7.9 0.917
Fiber (g) 16.5 9.6 14.2 10.2 0.115
Fiber (Beans) (g) 2.9 4.5 2.7 3.6 0.685
Fiber (Vegetables) (g) 6.5 5.1 6.2 5.9 0.675
Fiber (Grains) (g) 7.3 4.4 5.4 3.5 0.001**
Caffeine (mg) 25.8 31.4 17.1 23.4 0.032*
Fruits (servings/d) 1.1 0.7 1.3 0.9 0.035*
Vegetables (servings/d) 2.4 2.4 2.2 2.1 0.550
Grains (servings/d) 5.1 2.9 4.1 2.6 0.016*
Meats (servings/d) 2.9 2.0 1.7 1.1 0.0001***
Dairy (servings/d) 1.5 1.2 1.0 0.8 0.003**
Fats (servings/d) 1.6 1.2 1.4 0.8 0.115
* p<0.05; ** p<0.01; *** p<0.001
CHO = Carbohydrate; 2 SF = Saturated Fat; 3 MUFA = Monounsaturated Fatty Acids; 4 PUFA
Polyunsaturated Fatty Acids
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Males consumed significantly less energy from carbohydrates (51.3 11.3% vs. 55.3
8.2%; p < 0.01), but significantly more energy from protein (16.1 4.1% vs. 14.9
3.4%; p< 0.05) and fat (32.2 7.2% vs. 30.3 6.2%; p=0.050) compared to females.
Males also consumed more fiber from grains than females (7.3 4.4 g vs. 5.4 3.5 g; p<
0.01). The consumption of foods from the food groups, grains (5.1 2.9 servings vs. 4.1
2.6 servings; p< 0.05), meats (2.9 2.0 servings vs. 1.7 1.1 servings; p< 0.001) and
dairy (1.5 1.2 servings vs. 1.0 0.8 servings; p< 0.01) were also significantly higher in
males than females. However, males consumed significantly fewer serving of fruits per
day compared to females (1.1 0.7 servings vs. 1.3 0.9 servings; p< 0.05) (Table 14).
The FBCA participants compared to USBCA and AA participants consumed
significantly less protein (57.6 32.2 g vs. 74.0 44.1 g and 74.7 43.3 g; p< 0.05),
total fat (52.8 32.3 g vs. 66.3 41.7 g and 73.0 47.8 g; p< 0.05), saturated fat (18.6
11.5 g vs. 23.1 14.9 g and 24.9 15.8 g; p< 0.05), MUFA (19.7 13.3 g vs. 25.1
17.1 g and 27.9 18.9 g; p< 0.05), PUFA (9.5 5.9g vs. 12.0 7.5 g and 13.9 10.0 g;
p< 0.05), cholesterol (168.8 114.0 mg vs. 220.4 161.9 mg and 244.1 155.0 mg; p<
0.05) and meat serving per day (1.7 1.3 servings vs. 2.6 1.9 servings and 2.5 1.8
servings; p< 0.01). In addition, the FBCA participants compared to the USBCA and AA
participants consumed significantly more energy from carbohydrate (56.7 10.2% vs.
52.7 10.2% and 50.6 8.5%; p< 0.05). However, the FBCA participants compared to
the AA but not the USBCA participants consumed significantly less energy from fat
(29.3 6.8% vs. 33.1 6.5% and 31.4 6.4%; p< 0.01) and fat servings (1.2 0.9
servings vs. 1.8 1.2 servings and 1.5 1.0 servings; p< 0.05), respectively (Table 15).
97
Table 15 - Mean Energy and Nutrient Intakes of the Participants by Ethnicity
Variables FBCA USBCA AA p
Mean SD
n=65 n=61 n=59
Calories (Kcal) 1557.9 775.2 1843.4 976.8 1950.1 1096.0 0.061
CHO' (g) 216.4 102.4 235.1 120.8 244.5 140.8 0.423
Protein (g) 57.6 32.2a 74.0 4 4 .1b 74.7 4 3 .3b 0.027*
Total Fat (g) 52.8 32.3a 66.3 4 1 .7b 73.0 4 7 .8b 0.020*
SF2 (g) 18.6 11.5a 23.1 14.9 24.9  15.8b 0.042*
MUFA3 (g) 19.7 13.3a 25.1 17 .1b 27.9 1 8 .9b 0.019*
PUFA4 (g) 9.5 5.9a 12.0 7.5 13.9 10 .0b 0.011*
Cholesterol (mg) 168.8 114.0a 220.4 1 6 1 .9b 244.1 15 5 .0b 0.013*
Kcal CHO' (%) 56.7 10.2a 52.7 10 .2b 50.6 8 .5b 0.002**
Kcal Prot (%) 14.9 4.1 15.9 3.6 15.7 3.6 0.282
Kcal Fat (%) 29.3 6.8a 31.4 6.4ab 33.1 6 .5  0008**
Kcal Alcohol (%) 1.7 4.0 2.1 4.1 3.1 5.3 0.215
Kcal Sweet (%) 11.3 10.0 10.6 6.4 12.2 8.4 0.597
Fiber (g) 15.6 10.7 15.0 9.9 15.3 9.2 0.954
Fiber (Beans) (g) 3.0 4.6 2.9 3.9 2.5 3.5 0.773
Fiber (Vegetables) (g) 6.7 5.8 5.9 6.1 6.4 4.6 0.771
Fiber (Grains) (g) 6.1 4.1 6.2 3.9 6.6 4.2 0.712
Caffeine (mg) 18.4 26.2 21.0 24.6 24.8 32.3 0.440
Fruits (servings/d) 1.4 0.9 1.2 0.8 1.1 0.6 0.107
Vegetables (servings/d) 2.3 2.3 2.2 2.3 2.5 2.1 0.791
Grains (servings/d) 4.4 2.9 4.7 2.7 4.7 2.9 0.845
Meats (servings/d) 1.7 1.3a 2 .6  1.9  2 .5 1.8b 0.009**
Dairy (servings/d) 1.2 1.1 1.3 1.0 1.2 1.0 0.937
Fats (servings/d) 1.2 0.9a 1.5 1. 0 ab 1.8 1 .2b 0.015*
* p<0.05; ** p<0.01
a,b Values in a row with differing superscripts differed significantly at p<0.05 (Bonferroni's test).
1 CHO = Carbohydrate; 2 SF = Saturated Fat; 'MFA = Monounsaturated Fatty Acids; 4 PUFA =
Polyunsaturated Fatty Acids
FBCA = Foreign-born Afro Caribbeans
USBCA = US-born Afro Caribbean Americans
AA = African Americans
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In the male ethnic subgroups, the FBCA males compared to the USBCA and AA
males, consumed significantly less energy (1721.9 883.2 kcal vs. 2301.3 1016.0 kcal
and 2337.3 1271.6 kcal; p< 0.05), protein (66.9 38.0 g vs. 95.5 48.1 g and 91.3
50.4 g; p< 0.05), total fat (59.2 37.5 g vs. 86.7 47.0 g and 90.3 54.4 g; p< 0.05),
saturated fat (21.4 13.4 g vs. 30.3 17.1 g and 30.5 17.4 g; p< 0.05), MUFA (22.5
15.8 g vs. 33.8 19.5g and 35.1 21.5 g; p< 0.05) and PUPA (9.7 5.7 g vs. 14.8 7.9
g and 17.0 11.9 g; p< 0.01) (Table 15). In addition, the FBCA males, compared to the
USBCA and AA males, consumed significantly more energy from carbohydrates (56.0
12.2% vs. 49.5 11.7% and 48.4 8.1%; p< 0.05). The percentage energy intake from
fat of the FBCA males (29.4 7.6%) was significantly (p< 0.05) lower compared to the
AA (34.6 5.5%) but not the USBCA males. The FBCA males (2.1 1.5 servings)
compared to the USBCA (3.4 2.2 servings) but not the AA males (3.2 2.2) consumed
significantly less (p< 0.05) meat servings, whereas fat servings were significantly lower
in the FBCA males compared to the USBCA and AA males (1.2 1.0 servings vs. 1.9
1.2 servings and 1.9 1.4 servings; p< 0.05) (Table 16).
In the female ethnic subgroups, the only difference observed was that of the
FBCA females (132.6 78.6 mg) compared to the AA (188.4 126.7 mg) but not the
USBCA females (141.2 64.7 mg) consumed significantly (p< 0.05) less dietary
cholesterol (Table 17).
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Table 16 - Mean Energy and Nutrient Intakes of Males by Ethnicity
Variables FBCA USBCA AA p
Mean SD
n=30 n30 n=29
Calories (Kcal) 1721.9 883.2a 2301.3 1 0 1 6 .0b 2337.3 1 2 7 1 .6b 0.049*
CHO' (g) 234.1 112.9 273.8 118.9 283.5 165.9 0.328
Protein (g) 66.9 38.0a 95.5 4 8 .1 b 91.3 5 0 .4b 0.037*
Total Fat (g) 59.2 37.4a 86.7 4 7 .0b 90.3 5 4 .4b 0.023*
SF 2 (g) 21.4 13.4a 30.3 17 .1 30.5 17.4 0.048*
MUFA'(g) 22.5 15.6a 3 3 .8 19.5b 3 5.1 2 1 .5b 0.023*
PUFA4 (g) 9.7 5.7a 14 .8  7.9b 17.0 11. 9b 0.006**
Cholesterol (mg) 211.2 134.1 302.3 190.4 301.7 162.4 0.052
Kcal CHO' (%) 56.0 12.2a 49.5 11
.
7b 48.4 8.1b 0.017*
Kcal Prot (%) 15.8 5.0 16.4 3.6 16.0 3.6 0.873
Kcal Fat (%) 29.4 7.6a 32.8 7. 3 ab 34.6 5 .5b 0.015*
Kcal Alcohol (%) 1.2 2.7 3.6 5.4 3.2 3.9 0.058
Kcal Sweet (%) 10.6 10.7 10.9 5.9 12.8 9.6 0.600
Fiber (g) 16.6 10.3 15.5 7.0 17.4 11.3 0.757
Fiber (Beans) (g) 3.7 5.7 2.1 3.0 3.0 4.3 0.403
Fiber (Vegetables) (g) 6.6 5.3 5.9 4.2 7.2 5.7 0.641
Fiber (Grains) (g) 6.8 4.1 7.5 4.3 7.6 4.9 0.744
Caffeine (mg) 20.0 32.9 29.3 25.1 28.2 35.7 0.462
Fruits (servings/d) 1.2 0.9 1.0 0.6 0.9 0.6 0.229
Vegetables (servings/d) 2.3 2.6 2.2 2.1 2.8 2.5 0.590
Grains (servings/d) 4.9 2.8 5.1 2.6 5.5 3.5 0.838
Meats (servings/d) 2.1 1.5 3.4 2.2 3.2 2 .2ab 0.034*
Dairy (servings/d) 1.5 1.2 1.5 1.0 1.4 1.3 0.964
Fats (servings/d) 1.2 1.0a 1. 9  1. 2b 1. 9  1.4 b 0.042*
* p<0.05; ** p<0.01
a,b Values in a row with differing superscripts differed significantly at p<0.05 (Bonferroni's test)
CHO = Carbohydrate; 2 SF = Saturated Fat; 3 MUFA = Monounsaturated Fatty Acids; 4 PUFA =
Polyunsaturated Fatty Acids
FBCA = Foreign-born Afro Caribbeans
USBCA = US-born Afro Caribbean Arnericans
AA = African Americans
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Table 17 - Mean Energy and Nutrient Intakes of Females by Ethnicity
Variables FBCA USBCA AA p
Mean SD
n=35 n=31 n=30
Calories (Kcal) 1417.4 649.5 1400.2 705.5 1575.8 739.1 0.554
CHO' (g) 201.2 91.4 197.6 112.1 206.8 100.5 0.938
Protein (g) 49.6 24.1 53.1 27.2 58.8 27.7 0.374
Total Fat (g) 47.3 26.5 46.5 23.1 56.3 33.6 0.314
SF 2 (g) 16.3 9.2 16.2 8.0 19.5 12.2 0.338
MUFA3 (g) 17.3 10.4 16.6 8.2 21.1 13.0 0.220
PUFA 4 (g) 9.4 6.2 9.3 6.0 10.8 6.6 0.596
Cholesterol (mg) 132.6 78.6a 141.2 6 4 .7ab 188.4 126.7 0.042*
Kcal CHO' (%) 57.3 8.2 55.8 7.4 52.6 8.4 0.065
Kcal Prot (%) 14.0 3.0 15.3 3.5 15.4 3.7 0.176
Kcal Fat (%) 29.3 6.2 30.2 5.2 31.6 7.1 0.340
Kcal Alcohol (%) 2.1 4.8 0.6 1.0 3.0 3.9 0.143
Kcal Sweet (%) 11.9 9.4 10.3 6.9 11.6 6.5 0.714
Fiber (g) 14.7 11.2 14.6 12.3 13.3 6.2 0.831
Fiber (Beans) (g) 2.5 3.4 3.6 4.5 2.1 2.5 0.245
Fiber (Vegetables) (g) 6.9 6.3 5.9 7.6 5.7 3.0 0.687
Fiber (Grains) (g) 5.4 4.0 5.0 3.2 5.7 3.2 0.753
Caffeine (mg) 17.0 19.1 12.9 21.7 21.5 28.9 0.362
Fruits (servings/d) 1.5 0.9 1.3 1.0 1.2 0.6 0.440
Vegetables (servings/d) 2.3 2.0 2.2 2.6 2.2 1.5 0.958
Grains (servings/d) 4.1 3.0 4.2 2.7 4.1 2.2 0.975
Meats (servings/d) 1.4 1.0 1.7 1.1 1.9 1.1 0.150
Dairy (servings/d) 1.0 0.9 1.0 0.9 1.0 0.7 0.967
Fats (servings/d) 1.3 0.7 1.2 0.7 1.7 1.0 0.079
* p< 0 .0 5
a,b Values in a row with differing superscripts differed significantly at p<0.05 (Bonferroni's test)
1 CHO = Carbohydrate; 2 SF = Saturated Fat; ' MUFA = Monounsaturated Fatty Acids; 4 PUFA
Polyunsaturated Fatty Acids
FBCA = Foreign-born Afro Caribbeans
USBCA = US-born Afro Caribbean Americans
AA = African Americans
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Mineral Intakes
The mean sodium (2555.0 1365.6 mg vs. 1779.0 916.4 mg; p< 001),
potassium (3005.3 1470.2 mg vs. 2275.2 1136.9 mg; p< 0.001), calcium 724.7
408.9 mg vs. 546.8 311.0 mg; p< 0.01), iron (15.5 7.2 mg vs. 11.3 6.4 mg; p<
0.001), magnesium (292.1 150.2 mg vs. 220.4 116.2 mg; p< 0.001), zinc (11.4 6.4
mg vs. 7.2 4.1 mg; p< 0.001) and phosphorus intakes (1237.7 621.9 mg vs. 847.6
410.6 mg; p< 0.001) of the m ales were significantly higher than those of the females.
There were no significant differences between the gender groups with respect to mineral
intakes from supplements (Table 18).
With respect to the three ethnic groups, the mean sodium intake of the FBCA
participants (1838.0 983.4 mg) was significantly (p< 0.05) lower compared to AA
(2402.6 1359.3 mg) but not USBCA (2245.2 1238.3 mg) participants. However, the
mean iron intake of the FBCA participants (11.2 5.6 mg) was significantly (p< 0.01)
lower than USBCA (15.0 8.1 mg) but not AA participants (13.8 7.0 mg) (Table 19).
The mean sodium (2031.7 1101.3 mg vs. 2760.6 1296.7 mg and 2883.7 1553.4 mg;
p< 0.05) and iron intakes (12.7 6.0 mg vs. 17.3 7.0 mg and 16.4 7.9 mg; p < 0.05)
of the FBCA males were significantly lower compared to the USBCA and AA males.
There was no significant difference observed between the male ethnic subgroups with
respect to the consumption of minerals from supplements (Table 20). There were no
significant differences between the three female ethnic subgroups with respect to the
consumption of minerals or minerals from supplements (Table 21).
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Table 18 - Mean Mineral Intakes of the Participants by Gender
Variables Males Females p
Mean SD
n=89 n=96
Sodium (mg) 2555.0 1365.6 1779.0 916.4 0.0001***
Potassium (mg) 3005.3 1470.2 2275.2 1136.9 0.0001***
Calcium (mg) 724.7 408.9 546.8 311.0 0.001**
Iron (mg) 15.5 7.2 11.3 6.4 0.0001***
Magnesium (mg) 292.1 150.2 220.4 116.2 0.0001***
Zinc (mg) 11.4 6.4 7.2 4.1 0.0001***
Phosphorus (mg) 1237.7 621.9 847.6 410.6 0.0001***
From Supplements Only n=40 n=40
Calcium (mg) ' 65.9 154.0 91.6 191.8 0.318
Iron (mg) FS# 7.1 12.5 10.4 18.8 0.170
Magnesium (mg) 21.0 30.6 28.1 39.4 0.175
Zinc (mg) 4.8 8.8 4.7 6.4 0.876
Copper (mg) 0.4 0.6 0.6 0.8 0.187
Selenium (mg) 11.6 29.5 7.3 12.2 0.184
** p<0.01; *** p<0.001
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Vitamin Intakes
Males had significantly higher mean intakes of the energy-related vitamins such
as vitamin B1 (mg) (thiamin) (1.8 0.9 vs. 1.3 0.7; p< 0.001), vitamin B2 (mg)
(riboflavin) (1.8 0.9 vs. 1.3 0.7; p< 0.001) and niacin (mg) (22.7 12.3 vs. 14.6
7.3; p< 0.001). Males also had significantly higher intakes of folate (Ig) (409.9 204.1
vs. 332.0 + 189.1; p< 0.01), vitamin B6 (mg) (2.0 1.0 vs. 1.4 0.8; p< 0.001) and
vitamin B12 (pg) (6.2 6.0 vs. 2.9 2.5; p< 0.001). The mean intakes of retinol (pg)
(preformed vitamin A) (377.1 252.9 vs. 243.0 163.3; p< 0.001), vitamin E (mg) (7.9
5.3 vs. 6.3 4.9; p< 0.05) and vitamin D (IU) (207.0 210.3 vs. 112.0 91.3; p<
0.001) were also significantly higher in the males compared to females. There were no
significant differences between male and female groups with respect to vitamin intakes
consumed from supplements (Table 22).
Within ethnic groups comparison showed the FBCA participants compared to the
USBCA and AA participants had significantly lower mean intake of the energy-related
vitamin niacin (mg) (15.1 8.2 vs. 20.6 11.3 and 20.0 12.1; p< 0.01). However, the
mean intakes from supplements were significantly higher for vitamin B1 (mg) (1.4 2.7
vs. 0.4 0.7 and 0.7 1.7; p< 0.05), Vitamin B2 (mg) (1.4 2.7 vs. 0.4 0.7 and 0.8
1.8; p< 0.05), Niacin (mg) (15.0 26.9 vs. 5.0 8.1 and 8.3 18.3; p< 0.05), Vitamin B6
(mg) (1.1 1.5 vs. 0.5 0.7 and 0.6 1.2; p< 0.05), Vitamin B12 (pg) (2.9 3.8 vs. 1.4
2.2 and 1.7 3.1; p< 0.05) and Vitamin E (mg) (41.6 104.1 vs. 10.0 19.8 and 18.3
51.2; p< 0.05) in FBCA compared to USBCA but not AA participants (Table 23).
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Table 22 - Mean Vitamin Intakes of the Participants by Gender
Male Female p
Mean SD
n=89 n=96
VitaminBi (mg) 1.8 0.9 1.3 0.7 0.0001***
Vitamin B2 (mg) 1.8 0.9 1.3 0.7 0.0001***
Niacin (mg) 22.7 12.3 14.6 7.3 0.0001***
Folate (tg) 409.9 204.1 332.0 189.1 0.008**
Vitamin B6 (mg) 2.0 1.0 1.4 0.8 0.0001***
Vitamin B12 (pig) 6.2 6.0 2.9 2.5 0.0001***
Retinol (tg) 377.1 252.9 243.0 163.3 0.0001***
Vitamin A( g) 1188.8 948.1 975.4 856.4 0.109
Vitamin C (mg) 163.9 107.3 147.8 102.6 0.298
Vitamin E (mg) 7.9 5.3 6.3 4.9 0.024*
Vitamin D (IU) 207.0 210.3 112.0 91.3 0.0001***
From Supplements Only n=40 n=43
Vitamin B1 (mg) 0.8 1.9 0.9 2.0 0.631
Vitamin B2 (mg) 0.8 1.8 1.0 2.1 0.605
Niacin (mg) 8.7 18.7 10.4 21.1 0.566
Folate (pg) 118.2 172.1 144.7 208.1 0.349
Vitamin B6 (mg) 0.7 1.1 0.8 1.3 0.389
Vitamin B12 ( g) 1.8 2.9 2.3 3.4 0.323
Vitamin A (pg) 1372.7 2089.1 1689.2 2422.1 0.344
Vitamin C (mg) 102.9 199.7 113.6 216.3 0.728
Vitamin E (mg) 18.4 44.7 28.7 87.2 0.315
Vitamin D (IU) 93.8 134.1 118.2 164.4 0.272
* p<0.05; ** p<0.01; * p<0.001
Retinol = preformed Vitamin A
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Within male ethnic groups comparison showed the mean niacin intake (mg) of the
FBCA males (17.5 9.2) was significantly (p< 0.05) lower compared to the USBCA
(26.0 11.4) and AA males (24.8 14.5). The mean vitamin intakes from supplements
were significantly higher for niacin (mg) (15.3 28.2 vs. 4.2 7.9 and 6.5 11.5; p<
0.05), vitamin B6 (mg) (1.1 1.6 vs. 0.4 0.6 and 0.5 0.8; p< 0.05) and vitamin B12
(pg) (2.9 4.1 vs. 1.1 1.8 and 1.4 2.1; p< 0.05) in FBCA males compared to the
USBCA and AA males (Table 24).
There were no significant differences between the mean vitamin intakes or the
mean vitamin intakes from supplements between the three female ethnic subgroups
(Table 25).
Dietary Intakes of Carotenoids
The mean dietary intakes of carotenoids of the participants varied widely (Table
26). Within ethnic groups comparison showed the mean dietary intake of lycopene (pg)
was significantly (p< 0.01) lower in FBCA participants (3431.7 3403.3) compared to
USBCA (6038.2 6365.1) and AAparticipants (5291.9 4227.3) (Table 27).
Within male ethnic subgroups comparison showed the USBCA males compared to AA
but not FBCA males had significantly (p< 0.05) higher mean dietary intakes of daidzein
(pg) (559.1 1530.1 vs. 0.0 and 85.6 346.7) and genisten (pg) (807.5 2201.1 vs. 0.0
and 123.6 500.8), respectively (Table 28).
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Table 26 - Mean Carotenoid Intakes of the Participants by Gender
Variables Males Females p
Mean SD
n=89 n=96
Total Carotenes' (pg) 4870.9 5174.6 4396.0 4977.3 0.525
a-carotene (pg) 678.4 965.9 610.9 873.8 0.618
-carotene (g) 3679.0 3704.5 3261.5 3570.8 0.436
Cryptoxanthin (pg) 228.0 202.2 232.0 199.8 0.891
Lutein (pg) 1509.7 1652.9 1740.4 2179.4 0.421
Lycopene (pg) 5582.3 5390.5 4237.4 4347.8 0.063
n=7 n=14
Daidzein (pg) 217.3 934.0 505.7 1511.4 0.124
Genisten (ig) 313.9 1349.2 730.5 2183.2 0.124
1 Carotene, Provitamin A corotenoids
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Macronutrient Intakes Compared to NHANES III
Males in this study, compared to non-Hispanic Black males in the NHANES III
(1988-1994), had significantly (p< 0.05) lower total fat (78.6 48.2 g vs. 94.6 g),
saturated fat (27.3 16.4 g vs. 31.7 g) and dietary cholesterol (271.4 167.7 mg vs.
358.8 mg) intakes (Table 29). Similarly for the females, the total fat (49.8 28.0 g vs.
71.2 g), saturated fat (17.3 9.9 g vs. 23.8 g) and dietary cholesterol (152.8 95.0 g
vs. 245.6 mg) intakes were significantly (p< 0.05) lower than the NHANES III values,
whereas the fiber intake (14.2 10.2g vs. 12.0 g) was significantly (p< 0.05) higher than
the NHANES III value (Table 29).
Comparison by ethnic groups showed the FBCA and USBCA participants total fat
(52.8 32.3 g and 66.3 41.7 g vs. 82.0 g), saturated fat (18.6 11.5 g and 23.1 14.9 g
vs. 27.5 g) and dietary cholesterol (168.8 114.0 mg and 220.4 161.9 mg vs. 297.9 mg)
intakes were significantly (p< 0.05) lower than the NHANES III values, whereas for the
AA participants only dietary cholesterol (244.1 155.0 mg vs. 297.9 mg) intake was
significantly (p< 0.05) lower than the NHANES III value (Table 29).
Only the FBCA males total fat (59.2 37.4 g vs. 94.6 g), saturated fat (21.4
13.4 g vs. 31.7 g) and dietary cholesterol (211.2 134.1 mg vs. 358.8 mg) intakes were
significantly (p< 0.001) lower than the NHANES III values (Table 29).
For the FBCA and USBCA females, total fat (47.3 26.5 g and 46.5 23.1 g vs.
71.2 g), saturated fat (16.3 9.2 g and 16.2 8.0 g vs. 23.9 g) and dietary cholesterol
(132.6 78.6 mg and 141.2 64.7 mg vs. 245.6 mg) intakes were significantly (p<
0.001) lower than the NHANES III values (Table 29).
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Table 29 - Macronutrient Intakes of the Participants Compared with NHANES III by
Gender, Ethnicity and Gender-ethnicity Subgroups
Variable n Total Saturated Cholesterol Fiber
Fat (g) Fat (g) (mg) (g)
Mean SD
Gender
Male 89 78.6 48.2 27.3 16.4 271.4 167.7 16.5 9.6
NHANES III 94.6 31.7 358.8 15.0
p-value 0.002** 0.014* 0.0'1*** 0.141
Female 96 49.8 28.0 17.3 9.9 152.8 95.0 14.2 10.2
NHANES III 71.2 23.8 245.6 12.0
p-value 0.0001*** 0.0001*** 0.0001*** 0.037*
Ethnicity
FBCA 65 52.8 32.3 18.6 11.5 168.8 114.0 15.6 10.7
USBCA 61 66.3 41.7 23.1 14.9 220.4 161.9 15.0 .9
AA 59 73.0 47.8 24.9 15.8 244.1 155.0 15.3 9.2
NHANES I1 82.0 27.5 297.9 13.4
p-value (FBCA) 0.0001*** 0.0001*** 0.0001*** 0.105
p-value (USBCA) 0.005** 0.025* 0.0001*** 0.202
p-value (AA) 0.153 0.209 0.010* 0.121
Males by Ethnicity
FBCA 30 59.2 37.4 21.4 13.4 211.2 134.1 16.6 10.3
USBCA 30 86.7 47.0 30.3 17.1 302.3 190.4 15.5 7.0
AA 29 90.3 54.4 30.5 17.4 301.7 162.4 17.4 11.3
NIANES III 94.6 31.7 358.8 15.0
p-value (FBCA) 0.0001*** 0.0001*** 0.0001*** 0.390
p-value (USBCA) 0.366 0.652 0.115 0.680
p-value (AA) 0.672 0.706 0.069 0.264
Females by Ethnicity
FBCA 35 47.3 26.5 16.3 9.2 132.6 78.6 14.7 11.2
USBCA 31 46.5 23.1 16.2 8.0 141.2 64.7 14.6 12.3
AA 30 56.3 33.6 19.5 12.2 188.4 126.7 13.3 6.2
NHANES III 71.2 23.8 245.6 12.0
p-value (FBCA) 0.0001*** 0.0001*** 0.0001*** 0.164
p-value (USBCA) 0.0001*** 0.0001*** 0.0001*** 0.253
p-value (AA) 0.022* 0.062 0.019* 0.275
* p<0.05; ** p<0.01; *** p<0.001
NHANES III (values are for non-Hispanic Blacks, Popkin et al., 2001)
FBCA = Foreign-born Afro Caribbeans;
USBCA = US-born Afro Caribbean Americans
AA = African Americans
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However, for the AA females, only total fat (56.3 33.6 g vs. 71.2 g) and dietary
cholesterol (188.4 126.7 mg vs. 245.6 mg) intakes were significantly (p< 0.05) lower
than the NHANES III value (Table 29).
Dietary Guidelines and Food Group Servings
In comparing the participants reported dietary intakes with the American Heart
Association/National Cholesterol Education Program Dietary Guidelines and the USDA
Food Guide Pyramid serving guidelines, a tendency to over-consume sodium, energy
from fat and, under-consume the food group servings, especially fruits, vegetables, grains
and dairy was observed. More females compared to males, consumed significantly (p <
0.05) more energy from carbohydrate (50.0% vs. 31.5%), folate (71.9% vs. 53.9%),
vitamin B6 (43.8% vs. 27.0%) and vitamin B12 (54.2% vs. 23.6%), whereas more males
consumed significantly (p< 0.05) more energy from fat (69.7% vs. 53.1%), saturated fat
(56.2% vs. 32.3%), dietary cholesterol (38.2% vs. 7.3%) and sodium (48.3% vs. 20.8%)
(Table 30).
More FBCA (55.4%) participants than AA (25.4%) but not the USBCA
participants (41.0%) consumed significantly (p< 0.01) more energy from carbohydrate. In
addition, more FBCA participants than USBCA and AA participants consumed
significantly (p< 0.01) less energy from fat (46.2% vs. 65.6% and 72.9%). Also, more
FBCA (21.5%) participants compared to AA (5.1%) but not USBCA (13.1%) participants
consumed significantly (p< 0.01) more than two servings of fruits per day (Table 31).
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Table 30 - Percentages of the Participants Consuming Below or Above the Dietary
Guidelines and Food Guide Pyramid Servings 2 of Selected Macronutrients by Gender
Variables Males Females p Dietary
n=89 n=96 Guidelines & Food
% % Guide Sevings 2
Kcal Carbohydrate (%)
< 55 68.5 50.0 0.010* 55 - 60
> 55 31.5 50.0
Kcal Fat (%)
< 30 30.3 46.9 0.021* < 30
> 30 69.7 53.1
Saturated Fat (g)
< 20 43.8 67.7 0.001** 20
> 20 56.2 32.3
Cholesterol (mg)
< 300 61.8 92.7 0.0001*** 300
> 300 38.2 7.3
Sodium (mg)
< 2400 51.7 79.2 0.0001*** 2400
> 2400 48.3 20.8
Fiber (g)
> 25 15.7 11.5 0.396 25 -35
< 25 84.3 88.5
Fruits (servings/d)
> 2 10.1 16.7 0.193 2-4
< 2 89.9 83.3
Vegetables (servings/d)
>3 25.8 28.1 0.727 3-5
< 3 74.2 71.9
Folate (jag)
> 400 46.1 28.1 0.011* 400'
< 400 53.9 71.9
Vitamin B6 (mg)
> 1.3 73.0 56.3 0.017* 1.3
< 1.3 27.0 43.8
Vitamin B12 (pg)
> 2.4 76.4 45.8 0.0001*** 2.4
< 2.4 23.6 54.2
p<0.05; ** p< 0.01; * p<0.001
Dietary Guidelines of Americans (AHA statistical Update, 2003; NCEP: ATP III, 2001)
2 Food Guide Pyramid (w .usda.gov/fnic/Fpyr/pyramid.h 1, Accessed 05/16/04)
3 As dietary folate equivalent (DFE)
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Table 31 - Percentages of the Participants Consuming Below or Above the Dietary
Guidelines and Food Guide Pyramid Servings2 of Selected Macronutrients by Ethnicity
Variables FBCA USBCA AA p Dietary
n=65 n=61 n=59 Guidelines'&
Food Guide
% % % Sevings
Kcal Carbohydrate (%)
< 55 44.6 59.0 74.6 0.003** 55 - 60
> 55 55.4a 4 1 .0 ab 25.4b
Kcal Fat (%)
<30 53.8a 34.4b 27.1l 0.007** < 30
> 30 46.2 65.6 72.9
Saturated Fat (g)
< 20 64.6 54.1 49.2 0.205 < 20
> 20 35.4 45.9 50.8
Cholesterol (mg)
< 300 83.1 77.0 72.9 0.387 < 300
> 300 16.9 23.0 27.1
Sodium (mg)
< 2400 73.8 62.3 61.0 0.246 2400
> 2400 26.2 37.7 39.0
Fiber (g)
> 25 18.5 11.5 10.2 0.343 25-35
<25 81.5 88.5 89.8
Fruits (servings/d)
> 2 21.5a 13.1ab 5.1l 0,028* 2-4
<2 78.5 86.9 94.9
Vegetables (servings/d)
>3 30.8 19.7 30.5 0.287 3-5
<3 69.2 80.3 69.5
Folate (tg)
> 400 32.3 41.0 37.3 0.598 400
< 400 67.7 59.0 62.7
Vitamin B6 (mg)
> 1.3 58.5 65.6 69.5 0.427 1.3
< 1.3 41.5 34.4 30.5
Vitamin B12 (p:g)
> 2.4 56.9 62.3 62.7 0.759 2.4
<2.4 43.1 37.7 37.3
* p< 0.05; **p< 0.01
a,b Values in a row with differing superscripts differed significantly at p<0.05 (Bonferroni's test)
1 Dietary Guidelines of Americans (AHA statistical Update, 2003; NCEP: ATP III, 2001)
2 Food Guide Pyramid ( ,usdagov/fnic/Fpyr/pvramid.htm1. Accessed 05/16/04)
3 As dietary folate equivalent (DFE)
FBCA = Foreign-bom Afro Caribbeans
USBCA = US-bom Afro Caribbean Americans
AA = African Americans
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Within male ethnic groups comparison showed significantly (p< 0.05) more
FBCA males (50.0%) compared to AA (13.8%) but not USBCA males (30.0%),
consumed more energy from carbohydrate, whereas significantly (p< 0.05) more FBCA
(50.0%) males compared to AA (17.2%) but not USBCA (23.3%) males consumed less
energy from fat (Table 32). With respect to the dietary guidelines, no significant
differences between the three female ethnic subgroups were observed (Table 33).
Diet Score
A diet score was devised based on 7 selected recommended dietary behaviors
(percent energy from fat, saturated fat, dietary cholesterol, fiber, sodium, fruit and
vegetable servings). Individuals who exceeded the dietary recommendations for percent
energy from fat, saturated fat, cholesterol and sodium were assigned a score of 0 and a
score of 1 if they met the dietary requirements. Participants who consumed below the
dietary recommendations for dietary fiber, fruit and vegetable servings were assigned a
score of 0 and 1 if they met the dietary requirements. This score was summed across the
selected food items to give a total diet score. The diet score ranged from 0-7. Higher
scores were indicative of good diet quality. For this study, the diet scores 0 - 2 were
categorized as 'poor diet quality', 3 - 5 as 'moderate' and > 6 and greater as 'good'
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Table 32 - Percentages of Male Participants Consuming Below or Above the Dietary
Guidelines and Food Guide Pyramid Servings2 of Selected Macronutrients by Ethnicity
Variables FBCA USBCA AA p Dietary
n=30 n=30 n=29 Guidelines'
& Food Guide
% %o % Sevin2s 2
Kcal CHO 3 (%)
< 55 50.0 70.0 86.2 0.011* 55 - 60
> 55 50.Oa 30.ab 13 .8b
Kcal Fat (%)
< 30 50.0 23.3 17.2 0.014* < 30
> 30 50.0a 76.7ab 82.8b
Saturated Fat (g)
< 20 53.3 40.0 37.9 0.430 20
> 20 46.7 60.0 62.1
Cholesterol (mg)
< 300 70.0 56.7 58.6 0.519 300
> 300 30.0 43.3 41.4
Sodium (mg)
< 2400 66.7 46.7 41.4 0.120 2400
> 2400 33.3 53.3 58.6
Fiber (g)
> 25 20.0 10.0 17.2 0.547 25 - 35
< 25 80.0 90.0 82.8
Fruits (servings/d)
> 2 20.0 6.7 3.4 0.081 2-4
< 2 80.0 93.3 96.6
Vegetables (servings/d)
> 3 23.3 16.7 37.9 0.163 3-5
< 3 76.7 83.3 62.1
Folate (pg)
> 400 43.3 43.3 51.7 0.758 4003
< 400 56.7 56.7 48.3
Vitamin B6 (mg)
> 1.3 66.7 76.7 75.9 0.626 1.3
< 1.3 33.3 23.3 24.1
Vitamin B12 (fag)
> 2.4 66.7 80.0 82.8 0.295 2.4
< 2.4 33.3 20.0 17.2
*p< 0. 05
ab Values in a row with differing superscripts differed significantly at p<0.05 (Bonferroni's test)
1Dietary Guidelines of Americans (AHA statistical Update, 2003; NCEP: ATP III, 2001)
2 Food Guide Pyramid (www.usda.gov/fnic/Fp3/pramid.html. Accessed 05/16/04)
3 As dietary folate equivalent (DFE)
FBCA = Foreign-born Afro Caribbeans
USBCA = US-born Afro Caribbean Americans
AA= African Americans
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Table 33 - Percentages of Female Participants Consuming Below or Above the Dietary
Guidelines and Food Guide Pyramid Servings2 of Selected Macronutrients by Ethnicity
Variables FBCA USBCA AA p Dietary
n=30 n=30 n=29 Guidelines'
& Food Guide
% % % Sevin2s2
Kcal CO' (%)
<55 40.0 48.4 63.3 0.168 55 - 60
> 55 60.0 51.6 36.7
Kcal Fat (%)
<30 57.1 45.2 36.7 0.250 < 30
> 30 42.9 54.8 63.3
Saturated Fat
<20 74.3 67.7 60.0 0.471 20
> 20 25.7 32.3 40.0
Cholesterol (mg)
<300 94.3 96.8 86.7 0.286 300
> 300 5.7 3.2 13.3
Sodium (mg)
<2400 80.0 77.4 80.0 0.959 2400
> 2400 20.0 22.6 20.0
Fiber (g)
> 25 17.1 12.9 3.3 0.209 25 - 35
<25 82.9 87.1 96.7
Fruits (servings/d)
> 2 22.9 19.4 6.7 0.193 2-4
<2 77.1 80.6 93.3
Vegetables (servings/d)
>3 37.1 22.6 23.3 0.330 3-5
<3 62.9 77.4 76.7
Folate (pg)
> 400 22.9 38.7 23.3 0.281 400-
< 400 77.1 61.3 76.7
Vitamin B6 (mg)
? 1.3 51.4 54.8 63.3 0.617 1.3
<1.3 48.6 45.2 36.7
Vitamin B12 (pg)
> 2.4 48.6 45.2 43.3 0.911 2.4
<2.4 51.4 54.8 56.7
1 Dietary Guidelines of Americans (AHA statistical Update, 2003; NCEP: ATP III, 2001)
2 Food Guide Pyramid ( wwwusda gov/fnic/F /p i.htm1. Accessed 05/16/04)
3 CHO = Carbohydrate
FBCA = Foreign-born Afro Caribbeans
USBCA = US-born Afro Caribbean Americans
AA = African Americans
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The mean diet score of males (2.4 1.7) was significantly (p< 0.001) lower than
females (3.4 1.4). Also, the percentage of males (32.6%) with diet scores 0 - 2 was
significantly (p< 0.001) higher than females (8.3%) (Table 34).
Within ethnic groups comparison showed the mean diet score of the FBCA
participants (3.5 1.6) was significantly (< 0.01) higher than the USBCA (2.7 1.7)
and AA participants (2.6 1.5) (Table 34). Within male ethnic subgroups comparison
showed similar trends as the mean diet score of FBCA males (3.0 1.6) was significantly
(p< 0.05) higher than the USBCA (2.0 1.9) but not the AA males (2.1 1.4). Also, the
percentage of FBCA males (16.7%) with diet score 0 - 2 was significantly (p< 0.05)
lower than USBCA (50.0%) but not AA males (31.0%) (Table 34). However, the mean
diet score of FBCA females (3.8 1.5) was significantly (p< 0.05) higher compared to
the AA (3.0 1.5) but not the USBCA females (3.4 0.9) (Table 34).
Physical Activity Indices Scores, Sports, and Television Watching
The work activity index (WAI), sports activity index (SAI) and leisure time
activity index (LTAI) scores ranged from 0.0-5.0. The summation of these scores is
named the physical activity index (PAI) score. The PAI score ranged from 0.0-15.0.
Although more males than females had significantly (p< 0.001) higher mean PAI (8.4
1.1 vs. 7.2 1.3), WAI (2.7 0.7 vs. 2.4 0.5), SAI (3.0 0.8 vs. 2.2 0.8) and played
sports (73.6% vs. 26.5%), no significant differences were observed between the three
ethnic groups, the three male ethnic subgroups or the three female ethnic subgroups with
respect to these variables (Tables 35 and 36).
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Table 34 - Mean and Frequency Distribution of the Diet Scores of Participants by
Gender, Ethnicity and Gender-ethnicity Subgroups
Variable Diet Score Diet Score Categories
Mean SD 0-2 3-5 6
n% %
Gender
Male 89 2.4 1.7 32.6 56.2 11.2
Female 96 3.4 1.4 8.3 75.0 16.7
p-value 0.001*** 0.001***
Ethnicity
FBCA 65 3.5 1.6a 10.8 69.2 20.0
USBCA 61 2.7 1 .7b 26.2 62.3 11.5
AA 59 2.6 1 .5b 23.7 66.1 10.2
p-value 0.003** 0.128
Males by Ethnicity
FBCA 30 3.0 1.6a 16.7a 66.7 16.7
USBCA 30 2.0 1 .9 b 5.0 36.7 13.3
AA 29 2 .1 1.4 ab 31.Oa 65.5 3.4
p-value 0.038* 0.030*
Females by Ethnicity
FBCA 35 3.8 1.5a 3.2 87.1 9.7
USBCA 31 3 .4  0. 9 ab 3.2 87.1 9.7
AA 30 3.0 1.5 16.7 66.7 16.7
p-value 0.036* 0.170
* p<0.05; ** p<0.01; *** p<0.001
a,b Values in a column with differing superscripts differed significantly at p<0.05 (Bonferroni's
test)
Diet Score Range 0 - 7, where 0 is poor diet and 7 good diet
FBCA = Foreign-born Afro Caribbeans
USBCA = US-born Afro Caribbean Americans
AA = African Americans
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Table 35 - Mean Physical Activity Indices of the Participants by Gender, Ethnicity and
Gender-ethnicity Subgroups
Variable n ,P WAI SAl LTAI
Mean SD
Gender
Male 91 8.4 1.1 2.7 0.7 3.0 0.8 2.7 0.6
Female 98 7.2 1.3 2.4 0.5 2.2 0.8 2.7 0.6
p-value 0.001*** 0.001*** O.OO1*** 0.752
Ethnicity
FBCA 66 7.9 1.4 2.5 0.6 2.6 0.9 2.7 0.7
USBCA 62 7.7 1.2 2.5 0.6 2.5 0.9 2.7 0.5
AA 61 7.9 1.5 2.7 0.7 2.6 1.0 2.6 0.6
p-value 0.818 0.186 0.836 0.683
Males by Ethnicity
FBCA 31 8.4 1.2 2.6 0.7 3.0 0.7 2.8 0.7
USBCA 30 8.3 1.0 2.7 0.6 3.0 0.8 2.7 0.5
AA 30 8.5 1.2 3.0 0.7 3.1 0.9 2.5 0.5
p-value 0.784 0.071 0.862 0.085
Females by Ethnicity
FBCA 35 7.3 1.4 2.4 0.5 2.3 0.9 2.6 0.6
USBCA 32 7.1 1.2 2.4 0.5 2.1 0.8 2.7 0.6
AA 31 7.2 1.4 2.4 0.6 2.1 0.8 2.7 0.7
p-value 0.907 0.875 0.536 0.713
*** p<0.0 0 1
PAI= Physical Activity Index, Range 3.0 - 15.0, where 3.0 is low and 15.0 is high; WAI = Work
Activity Index, Range 1.0 - 5.0, where 1.0 is low and 5.0 is high; SA= Sports Activity Index,
Range 1.0 - 5.0, where 1.0 is low and 5.0 is high; LTAI = Leisure Time Activity Index, Range
1.0 - 5.0, where 1.0 is low and 5.0 is high
FBCA = Foreign-born Afro Caribbeans
USBCA = US-born Afro Caribbean Americans
AA = African Americans
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Table 36 - Distribution of the Physical Activities of the Participants by Gender, Ethnicity
and Gender-ethnicity Subgroups
Variable n Played Sports Watched Television
No Yes Never/ Often/
Sometimes Very Often
Gender
Male 91 26.4 73.6 43.7 52.7
Female 98 73.5 26.5 53.1 46.9
p-value 0.001*** 0.425
Ethnicity
FBCA 66 40.9 59.1 54.5 45.5
USBCA 62 56.5 43.5 45.2 54.8
AA 61 55.7 44.3 50.8 49.2
p-value 0.137 0.566
Males by Ethnicity
FBCA 31 16.1 83.9 58.1 41.9
USBCA 30 30.0 70.0 40.0 60.0
AA 30 33.3 66.7 43.3 56.7
p-value 0.269 0.321
Females by Ethnicity
FBCA 35 62.9 37.1 51.4 48.6
USBCA 32 81.3 18.7 50.0 50.0
AA 31 77.4 22.6 58.1 41.9
p-value 0.196 0.791
*** p<0 .0 0 1
FBCA = Foreign-born Afro Caribbeans
USBCA = US-born Afro Caribbean Americans
AA = African Americans
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Anthropometrics
Body mass index [BMI; body weight (kg)/height (in 2)] was used as an indicator of
overall adiposity. Normal weight is defined as BMI 18.5 - 24.9 kg/ 2, overweight as
BMI 25-29.9 kg/r2 and obesity as BMI ? 30 kg/m2 (Obesity: Class I BMI 30.0-34.9
kg/ 2 ; Class II BMI 35.0-39.9 kg/ 2 ; Class III BMI 40.0 kg/m 2). Abdominal obesity was
defined as waist circumference (WC) greater than 40 inches for males and 35 inches for
females (NCEP: ATP III, 2001).
The mean body weight (85.1 21.0 kg vs. 66.1 13.6 kg), height (1.8 0.1 m vs.
1.6 0.1), BMI (26.9 5.8 vs. 24.9 4.4) and WC (34.8 4.7 vs. 31.6 4.0) were
significantly (p< 0.001) higher in males than females (Table 37). Also, significantly (p<
0.05) more males than females were overweight (36.3% vs. 26.5%) and obese (19.8% vs.
12.2%) (Table 38). Ethnic groups comparison showed that although there were no
significant differences between the three ethnic groups with respect to the mean weight,
height, BMI and WC values (Table 37), significantly (p< 0.05) more AA (23.0%) and
USBCA participants (17.7%) were obese compared to the FBCA participants (7.6%)
(Table 38). Similarly, although there were no significant differences between the three
male ethnic subgroups with respect to the mean weight, height, BMI and WC values
(Table 37), significantly (p< 0.01) more AA (33.3%) and USBCA males (20.0%) were
obese compared to the FBCA males (6.5%) (Table 38). There were no significant
differences between the three female ethnic subgroups with respect to the mean weight,
height, BMI and WC values (Table 37) or the percentages of those who were obese and
had abdominal obesity (Table 38).
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Table 37 - Anthropometrics of the Participants by Gender, Ethnicity and Gender-
ethnicity Subgroups
Variable n Height Weight BMI WC
(i) (kg) (kg/m2) (inches)
Mean SD
Gender
Male 91 1.8 0.1 85.1 21.0 26.9 5.8 34.8 4.7
Female 98 1.6 0.1 66.1 13.6 24.9 4.4 31.6 4.0
p-value 0.001*** 0.001*** 0.008** 0.001***
Ethnicity
FBCA 66 1.7 0.1 71.7 15.1 24.8 4.0 32.6 4.1
USBCA 62 1.7 0.1 76.1 17.9 26.2 4.8 33.5 4.6
AA 61 1.7 1.0 78.4 25.4 26.7 6.6 33.5 5.2
p-value 0.740 0.144 0.104 0.430
Males by Ethnicity
FBCA 31 1.8 0.1 80.6 14.1 25.4 4.2 33.8 3.9
USBCA 30 1.8 0.1 85.4 16.9 27.3 4.9 35.6 4.2
AA 30 1.8 0.1 89.5 28.9 28.2 7.7 35.0 5.8
p-value 0.735 0.258 0.165 0.346
Females by Ethnicity
FBCA 35 1.6 0.1 63.6 11.1 24.3 3.8 31.5 4.0
USBCA 32 1.6 0.1 67.3 14.2 25.2 4.5 31.6 4.0
AA 31 1.6 0.1 67.7 15.6 25.3 5.0 32.1 4.1
p-value 0.593 0.400 0.601 0.826
** p<0.01; *** p<O.001
BMI = Body Mass Index; WC = Waist Circumference
FBCA = Foreign-born Afro Caribbeans
USBCA = US-born Afro Caribbean Americans
AA = African Americans
129
Table 38 - Distribution of the Anthropometrics of the Participants by Gender, Ethnicity
and Gender-ethnicity Subgroups
Variable n BMI (kg/m2) WC (inches)
< 25.0 25.0-29.9 30.0 < 40m/35f > 40m/35f
Gender
Male 91 44.0 36.2 19.8 87.9 12.1
Female 98 61.2 26.5 12.2 83.7 16.3
p-value 0.017* 0.405
Ethnicity
FBCA 66 62.1 30.3 7.6a 89.4 10.6
USBCA 62 41.9 40.3 17 .7b 83.9 16.1
AA 61 54.0 23.0 2 3 .0 b 83.6 16.4
p-value 0.034* 0.570
Males by Ethnicity
FBCA 31 58.0 35.5 6.5a 93.5 6.5
USBCA 30 26.7 53.3 2 0 .0 b 86.7 13.3
AA 30 46.7 20.0 3 3 .3b 83.3 16.7
p-value 0.008** 0.458
Females by Ethnicity
FBCA 35 65.7 25.7 8.6 88.6 11.4
USBCA 32 56.3 28.1 15.6 81.3 18.8
AA 31 61.3 25.8 12.9 83.9 16.1
p-value 0.912 0.885
* p<0.05; ** p<0.01
a,b Values in a colun with differing superscripts differed significantly at p<0.05 (Bonferroni's
test)
BMI = Body Mass Index; WC = Waist Circumference
FBCA = Foreign-born Afro Caribbeans
USBCA = US-born Afro Caribbean Americans
AA = African Americans
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Cigarette Smoking and Alcohol Consumption
Although significantly (p< 0.05) more AA (n=3, 9.7%) females smoked cigarettes
compared to FBCA (0.0%) and USBCA (0.0%) females, additional analysis using the
Bonferroni's post hoc test showed no significant differences in smoking habits between
the three females ethnic subgroups (Table 39). The percentage of FBCA (n=16, 24.2%)
participants who consumed more than one alcoholic beverage per month was
significantly (p< 0.05) lower than AA (n=31, 50.8%) participants but not the USBCA
(n=18, 29.0%) participants. However, further analysis using the Bonferroni's post hoc
test showed no significant differences in alcohol consumption between the three ethnic
groups (Table 39).
Similarly, the percentage of FBCA (n=5, 16.1%) males who consumed more than
one alcoholic beverage per month was significantly (p< 0.01) lower compared to USBCA
(n=13, 43.3%) and AA (n=19, 63.3%) participants, but further analysis using the
Bonferroni's post hoc test showed no significant differences in alcohol consumption
between the three male ethnic subgroups (Table 39).
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Table 39 - Distribution Cigarette Smoking and Alcohol Consumption of the of the
Participants by Gender, Ethnicity and Gender-ethnicity Subgroups
Variable Cigarette Smoking Alcohol Consumption
No Yes No < 1 drink/ > 1 drink/
month month
Gender
Male 91 95.6 4.4 22.0 37.3 40.7
Female 98 96.9 3.1 33.7 37.8 28.6
p-value 0.627 0.080
Ethnicity
FBCA 66 100.0 0.0 27.3 48.5 24.2
USBCA 62 95.2 4.8 33.9 37.1 29.0
AA 61 93.4 6.6 23.0 26.2 50.8
p-value 0.125 0.012*
Males by Ethnicity
FBCA 31 100.0 0.0 29.0 54.8 16.1
USBCA 30 90.0 10.0 26.7 30.0 43.3
AA 30 96.7 3.3 10.0 26.7 63.3
p-value 0.154 0.004**
Females by Ethnicity
FBCA 35 100.0 0.0 25.7 42.9 31.4
USBCA 32 100.0 0.0 40.6 43.8 15.6
AA 31 90.3 9.7 35.5 25.8 38.7
p-value 0.035* 0.202
* p<0.05; ** p<0.01
FBCA = Foreign-born Afro Caribbeans
USBCA = US-born Afro Caribbean Americans
AA = African Americans
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Section 3 - Research Question 3: Are FBCA adults less likely to have physiological
risk factors for CHD as compared to USBCA and AA adults?
Systolic Blood pressure (SBP) (> 120 mm Hg), diastolic blood pressure (DBP) (>
80 mm Hg), fasting blood glucose (FBG) (> 110 mg/dL), total cholesterol (TC) ( 200
mg/dL), low-density lipoprotein cholesterol (LDL-C) ( 130 mg/dL) and triglyceride
(TG) levels ( 200 mg/dL) are considered elevated, whereas high-density lipoprotein
cholesterol (HDL-C) levels < 40 mg/dL, males and < 50 mg/dL, females are considered
undesirable. These risk factors are those currently used to evaluate risk for CHD (NCEP:
ATP III, 2001; AHA Statistical Update, 2004).
Blood Pressures
The mean SBP (mm Hg) (111.9 11.7 vs. 104.6 9.9) and DBP (74.6 8.6 vs.
69.9 8.8) of the males were significantly (p< 0.001) higher than the females (Table 40).
Also, significantly (p< 0.05) more males than females (22.0% vs. 13.3%) had elevated
SBP and DBP (35.2% vs. 19.4%) (Table 41).
There were no significant differences between the three ethnic groups or the three
male and three female ethnic subgroups with respect to the mean SBP, DBP or the
percentages of the three ethnic groups or the three male and three female ethnic
subgroups with elevated SBP and DBP (Tables 40 and 41).
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Table 40 - Mean Blood Pressure Levels of Participants by Gender, Ethnicity and
Gender-ethnicity Subgroups
Variable n SBP (mm Hg) DBP (mm Hg)
Mean SD
Gender
Male 91 111.9 11.7 74.6 8.6
Female 98 104.6 9.9 69.9 8.8
p-value 0.001*** 0.001***
Ethnicity
FBCA 66 107.8 10.3 72.6 9.1
USBCA 62 107.6 11.0 71.5 8.9
AA 61 109.0 12.8 72.4 9.3
p-value 0.753 0.790
Males by Ethnicity
FBCA 31 110.3 12.0 74.0 9.6
USBCA 30 111.0 10.2 74.0 7.4
AA 30 114.3 12.8 75.8 8.9
p-value 0.365 0.646
Females by Ethnicity
FBCA 35 105.6 8.0 71.3 8.5
USBCA 32 104.4 10.9 69.2 9.6
AA 31 103.9 10.8 69.0 8.4
p-value 0.773 0.513
*** p< 0 .0 0 1
SBP = Systolic Blood Pressure; DBP = Diastolic Blood Pressure
FBCA = Foreign-born Afro Caribbeans
USBCA = US-born Afro Caribbean Americans
AA = African Americans
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Table 41 - Distribution of Blood Pressures of the Participants by Gender, Ethnicity and
Gender-ethnicity Subgroups
Variable n SBP (mm Hg) DBP (mm Hg)
<120 >20 <80 80
% c% %'l %D
Gender
Male 91 78.0 22.0 64.8 35.2
Female 98 90.8 13.3 80.6 19.4
p-value 0.015* 0.015*
Ethnicity
FBCA 66 84.8 15.2 72.2 27.3
USBCA 62 87.1 12.9 79.0 21.0
AA 61 80.0 18.0 67.2 32.8
p-value 0.731 0.335
Males by Ethnicity
FBCA 31 74.2 25.8 71.0 29.0
USBCA 30 86.7 13.3 73.3 26.7
AA 30 73.3 26.7 50.0 50.0
p-value 0.376 0.113
Females by Ethnicity
FBCA 35 94.3 5.7 74.3 25.7
USBCA 32 87.5 12.5 84.4 15.6
AA 31 90.3 9.7 83.9 16.1
p-value 0.626 0.386
* p< 0
.
05
SBP = Systolic Blood Pressure; DBP = Diastolic Blood Pressure
FBCA = Foreign-born Afro Caribbeans
USBCA = US-born Afro Caribbean Americans
AA = African Americans
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Blood Glucose and Blood Lipids
The mean FBG, TC, LDL-C, TG and VLDL values were not significantly
different between the genders, the three ethnic groups or between the three male and
three female ethnic subgroups (Table 42). Although no significant differences were
observed between the percentages of participants with elevated FBG (? 110 mg/dL), TC
(? 200 mg/dL), LDL-C ( 130 mg/dL), and TG (? 150 mg/dL), the percentages of those
with elevated FBG levels ranged from 5.7% in FBCA females to 6.7% in USBCA and
AA males, those with elevated TC ranged from 19.4% in FBCA males to 37.5% in
USBCA females, those with elevated LDL-C ranged from 22.6% in FBCA males to
43.3% in USBCA males and those with elevated TG ranged from 8.6% in FBCA females
to 16.1% in FBCA males (Table 43).
However, the mean HDL-C level (mg/dL) of the males (43.7 7.7) was
significantly (p< 0.001) lower compared to the females (55.0 12.5) (Table 42). Also,
the percentage of the males (35.2%) with undesirable HDL-C (< 40 mg/dL) was
significantly (p< 0.001) higher compared to the females (8.2%) (Table 43).
The mean HDL-C levels or the percentages of individuals with undesirable HDL-
C levels did not differ between the three ethnic groups (Tables 42 and 44). However, the
percentage of the FBCA males (48.1%) with undesirable HDL-C (< 40 mg/dL) was
higher than the USBCA (20.0%) and the AA males (36.7%) (Table 45) whereas, the
percentage of USBCA (50.0%) females with undesirable HDL-C level was higher
compared to FBCA (31.4%) and AA (19.4%) females (Table 46).
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Table 43 - Distribution of Physiological Risk Factors of the Participants by Gender
Variables Males Females p
n=91 n=98
FBG (mg/dL)
<110 93.4 93.9 0.894
>110 6.6 6.1
TC (mg/dL)
<200 72.5 65.3 0.284
>200 27.5 34.7
LDL-C (mg/dL)
< 130 69.2 72.4 0.626
> 130 30.8 27.6
TG (mg/dL)
< 150 87.9 88.8 0.853
>150 12.1 11.2
HDL-C (mg/dL)
40"/< 50 35.2 8.2 0.001***
40-59.9"/50-59.9' 61.6 61.2
> 60 3.3 30.6
m= male
f= female
FBG = Fasting Blood Glucose 110 mg/dL undesirable; TC = Total Cholesterol 200 mg/dL =
elevated; LDL-C = Low-density Lipoprotein Cholesterol 130 mg/dL = Undesirable; HDL-C =
High-density Lipoprotein Cholesterol (mg/dL) < 40 (males), < 50 (females) = Undesirable; TG
= Triglyceride 150 = undesirable (NCEP: ATP III, 2001; JNC VII, 2003).
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Table 44 - Distribution of Physiological Risk Factors of the Participants by Ethnicity
Variables FBCA USBCA AA p
n=66 n=62 n=61
FBG (mg/dL)
< 110 93.9 93.5 93.4 0.993
>110 6.1 6.5 6.6
TC (mg/dL)
< 200 74.2 62.9 68.9 0.384
>200 25.8 37.1 31.1
LDL-C (mg/dL)
< 130 72.7 64.5 75.4 0.380
> 130 27.3 35.5 24.6
TG (mg/dL)
< 150 87.9 88.7 88.5 0.988
> 150 12.1 11.3 11.5
HDL-C (mg/dL)
< 40/50 39.4 35.5 29.5 0.425
40-59.9m/5 -59f 50.0 46.8 47.5
>60 10.6 17.7 23.0
f= female
FBG = Fasting Blood Glucose 110 mg/dL undesirable; TC = Total Cholesterol 200 mg/dL
elevated; LDL-C = Low-density Lipoprotein Cholesterol > 130 mg/dL = Undesirable; HDL-C =
High-density Lipoprotein Cholesterol (mg/dL) < 40 (males), < 50 (females) = Undesirable; TG
= Triglyceride 150 = undesirable (NCEP: ATP III, 2001; JNC VII, 2003).
FBCA = Foreign-born Afro Caribbeans
USBCA = US-born Afro Caribbean Americans
AA = African Americans
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Table 45 - Distribution of the Physiological Risk Factors of the Male Participants by
Ethnicity
Variables FBCA USBCA AA p
n=31 n=30 n=30
FBG (mg/dL)
< 110 93.5 93.3 93.3 0.999
>110 6.5 6.7 6.7
TC (mg/dL)
< 200 80.6 63.3 73.3 0.315
200 19.4 36.7 26.7
LDL-C (mg/dL)
< 130 77.4 56.7 73.3 0.179
> 130 22.6 43.3 26.7
TG (mg/dL)
< 150 83.9 90.0 90.0 0.697
? 150 16.1 10.0 10.0
HDL-C (mg/dL)
< 40 48.4a 20.0b 36.7 0.002**
40-59.9 51.6 73.3 60.0
>60 0.0 6.7 3.3
**p< 0.0 1
a,b Values in a row with differing superscripts differed significantly at p<0.05 (Bonferroni's test)
FBG = Fasting Blood Glucose > 110 mg/dL undesirable; TC = Total Cholesterol 200 mg/dL =
elevated; LDL-C = Low-density Lipoprotein Cholesterol 130 mg/dL = Undesirable; HDL-C =
High-density Lipoprotein Cholesterol < 40 mg/dL = Undesirable; TG = Triglyceride = 150
undesirable (NCEP: ATP III, 2001; JNC VII, 2003).
FBCA = Foreign-born Afro Caribbeans
USBCA = US-born Afro Caribbean Americans
AA = African Americans
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Table 46 - Distribution of the Physiological Risk Factors of the Female Participants by
Ethnicity
Variable FBCA USBCA AA p
n=35 n=32 n=31
FBG (mg/dL)
< 110 94.3 93.8 93.5 0.384
>110 5.7 6.2 6.6
TC (mg/dL)
< 200 68.6 62.5 64.5 0.681
>200 31.4 37.5 35.5
LDL-C (mg/dL)
< 130 68.5 71.9 77.4 0.525
> 130 31.4 30.0 23.3
TG (mg/dL)
< 150 91.4 87.5 87.1 0.425
> 150 8.6 12.5 12.9
HDL-C (mg/dL)
< 50 31.4a 50 .0b 19.5a 0.033*
50.0-59.9 48.6 21.9 38.7
> 60 20.0 28.1 41.9
*p< 0 .05
a,b Values in a row with differing superscripts differed significantly at p<0.05 (Bonferroni's test)
FBG = Fasting Blood Glucose ? 110 mg/dL undesirable; TC = Total Cholesterol 200 mg/dL =
elevated; LDL-C = Low-density Lipoprotein Cholesterol 130 mg/dL = Undesirable; HDL-C =
High-density Lipoprotein Cholesterol < 50 mg/dL = Undesirable; TG = Triglyceride 150
undesirable (NCEP: ATP III, 2001; JNC 7, 2003).
FBCA = Foreign-born Afro Caribbeans
USBCA = US-born Afro Caribbean Americans
AA = African Americans
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Section 4- Research Question 4: Are FBCA Less Likely to have Emerging Risk
Factors for Coronary Heart Disease compared to USBCA and AA Adults?
High-sensitivity C-Reactive Protein
It is suggested that high-sensitivity CRP (hs-CRP) levels greater than 10 mg/L
should not be used to assess CYD risk since this may reflect ongoing infection, systemic
inflammation or trauma (Pearson et al., 2003). Thus, individuals (3 males; 12 females)
with hs-CRP levels greater than 10 mg/L were excluded from data analysis in this study (.
Participants with hs-CRP levels greater than 3.0 mg/L were considered to be at increased
risk for CHD (Pearson et al., 2003).
Comparing by ethnicity, the mean hs-CRP levels of the FBCA (1.1 1.3 mg/L)
and USBCA participants (1.3 1.6 mg/L) were significantly (p< 0.01) lower compared to
the AA participants (2.2 2.7 mg/L) (Table 47). Comparing by female ethnic subgroups,
the mean hs-CRP levels (mg/L) of the FBCA (1.0 1.3) and USBCA females (1.1 1.4)
were significantly (p< 0.05) lower compared to the AA females (2.4 2.8) (Table 47).
Total Cholesterol/High-density Lipoprotein Cholesterol (TC/HDL-C) Ratio
Participants with a TC/HDL-C ratio 5.0 were considered to be at increased risk for
CHD (Rifai and Ridker, 2001; Natarajan et al., 2003). In our study, the mean TC/HDL-C
ratio of the males (4.0 1.2) was significantly (p< 0.01) higher than females (3.5 1.4)
(Table 47). Also, the percentage of the males (18.7%) with elevated TC/HDL-C ratio (
5.0) was significantly (p< 0.001) higher than that of the females (12.23%) (Table 48).
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Table 47- Mean Emerging Risk Factors of the Participants by Gender, ethnicity and
Gender-ethnicity Subgroups
Variables n hs-CRP n TC/HDL-C n Homocysteine
(mg/L) Ratio (pmol/L)
Mean SD
Gender
Male 88 1.6 2.0 91 4.0 1.2 88 7.4 2.2
Female 86 1.5 2.1 98 3.5 1.4 95 6.0 2.3
p-value 0.803 0.003** 0.001***
Ethnicity
FBCA 57 1.1 1.3a 66 3.6 1.3 62 6.6 2.7
USBCA 57 1.3 1.6a 62 4.0 1.5 60 6.6 1.8
AA 60 2 ,2 2 .7b 61 3.6 1.1 61 6.8 2.5
p-value 0.004** 0.190 0.895
Males by Ethnicity
FBCA 28 1.2 1.2 31 3.8 1.3 28 7.4 1.5
USBCA 30 1.4 1.8 30 4.2 1.1 30 7.4 1.7
AA 30 2.1 2.7 30 4.1 1.2 30 7.4 3.2
p-value 0.219 0.458 0.999
Females by Ethnicity
FBCA 29 1.0 1.3a 35 3.5 1.2 34 6.0 3.2
USBCA 27 11 1.4a 32 3.8 1.8 30 5.8 1.5
AA 30 2 .4 2 .8b 31 3.2 0.8 31 6.2 1.5
p-value 0.013* 0.169 0.799
* p<0.05; ** p<0.01; *** p<0.001
a,b Values in a column with differing superscripts differed significantly at p<0.05 (Bonferroni test)
hs-CRP = high-sensitivity C-reactive Protein
TC/HDL-C = Total Cholesterol/High-density Lipoprotein Cholesterol Ratio
FBCA = Foreign-born Afro Caribbeans
USBCA = US-born Afro Caribbean Americans
AA = African Americans
143
p Al C> C 4 
00 cn
" C Ili cli 06
C> C) 00 1%0 i<= 00 V- rq V- 00 00 r-kn 
16
r 9J 
C " { l C C31 C71 C C C7 CT C> C1 cn oa ,- + C>
as
00 kn 00
00 M M M p
06 C^ e C' i 0 'CC * -+ da C' p C> aO O t 7C'i cli c 116 N 06-4
ri Ca kn C71 LO C3 ,'
' w
AA
CC3 C C? 06 wi ' M OQ cli *- a-
.. F-9 V o N ' ' M S6 M N IZT r- 'TtI t
00 kn
C7' c l1 LO LO M M M M Cn M $
I I
C?
00 cn V) 00 t--
06 16
p
rte. t j M 'm 00
tt"S M 00 M C> IND M M r- 00 W t ~- M
a
03
ass
cz 
-
dW t' ® C7 a c [ a M cn' p
00 r- C) 00 0 r C> (= p -0 as
en M N M V ' p
~' 
C O Cd
00 II '' II c
as a U a> as 
11
' 
I1
w '
P. 4, sn ;'
fomocysteine
Homocysteine levels greater than 10 ptmol/L were considered elevated (Malinow
et al., 1999). In the present study, the mean homocysteine level (ptmol/L) of males (7.4
2.2) was significantly (p< 0.001) higher than that of the females (6.0 2.3) (Table 47).
Additional Findings
Clustering of Behavioral and Metabolic Risk Factors
The risk of CHD rises sharply as the number of risk factors increase. Individuals
in whom CHD develops generally have more than one risk factor.
For the purposes of this study behavioral and metabolic risk factors were
organized into 2 categories:
1. Behavioral/Environmental Risks (diet score 0 - 2, watched TV often/very
often (an indication of sedentary lifestyle), BMI > 25.0, cigarette smoking,
consuming alcoholic beverages > once per month) were each given a score of
1 and, (diet score > 3, watched TV never/sometimes, BMI < 25.0, no cigarette
smoking, consuming alcoholic beverages < once per month) were each given
a score of 0. The scores were summed across the selected
behavioral/environmental risks to give a total score. Higher scores were
indicative of 'poor' behavioral/environmental habits.
2. According to the NCEP: ATP III Panel, individuals with 3 of the following 5
factors: (1) abdominal obesity - waist circumference > 40 inches in men and >
35 inches in women; (2) S/DBP 130/85 mm Hg; (3) FBG 110 mg/dL; (4)
TG 150 mg/dL; (5) HDL-C < 40 mg/dL, were classified as meeting the
145
criteria for the metabolic syndrome (MS). Waist circumference was used
because it correlates more strongly with abdominal obesity than BMI. An
additional evaluation of the individuals classified with or without the MS was
done using the new guideline for BP cut-points (JNC VII, 2004).
The mean behavioral/environmental risk factors for CHD was significantly (p<
0.001) lower in females (1.2 0.9) compared to males (1.9 1.1). Significantly (p< 0.01)
more males (24.2%) than females (8.2%) had three or more behavioral risk factors (Table
49).
By ethnicity, the mean behavioral/environmental risk factors for CHD was
significantly (p< 0.01) lower in FBCA (1.2 0.8) participants compared to USBCA (1.7
1.2) and AA (1.7 1.0) participants (Table 49). Significantly (p< 0.05) more USBCA
(22.6%) and AA (19.7%) participants had 3 or more behavioral/environmental risk
factors compared to the FBCA (6.1%) participants (Table 49). By ethnicity subgroups,
the mean behavioral/environment risk factors for CUD of the FBCA (1.2 0.8) males
was significantly (p< 0.001) lower compared to the USBCA (2.4 1.2) and AA (2.0
1.0) males (Table 49). Similarly, the percentages of USBCA (36.7%) and AA (33.3%)
males with 3 or more behavioral/environmental risk factors were significantly (p< 0.01)
higher compared to FBCA (3.2%) males (Table 49).
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Table 49 - Mean and Frequency Distribution of the Behavioral/Environmental Risk
Factors of Participants by Gender, Ethnicity and Gender-ethnicity Subgroups
Variables n Behavioral/Environmental Risk Factors
Risk Categories
0 1-2 3
n Mean SD % % %
Gender
Male 91 1.9 1.1 9.9 65.9 24.2
Female 98 1.2 0.9 18.8 73.5 8.2
p-value 0.001*** 0.006**
Ethnicity
FBCA 66 1.2 0.8a 21.2 72.7 6.1a
USBCA 62 1.7 1 .2b 11.3 66.1 22.6b
AA 61 1. 7  1.0b 9.8 70.5 19.7b
p-value 0.01** 0.041*
Males by Ethnicity
FBCA 31 1.2 0.8a 22.6 74.2 3.2a
USBCA 30 2.4 1 .2b 0.0 63.3 36.7b
AA 30 2 .0 1.0b 6.7 60.0 3.3b
p-value 0.0001*** 0.002**
Females by Ethnicity
FBCA 35 1.2 0.9 20.0 71.4 8.6
USBCA 32 1.1 0.9 21.9 68.8 9.4
AA 31 1.5 0.8 12.9 80.6 6.5
p-value 0.258 0.865
* p<0.05; ** p<0.01; * p<0.001
a,b Values in a column with differing superscripts differed significantly at p<0.05 (Bonferroni's
test)
'Range 0 -5 for Behavioral/Environmental Risks
FBCA = Foreign-born Afro Caribbeans
USBCA = US-born Afro Caribbean Americans
AA = African Americans
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The NCEP: ATP III (2001) criteria for the MS were detected in 2.1% of this population
(males, 2.2%; females, 2.0%). However, significantly (p< 0.05) more female (71.4%)
than male (49.5%) participants had no risk factors for the MS (Table 50). There was no
significant difference in the percentages of FBCA (1.5%), USBCA (1.6%) or AA (3.2%)
participants who met the criteria for the MS (Table 50). When the JNC VII Guidelines for
elevated blood pressure (S/DBP ? 120/80 mm Hg) were used, with respect to the
metabolic syndrome, an additional 4 males met the criteria for the MS compared to the
females (6.6% vs. 2.0%) (Table 51).
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Table 50 - Risk Factor Categories for the Metabolic Syndrome of Participants by
Gender, Ethnicity and Gender-ethnicity Subgroups
Variables Number of Risk Factors for the Metabolic Syndrome
0 1-2 >3(MS)
n% %
Gender
Male 91 49.5 48.4 2.2
Female 98 71.4 26.5 2.0
p-value 0.023*
Ethnicity
FBCA 66 59.1 39.4 1.5
USBCA 62 61.3 37.1 1.6
AA 61 62.3 34.4 3.2
p-value 0.932
Males by Ethnicity
FBCA 31 41.9 58.1 0.0
USBCA 30 56.7 43.3 0.0
AA 30 50.0 43.3 6.7
p-value 0.642
Females by Ethnicity
FBCA 35 74.3 22.9 2.9
USBCA 32 65.6 31.3 3.1
AA 31 74.2 25.8 0.0
p-value 0.865
* p<0 .05
MS = Metabolic Syndrome
FBCA = Foreign-born Afro Caribbeans
USBCA = US-born Afro Caribbean Americans
AA = African Americans
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Table 51 - Risk Factor Categories for the Metabolic Syndrome of Participants by
Gender, Ethnicity and Gender-ethnicity Subgroups Using JNC VII Cut-points for Blood
Pressure
Variables Number of Risk Factors for the Metabolic Syndrome
0 1-2 3(MS)
n% % %
Gender
Male 91 45.1 48.4 6.6
Female 98 66.3 31.7 2.0
p-value 0.039*
Ethnicity
FBCA 66 54.5 37.8 4.5
USBCA 62 58.1 40.3 1.6
AA 61 55.7 32.8 6.5
p-value 0.867
Males by Ethnicity
FBCA 31 38.7 54.9 6.5
USBCA 30 53.5 46.7 0.0
AA 30 43.3 43.3 13.4
p-value 0.505
Females by Ethnicity
FBCA 35 68.6 28.6 2.9
USBCA 32 62.5 34.4 3.1
AA 31 67.7 32.3 0.0
p-value 0.366
* p< 0 .0 5
MS = Metabolic Syndrome
FBCA = Foreign-born Afro Caribbeans
USBCA = US-born Afro Caribbean Americans
AA = African Americans
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Section 5- Relationships between Socio-demographic Variables and
Behavioral/Environmental Risk Factors in FBCA, USBCA and AA Participants
There were no associations between either education or household income (proxy
for socio-economic status) with the behavioral/environmental risk factors by gender
(Table 52). Age correlated positively with the diet score (r=0.245; p< 0.05) and positively
with body mass index (BMI) in males but not in females, whereas age correlated
positively with cigarette smoking in the females. Family history of CHD was positively
associated with cigarette smoking (r=0.213; p< 0.05) in males but not females (Table 52).
Like the gender groups, there were no associations between the socio-economic
status (SES) and the behavioral/environmental risk factors by ethnicity (Table 53). In the
FBCA and USBCA participants, age was positively associated with BMI (r=0.277, p<
0.05; r=0.277, p< 0.05, respectively). Also, age was positively associated with the diet
score (r=0.321; p< 0.05) in FBCA participants and positively with cigarette smoking
(r=0.413; p< 0.01) in AA participants (Table 53). Knowledge of CHD risk factors was
negatively associated with the physical activity index (PAI) (r=-0.413; p< 0.01) in the
FBCA participants and positively associated with BMI in AA participants (Table 53).
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Table 52 - Correlations between Selected Socio-demographic Variables and the
Behavioral/Environmental Risk Factors of the Participants by Gender
Males Females
Variables n=91 n=98
Age
Diet Score 0.245* -0.159
Physical Activity Index -0.096 0.054
Body Mass Index 0.296** 0.080
Cigarette Smoking 0.098 0.259*
Alcohol Intake -0.073 0.122
Education
Diet Score -0.154 0.105
Physical Activity Index -0.064 -0.141
Body Mass Index 0.102 0.010
Cigarette Smoking -0.145 -0.073
Alcohol Intake -0.045 0.132
Household Income
Diet Score -0.121 -0.023
Physical Activity Index -0.159 0.037
Body Mass Index 0.111 -0.111
Cigarette Smoking -0.084 -0.024
Alcohol Intake -0.004 0.069
Knowledge of CHD Risks
Diet Score 0.056 -0.109
Physical Activity Index -0.158 -0.061
Body Mass Index 0.175 0.064
Cigarette Smoking 0.027 0.069
Alcohol Intake -0.031 0.020
Family History of CHD
Diet Score 0.058 0.034
Physical Activity Index -0.071 -0.064
Body Mass Index -0.019 0.159
Cigarette Smoking 0.213* 0.010
Alcohol Intake 0.064 0.020
*p< 0.05,;** p< 0.01
CHD = Coronary Heart Disease
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Table 53 - Correlations between Selected Socio-demographic Variables and the
behavioral/Environmental Risk Factors of the Participants by Ethnicity
FBCA USBCA AA
Variables n=66 n=62 n=61
Age
Diet Score 0.321* -0.140 0.016
Physical Activity Index 0.017 -0.207 0.139
Body Mass Index 0.277* 0.255* 0.204
Cigarette Smoking -- 0.043 0.413**
Alcohol Intake -0.032 0.083 -0.002
Knowledge of CHD Risks
Diet Score -0.045 0.003 -0.182
Physical Activity Index -0.413** -0.102 0.059
Body Mass Index -0.039 -0.130 0.378**
Cigarette Smoking -- 0.020 0.031
Alcohol Intake 0.081 -0.003 -0.109
Family History of CHD
Diet Score 0.085 0.077 -0.132
Physical Activity Index -0.060 -0.191 0.008
Body Mass Index -0.039 0.184 -0.004
Cigarette Smoking -- 0.152 0.154
Alcohol Intake -0.011 0.102 0.093
Education
Diet Score -0.044 -0.153 0.087
Physical Activity Index -0.162 -0.192 0.001
Body Mass Index 0.080 0.023 0.072
Cigarette Smoking -- -0.203 -0.111
Alcohol Intake 0.085 0.021 0.009
Household Income
Diet Score 0.005 -0.150 -0.014
Physical Activity Index -0.112 0.140 -0.068
Body Mass Index -0.054 0.012 0.089
Cigarette Smoking -- -0.142 0.003
Alcohol Intake 0.114 0.077 -0.081
* p<0.05; ** p<0.01
CHD = Coronary Heart Disease
FBCA = Foreign-born Afro Caribbeans
USBCA = US-born Afro Caribbean Americans
AA = African Americans
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Relationships between Socio-demographic Variables and Physiological Risk Factors
In females, age was positively associated with diastolic blood pressure (DBP)
(r=0.231; p< 0.05). In males, education was negatively associated with systolic blood
pressure (SBP) (r=-0.227; p< 0.05) whereas in females, education was positively
associated with total cholesterol (TC) (r=0.254; p< 0.05) and low-density lipoprotein
cholesterol (LDL-C) (r=0.257; p< 0.05) (Table 54). males, the perceived stress (PS)
score was positively associated with HDL-C (r=0.210; p< 0.05) (Table 54).
In the AA participants, age was positively associated with SBP (r=0.500; p< 0.01)
and DBP (r=0.406; p< 0.01) (Table 55). In USBCA participants, education was positively
associated with total cholesterol (TC) (r=0.307; p< 0.05) and, in USBCA and AA
participants, positively associated with LDL-C (r=0.302, p< 0.05; r=0.309; p< 0.05),
respectively (Table 55). In the FBCA participants, household income was negatively
associated with TC (r=-0.297; p< 0.05) and LDL-C (r=-0.329; p< 0.01) (Table 55).
The PS score in USBCA participants was negatively associated with SBP (r=-0.377; p<
0.01) and DBP (r=-0.365; p< 0.01). Also, the PS score was positively associated with
fasting blood glucose (FBG) (r=0.284; p< 0.05) in AA participants whereas, in FBCA
participants, the PS score was positively associated with high-density lipoprotein
cholesterol (HDL-C) (Table 55).
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Table 54 - Correlations between Selected Socio-demographic Variables and the
Physiological Risk Factors of the Participants by Gender
Males Females
Variables n=91 n=98
Age
Systolic Blood Pressure 0.129 0.163
Diastolic Blood Pressure 0.080 0.231*
Fasting Blood Glucose 0.037 -0.076
Total Cholesterol 0.149 0.018
LDL-C 0.045 0.066
TG -0.034 -0.106
HDL-C 0.151 -0.089
Education
Systolic Blood Pressure -0.227* 0.167
Diastolic Blood Pressure -0.129 0.174
Fasting Blood Glucose 0.072 0.007
Total Cholesterol 0.030 0.254*
LDL-C 0.036 0.257*
TG 0.030 -0.081
HDL-C -0.122 0.094
Household Income
Systolic Blood Pressure 0.019 0.003
Diastolic Blood Pressure -0.076 0.131
Fasting Blood Glucose 0.045 -0.026
Total Cholesterol -0.128 -0.118
LDL-C -0.111 -0.178
TG -0.028 -0.134
HDL-C 0.110 -0.106
Perceived Stress Score
Systolic Blood Pressure -0.119 -0.170
Diastolic Blood Pressure -0.156 -0.132
Fasting Blood Glucose -0.066 0.118
Total Cholesterol -0.093 -0.094
LDL-C -0.110 -0.073
TG -0.065 -0.006
HDL-C 0.210* -0.167
Family History of CuD
Systolic Blood Pressure -0.021 -0.162
Diastolic Blood Pressure 0.035 -0.146
Fasting Blood Glucose -0.140 -0.105
Total Cholesterol 0.198 0.110
LDL-C 0.161 0.148
TG 0.048 0.054
HDL-C 0.132 -0.091
* p< 0.05; ** p< 0.01
CHD = Coronary Heart Disease; LDL-C = Low-density Lipoprotein Cholesterol; TG =
Triglyceride; HDL-C = High-density Lipoprotein Cholesterol
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Table 55 - Correlations between Selected Socio-demographic Variables and the
Physiological Risk Factors of the Participants by Ethnicity
FBCA USBCA AA
Variables n=66 n=62 n=61
Age
Systolic Blood Pressure -0.045 -0.087 0.500**
Diastolic Blood Pressure 0.054 -0.116 0.406**
Fasting Blood Glucose -0.101 -0.059 0.112
Total Cholesterol 0.069 -0.018 0.202
LDL-C 0.054 -0.010 0.153
TG -0.148 -0.080 0.032
HDL-C 0.170 -0.099 0.064
Education
Systolic Blood Pressure -0.078 -0.066 -0.012
Diastolic Blood Pressure 0.047 -0.112 0.080
Fasting Blood Glucose 0.073 0.040 -0.043
Total Cholesterol 0.003 0.307* 0.247
LDL-C -0.022 0.302* 0.309*
TG -0.093 0.013 0.009
HDL-C 0.083 0.124 -0.119
Household Income
Systolic Blood Pressure 0.046 -0.089 0.090
Diastolic Blood Pressure 0.081 -0.079 0.083
Fasting Blood Glucose -0.151 0.074 0.111
Total Cholesterol -0.297* -0.144 0.051
LDL-C -0.329** -0.172 0.068
TG -0.127 -0.030 -0.081
HDL-C -0.019 -0.012 0.158
Perceived Stress Score
Systolic Blood Pressure -0.172 -0.377** -0.008
Diastolic Blood Pressure -0.109 -0.365** -0.059
Fasting Blood Glucose -0.145 -0.057 0.284*
Total Cholesterol -0.024 -0.073 -0.131
LDL-C -0.070 -0.062 -0.134
TG -0.075 -0.039 -0.005
HDL-C 0.267* -0.079 -0.028
Family History of CHD
Systolic Blood Pressure -0.193 0.009 -0.103
Diastolic Blood Pressure -0.160 0.041 -0.065
Fasting Blood Glucose -0.081 -0.058 -0.208
Total Cholesterol 0.099 0.273* 0.025
LDL-C 0.067 0.319* -0.005
HDL-C 0.055 -0.114 0.123
* p<0.05; ** p<0.01
CHD = Coronary Heart Disease; LDL-C = Low-density Lipoprotein Cholesterol; HDL-C = High-
density Lipoprotein Cholesterol
FBCA = Foreign-born Afro Caribbeans
USBCA = US-born Afro Caribbean Americans
AA = African Americans
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Relationships between Behavioral/Environmental and Physiological Risk Factors
The number of vegetable servings was negatively associated with TC (r=0.231;
p< 0.05) in females (Table 56). In the male and female groups, there were strong and
positive associations between BMI and SBP (r=0.503, p< 0.01; r=0.261; p< 0.01) and,
BMI and DBP (r=0.471, p< 0.01; r=0.309; p< 0.01), respectively (Table 57). Also, in
males, BMI was positively associated with TC (r=0.293; p< 0.01), LDL-C (r=0.275; p<
0.01) and TG (r=0.256; p< 0.05), whereas in females, BMI was negatively associated
with HDL-C (r=-0.277; p< 0.01) (Table 57). Cigarette smoking was positively associated
with FBG (r=0.202; p< 0.05) in females, whereas alcohol consumption was positively
associated with triglyceride (TG) (r=0.253; p< 0.05) in males (Table 57).
Within ethnic groups comparison showed the diet score was positively associated
with HDL-C (r=0.287; p< 0.05) in the AA participants (Table 58). The number of
vegetable servings was positively associated with DBP (r=0.264; p< 0.05) and negatively
with TC (r=-0.325; p< 0.05) in USBCA participants. Also, in the USBCA participants,
fiber intake was negatively associated with TC (r=-0.306; p< 0.05), whereas in AA
participants dietary cholesterol intake was negatively associated with HDL-C (r=-0.297;
p< 0.05) (Table 58).
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Table 56 - Correlations between Selected Dietary Components and Physiological Risk
Factors of the Participants by Gender
Males Ferales
Variables n=89 n=96
Diet Score
Systolic BP 
-0.083 -0.145
Diastolic BP -0.081 -0.164
Fasting BG -0.108 -0.018
Total Cholesterol 0.187 0.001
LDL-C 0.190 0.007
TG -0.041 0.040
HDL-C 0.093 -0.083
Vegetable Servings
Systolic BP 0.165 0.110
Diastolic BP 0.031 0.133
Fasting BG -0.017 0.183
Total Cholesterol 0.009 -. 231*
LDL-C 0.030 -0.192
TG -0.069 -0.025
HDL-C -0.010 0.009
Fiber
Body Mass Index 0.086 0.011
Systolic BP 0.145 0.018
Diastolic BP 0.004 0.063
Fasting BG -0.002 0.071
Total Cholesterol -0.057 -0.162
LDL-C -0.062 -0.100
TG -0.047 0.032
HDL-C 0.133 -0.068
Cholesterol
Body Mass Index 0.013 -0.101
Systolic BP -0.032 -0.002
Diastolic BP -0.067 -0.078
Fasting BG -0.070 -0.046
Total Cholesterol 0.199 -0.064
LDL-C 0.190 -0.045
TG 0.018 -0.079
HDL-C 0.073 -0.032
* <0 .05
BP = Blood Pressure; BG = Blood Glucose; LDL-C = Low-density Lipoprotein Cholesterol; TG
= Triglyceride; HDL-C = High-density Lipoprotein Cholesterol
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Table 57 - Correlations between the Behavioral/Environmental and Physiological Risk
Factors of the Participants by Gender
Males Females
Variables n=89 n=96
Physical Activity Index
Systolic BP 0.091 -0.013
Diastolic BP 0.018 -0.013
Fasting BG 0.085 0.018
Total Cholesterol 0.008 -0.112
LDL-C 0.041 -0.138
TG -0.059 0.024
HDL-C -0.045 0.163
Body Mass Index
Systolic BP 0.503** 0.261**
Diastolic BP 0.471** 0.309**
Fasting BG 0.156 0.075
Total Cholesterol 0.293** -0.059
LDL-C 0.275** -0.002
TG 0.256* 0.088
HDL-C -0.140 -0.277**
Cigarette Smoking
Body Mass Index 0.077 -0.107
Systolic BP -0.114 0.149
Diastolic BP -0.158 0.063
Fasting BG -0.057 0.202*
Total Cholesterol 0.108 -0.005
LDL-C 0.205 -0.110
TG 0.085 0.124
HDL-C -0.158 -0.053
Alcohol Intake
Systolic BP -0.158 0.044
Diastolic BP 0.002 0.060
Fasting BG 0.031 -0.054
Total Cholesterol 0.102 -0.016
LDL-C 0.054 0.019
TG 0.253* 0.065
HDL-C -0.140 -0.034
* p<0.05; * p<0.01
BP = Blood Pressure; BG = Blood Glucose; LDL-C = Low-density Lipoprotein Cholesterol; TG
= Triglyceride; HDL-C =, High-density Lipoprotein Cholesterol
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Table 58 - Correlations between Selected Dietary Components and Physiological Risk
Factors of the Participants by Ethnicity
FBCA USBCA AA
Variables n=65 n=61 n=59
Diet Score
Systolic BP -0.050 0.048 0.015
Diastolic BP -0.013 0.087 -0.144
Fasting BG -0.091 0.043 -0.052
Total Cholesterol -0.071 0.201 -0.103
LDL-C -0.081 0.234 0.013
TG 0.203 -0.095 -0.124
HDL-C -0.181 -0.056 0.287*
Vegetable Servings
Systolic BP 0.091 0.187 0.161
Diastolic BP -0.065 0.264* 0.077
Fasting BG 0.011 0.146 0.143
Total Cholesterol -0.038 -0.325* 0.063
LDL-C -0.012 -0.210 0.004
TG -0.237 -0.111 0.229
HDL-C 0.057 -0.144 0.015
Fiber
Systolic BP 0.139 0.037 0.172
Diastolic BP -0.128 0.246 0.109
Fasting BG -0.014 0.202 -0.003
Total Cholesterol -0.077 -0.306* 0.038
LDL-C -0.055 -0.197 0.024
TG -0.131 0.013 0.146
HDL-C 0.075 -0.187 -0.062
Cholesterol
Systolic BP 0.059 0.078 0.183
Diastolic BP -0.118 0.119 0.114
Fasting BG -0.097 0.075 -0.065
Total Cholesterol 0.016 0.088 -0.093
LDL-C -0.021 0.157 0.000
TG 0.154 -0.129 -0.018
HDL-C -0.147 -0.129 -0.297*
* p<0 .0 5 .
BP = Blood Pressure; BG = Blood Glucose; LDL-C = Low-density Lipoprotein Cholesterol; TG
= Triglyceride; HDL-C = High-density Lipoprotein Cholesterol
FBCA = Foreign-born Afro Caribbeans
USBCA = US-born Afro Caribbean Americans
AA = African Americans
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For the AA participants, the physical activity index (PAI) was positively
associated with SBP (r=0.312; p< 0.05), whereas for the USBCA participants, the PAI
was negatively associated with TC (r=-0.319; p< 0.05) and LDL-C (r=-0.329; p< 0.01)
(Table 59). For the FBCA participants, BMI was positively correlated with DBP
(r=0.270; p< 0.05), whereas for the USBCA and AA participants, BMI was strongly and
positively associated with SBP (r=0.514, p< 0.01; r=0.566; p< 0.01) and DBP (r=0.434,
p< 0.01; r=0.555; p< 0.01), respectively. The BMI was also associated positively with TC
(r=0.270; p< 0.05) and LDL-C (r=0.307; p< 0.05) in the USBCA participants, whereas
the BMI was negatively associated with HDL-C in the FBCA (r=-0.309; p< 0.05) and AA
participants (r=-0.306; p< 0.05) (Table 59).
Relationships between Socio-demographic Variables and Emerging Risk Factors
Within gender groups comparison showed no significant relationship between the
socio-demographic variables and the emerging risk factors for CHD (Table 60). Within
ethnic groups comparison showed age was positively associated with TC/HDL-C ratio
(r=0.282; p< 0.05) in AA participants (Table 60). For the AA participants, education was
positively associated with TC/HDL-C ratio (r=0.289; p< 0.05), whereas for the USBCA
participants, family history of CHD was positively associated with hs-CRP (r=0.270; p<
0.05) (Table 60).
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Table 59 - Correlations between Behavioral/Environmental and Physiological Risk
Factors of the Participants by Ethnicity
FBCA USBCA AA
Variables n=66 n=62 n=61
Physical Activity Index
Systolic BP 0.044 0.121 0.312*
Diastolic BP -0.067 0.196 0.229
Fasting BG 0.096 0.030 0.058
Total Cholesterol -0.118 -0.319* 0.143
LDL-C -0.058 -0.329** 0.219
TG 0.125 -0.211 0.052
HDL-C -0.232 0.079 -0.226
Body Mass Index
SBP 0.114 0.514** 0.566**
DBP 0.270* 0.434** 0.555**
FBG 0.172 0.151 0.088
TC 0.041 0.270* -0.036
LDL-C 0.111 0.307* -0.002
TG 0.126 0.157 0.241
HDL-C -0.309* -0.219 -0.306*
Cigarette Smoking
Systolic BP -- 0.084 0.020
Diastolic BP -- 0.046 -0.033
Fasting BG-- 0.072 0.136
Total Cholesterol -- 0.177 0.082
LDL-C -- 0.209 0.009
TG -- 0.081 0.049
HDL-C -- -0.121 0.206
Alcohol Intake
Systolic BP -0.094 -0.137 0.049
Diastolic BP -0.005 0.016 0.067
Fasting BG 0.004 0.002 -0.092
Total Cholesterol 0.114 0.006 0.085
LDL-C 0.070 -0.009 0.098
TG 0.147 0.078 0.214
HDL-C 0.224 -0.089 -0.181
* p<0.05; ** p<0.01
BP = Blood Pressure; BG = Blood Glucose; LDL-C = Low-density Lipoprotein Cholesterol; TG
= Triglyceride; HDL-C = High-density Lipoprotein Cholesterol
FBCA = Foreign-born Afro Caribbeans
USBCA = US-born Afro Caribbean Americans
AA = African Americans
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Table 60 - Correlations between selected Socio-demographic Variables and the
Emerging Risk Factors of the Participants by Gender and by Ethnicity
Gender Males Females
Variables n=91 n=98
Age
hs-CRP 0.089 0.115
TC/HDL-C Ratio 0.135 0.071
Education
hs-CRP -0.077 0.088
TC/HDL-C Ratio 0.046 0.079
Household Income
hs-CRP -0.017 0.065
TC/HDL-C Ratio -0.005 -0.112
Family History of CHD
hs-CRP 0.153 0.107
TC/HDL-C Ratio 0.042 0.136
Ethnicity FBCA USBCA AA
Variables n=66 n=62 n=61
Age
hs-CRP 0.070 0.106 0.076
TC/HDL-C Ratio 0.113 0.097 0.282*
Education
hs-CRP 0.155 0.087 -0.131
TC/IDL-C Ratio -0.105 0.103 0.289*
Household Income
hs-CRP 0.128 -0.016 0.074
TC/HDL-C Ratio -0.172 -0.049 0.048
Family History of
CHD
hs-CRP -0.015 0.270* 0.160
TC/HDL-C Ratio 0.065 0.158 -0.082
* p0 .05
CHD = Coronary Heart Disease; hs-CRP = high-sensitivity C-reactive Protein, TC/IDL-C =
Total Cholesterol to High-density Lipoprotein Cholesterol
FBCA = Foreign-born Afro Caribbeans
USBCA = US-born Afro Caribbean Americans
AA = African Americans
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Relationships between Behavioral/Environmental and Emerging Risk Factors
The number of vegetable servings was negatively associated with TC/HDL-C
ratio (r--0.201; p< 0.05) in females (Table 61). In males and females, BMI was positively
associated with hs-CRP (r=0.258, p< 0.05; r=0.377, p< 0.01), whereas in males only,
BMI was positively associated with TC/HDL-C ratio (r=0.325; p< 0.01) (Table 62). Also,
cigarette smoking was positively associated with hs-CRP (r=0.397; p< 0.01) in males
(Table 62). Within ethnic groups comparison showed the PAI was negatively associated
with TC/HDL-C ratio (r=-0.340; p< 0.01) in USBCA participants (Table 62). For the
FBCA and USBCA participants, BMI was positively associated with hs-CRP (r=0.278,
p< 0.05; r=0.357, p< 0.05) and TC/HDL-C ratio (r=0.287, p< 0.05; r=0.298, p< 0.05),
respectively, whereas BMI was only positively associated with hs-CRP (r=0.308; p<
0.05) in the AA participants (Table 62). Also, cigarette smoking was strongly and
positively associated with hs-CRP (r=0.522; p< 0.01) in USBCA participants (Table 62).
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Table 61 - Correlations between Selected Dietary Components and the Emerging Risk
Factors of the Participants by Gender and by Ethnicity
Gender Males Female
Variables n=91 n=98
Diet Score
hs-CRP -0.051 0.041
TC/HDL-C Ratio 0.073 0.053
Vegetable Servings
hs-CRP 0.211 -0.047
TC/HDL-C Ratio -0.006 -O.2O1*
Fiber
hs-CRP 0.063 -0.037
TC/HDL-C Ratio -0.123 -0.105
Homocysteine 0.129 0.182
Cholesterol
hs-CRP 0.030 -0.068
TC/HDL-C Ratio 0.090 -0.057
Ethnicity FBCA USBCA AA
Variables n=66 n=62 n=61
Diet Score
hs-CRP 0.150 0.049 -0.214
TC/HDL-C Ratio 0.056 0.138 0.146
Vegetable Servings
hs-CRP 0.023 0.036 -0.018
TC/HDL-C Ratio -0.072 -0.202 0.063
Fiber
hs-CRP -0.004 -0.025 -0.091
TC/HDL-C Ratio -0.111 -0.170 0.087
Cholesterol
hs-CRP -0.072 -0.126 -0.074
TC/HDL-C Ratio 0.046 0.083 0.181
*p< 0.0 5
hs-CRP = high-sensitivity C-reactive Protein, TC/HDL-C = Total Cholesterol to High-density
Lipoprotein Cholesterol
FBCA = Foreign-born Afro Caribbeans
USBCA = US-born Afro Caribbean Americans
AA = African Americans
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Table 62 - Correlations between the Behavioral/Environmental and the Emerging Risk
Factors of the Participants by Gender and Ethnicity
Males Females
n=91 n=98
Variables r value
Physical Activity Index
hs-CRP -0.039 -0.022
TC/HDL-C Ratio 0.055 -0.232*
Body Mass Index
hs-CRP 0.258* 0.377**
TC/HDL-C Ratio 0.325** 0.136
Cigarette Smoking
hs-CRP 0.397** -0.102
TC/HDL-C Ratio 0.121 -0.066
Alcohol Intake
hs-CRP 0.059 0.129
TC/HDL-C Ratio 0.090 0.034
By Ethnicity FBCA USBCA AA
n=66 n=62 n=61
Physical Activity Index
hs-CRP -0.060 -0.141 -0.112
TC/HDL-C Ratio 0.076 -0.340** -0.141
Body Mass Index
hs-CRP 0.278* 0.357* 0.308*
TC/HDL-C Ratio 0.287* 0.298* 0.239
Cigarette Smoking
hs-CRP -- 0.522** -0.010
TC/HDL-C Ratio -- 0.137 -0.079
Alcohol Intake
hs-CRP -0.231 0.189 0.241
TC/HDL-C Ratio -0.043 0.058 0.233
* p<0.05; ** p<0.01
hs-CRP, high-sensitivity C-reactive Protein, TC/HDL-C, Total Cholesterol to High-density
Lipoprotein Cholesterol
FBCA = Foreign-born Afro Caribbeans
USBCA = US-born Afro Caribbean Americans
AA = African Americans
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Relationships between Bio-physiological and Emerging Risk Factors
In females, the DBP (r=0.329; p< 0.01) and the SBP (r=0.257; p< 0.05) were
positively associated with hs-CRP, whereas in males, DBP was positively associated with
TC/HDL-C ratio (r=0.257; p< 0.05) (Table 63). In both gender groups, TC (r=0.797, p<
0.001; r=0.676, p< 0.001) and LDL-C (r=0.843, p< 0.001; r=0.809, p< 0.001),
respectively were strongly and positively associated with TC/HDL-C ratio. In males,
serum triglyceride (TG) was positively associated with hs-CRP (r=0.250; p< 0.05) and
TC/HDL-C ratio (r=0.471; p< 0.01). In both male and female groups, high HDL-C levels
were negatively associated with TC/HDL-C ratio (r=-0.480, p< 0.01; r=-0.525, p< 0.01),
respectively (Table 63).
For the FBCA, USBCA and AA participants, the TC and LDL-C levels correlated
strongly and positively with the TC/HDL-C ratio (r=0.699, p< 0.001; r=0.703, p< 0.001;
r=0.627, p< 0.001), respectively (Table 64). Also, for the USBCA participants, serum TG
was positively associated with TC/HDL-C ratio (r=0.421; p< 0.01). For the FBCA,
USBCA and AA participants, HDL-C levels were negatively associated with TC/HDL-C
ratio (r=-0.582, p< 0.01; r=-0.548, p< 0.01; r=-0.490, p< 0.01), respectively (Table 64).
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Table 63 - Correlations between the Physiological and the Emerging Risk Factors of the
Participant by Gender
Males Females
Variables n=91 n=98
Systolic Blood Pressure
hs-CRP 0.063 0.257*
TC/HDL-C Ratio 0.178 -0.193
Diastolic Blood Pressure
hs-CRP 0.143 0.329**
TC/HDL-C Ratio 0.257* -0.182
Fasting Blood Glucose
hs-CRP 0.041 -0.069
TC/HDL-C Ratio -0.009 -0.038
Total Cholesterol
hs-CRP 0.131 -0.088
TC/HDL-C Ratio 0.797*** 0.676***
Horocysteine 0.096 -0.060
LDL-C
hs-CRP 0.112 -0.097
TC/HDL-C Ratio 0.843*** 0.809***
Triglyceride
hs-CRP 0.250* -0.047
TC/HDL-C Ratio 0.471** 0.110
HDL-C
hs-CRP -0.189 -0.027
TC/HDL-C Ratio -0.480** -0.525**
* p<0.05; ** p<0.01; * p<0.001
hs-CRP = high-sensitivity C-reactive Protein, TC/HDL-C = Total Cholesterol to High-density
Lipoprotein Cholesterol
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Table 64 - Correlations between the Physiological and the Emerging Risk Factors of the
Participant by Ethnicity
FBCA USBCA A
Variables n=31 n=30 n=30
Systolic Blood Presssure
hs-CRP 0.123 0.170 0.027
TC/HDL-C Ratio 0.003 -0.008 0.220
Diastolic Blood Pressure
hs-CRP 0.165 0.225 0.224
TC/HDL-C Ratio 0.139 -0.082 0.216
Fasting Blood Glucose
hs-CRP -0.064 0.047 -0.129
TC/HDL-C Ratio 0.132 -0.139 -0.051
Total Cholesterol
hs-CRP -0.184 0.235 -0.137
TC/HDL-C Ratio 0.699*** 0.703*** .627***
LDL-C
hs-CRP -0.214 0.223 -0.155
TC/HDL-C Ratio 0.805*** 0.801*** .797***
Triglyceride
hs-CRP -0.191 0.139 0.177
TC/HDL-C Ratio 0.197 0.421** 0.219
HDL-C
hs-CRP 0.182 0.013 -0.130
TC/HDL-C Ratio -0.582** -0.548** -0.490**
* p<0.05; ** p<0.01; * p<0.001
hs-CRP = high-sensitivity C-reactive Protein, TC/HDL-C = Total Cholesterol to High-density
Lipoprotein Cholesterol
FBCA = Foreign-born Afro Caribbeans
USBCA = US-born Afro Caribbean Americans
AA = African Americans
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Research Questions Summary
Research Question 1 - Are the socio-demographic profiles of FBCA, USBCA and AA
adults similar?
The mean age of USBCA participants was significant (p< 0.01) lower than the
mean age of the AA participants but not the FBCA participants. Also, the mean age of the
USBCA males was significantly (p< 0.01) lower than the mean age of the AA males but
not the FBCA males. Significantly (p< 0.05) more USBCA (96.8%) participants were
attending school compared to FIBCA (83.4%) and AA (73.8%) participants. However,
school attendance was significantly (p< 0.05) higher in the USBCA (96.7%) males
compared to the AA (60.0%) males but not the FBCA (77.4%) males. However, no
significance differences between the three female ethnic subgroups with respect to the
socio-demographic variables were observed
Research Question 2 -Are FBCA adults less likely to have behavioral/environmental
risk factors for CHD as compared to USBCA and AA adults?
The behavioral/environmental risk factors for CHD were significantly (p< 0.05)
lower in FBCA participants compared to the USBCA and AA participants. The FBCA
participants compared to the USBCA and AA participants had higher quality of dietary
intakes (diet score 3.5 1.6 vs. 2.7 1.7 and 2.6 1.5, range 0 - 7, where 0 = 'poor' diet
quality and 7 'good' diet quality), were less likely to watch television often/very often
(45.5% vs. 54.8% and 49.2%), were less obese (7.6% vs. 17.7% and 23.0%), did not
smoke cigarettes (0.0% vs. 4.8% and 6.6%) and consumed less alcoholic beverages
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(24.2% vs. 29.0% and 50.8%), respectively. Significantly (p< 0.05) more FBCA
participants than USBCA and AA participants met Dietary Guidelines for percent energy
from fat, whereas significantly (p< 0.05) more FBCA participants compared to AA but
not USBCA participants met the Dietary and Food Guide Pyramid Guidelines for percent
energy from carbohydrate and servings of fruits, respectively.
Additionally, significantly (p< 0.05) more USBCA (22.6%) and AA (19.7%)
participants compared to FBCA participants (6.1%) had three or more combined
behavioral/environmental risk factors for CHD.
Research Question 3 - Are FBCA adults less likely to have physiological risk factors for
CHD as compared to USBCA and AA adults?
In general, there were no statistical significant differences between the
physiological risk factors for CHD of the FBCA, USBCA and AA participants.
Research Question 4 - Are FBCA adults less likely to have emerging risk factors for
CHD as compared to USBCA and AA adults?
The FBCA and USBCA participants compared to the AA participants had
significantly (p< 0.01) lower mean hs-CRP levels (1.1 1.3 and 1.3 1.6 vs. 2.2 2.7),
respectively. In general, significant differences were observed between males and
females. The significant differences observed within the ethnic groups were also
observed more frequently within the male ethnic subgroups than within the female ethnic
subgroups.
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CHAPTER V
DISCUSSION
This study investigated the relationship between risk factors for coronary heart
disease (CHD) in three ethnic groups of a predominantly Black population in South
Florida. The study addressed the question of (keeping race and geography constant)
whether there are differences in (a) socio-demographic (b) behavioral/environmental (c)
bio-physiological and, (d) emerging risk factors for CHD between apparently healthy
foreign-born Afro Caribbean American (FBCA) living in the US for less than 10 years,
US-born Afro Caribbean American (USBCA) and African American (AA) adults (18-40
years), living in South Florida. This is the first comprehensive study of its kind presenting
socio-demographic, behavioral, bio-physiological and emerging risk profiles for FBCA
and USBCA in South Florida.
Research Question 1: Are the socio-demographic profiles of FBCA, USBCA and AA
adults similar?
Socio-economic status and Perceived Stress
The risk for CHD in males and females increases with advancing age (NCEP:
ATP III, 2001). In our study, the AA participants were significantly older than the
USBCA but not the FBCA participants. Age was positively associated with the diet score
(r=0.245; p< 0.05) in males and FBCA participants (r=0.321; p< 0.05) an indication that
older individuals had better diet practices.
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There is evidence indicating that individuals with lower socio-economic status
(SES), using income and educational levels as proxies for SES, have a higher risk for
stroke and CHD compared to those in the higher SES groups (AHA Statistical Update,
2002; Kaplan and Keil, 1993). Individuals from lower socio-economic groups also have
poorer health habits and health knowledge (Wood et al., 1998).
In our study, the reported socio-demographic variables of the FBCA, USBCA and
AA participants showed differences. However, these differences did not reach
significance possibly due to small sample sizes and non-randomized study design. In our
study, although more AA (71%) and USBCA (82%) compared to FBCA (67%)
participants reported completing high school, more FBCA (33%) compared to AA (29%)
and USBCA (18%) participants were in graduate school. This is in contrast to the report
of Harris (1999) that showed foreign-bom adults (64.5%) were less educated (completed
12 years or more of school) than US-born (78.7%) adults. Our study is supported by the
reports of Fang et al (1996), Singh and Siahpush (2002) and Logan and Deane (2003)
who used larger sample sizes. Fang et al (1996) reported that 77.9% and 10.1% of non-
Hispanic Black Caribbeans attained at least a high school education and were
unemployed compared to Blacks in the Northwest (74.6%; 19.7%) and Southwest
(64.5%; 19.2%) of the US, respectively. In the Singh and Siahpush (2002) report, 18%
and 1.4% of non-Hispanic Blacks had more than 16 years of education and had a family
income in excess of $50,000 compared to their US-born counterparts (8%, 0.9%),
respectively. The authors did not report if these differences in the socio-economic
parameters they observed were significant. The report by Logan and Deane (2003)
showed Afro Caribbeans were better educated, have higher median household incomes,
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and typically live in better neighborhoods with higher socio-economic standings
compared to African Americans. This maybe due to selective migration (Logan and
Deane, 2003) by the Afro Caribbeans based on their educational attainment or their plans
for higher education.
Although limited data are available about the pathways through which SES
influences health-related outcomes, one hypothesis is that SES may work through chronic
stress (Baum et al., 1999). This report stated that chronic stress burden is normally
associated with overcrowding, crime, noise pollution, discrimination, personal distress,
mental health problems and health-impairing behaviors.
In our study, a negative association between SES and PS in males compared to
females was observed. Additionally, the relationship between SES, total cholesterol (TC)
and low-density lipoprotein cholesterol (LDL-C) were inconsistent. Higher education was
positively associated with TC and LDL-C in USBCA and LDL-C and TC/HDL-C ratio in
AA participants, whereas higher household income was negatively associated with TC
and LDL-C in FBCA participants, which is in the direction associating lower SES with
CHD. Other investigators have reported an association between SES and CHD (AHA
Update, 2002; Kaplan and Keil, 1993; Wood et al., 1998; Davey et al., 1996). It is
suggested that individuals with lower SES may have higher cumulative levels of stress
and that biological reaction to this stress may contribute to hypertension (Kington and
Smith, 1997; Williams, 1992), overeating and/or increased cigarette smoking (AHA
Statistical Update, 2002).
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Knowledge of CHD Risk Factors
Little is known about the attitudes and knowledge of CUD risk factors in
individuals and the factors will motivate individuals to effect changes in their behaviors
in an attempt to reduce the onset of chronic diseases, such as CUD are not properly
understood (shepherd, 1998; Erhardt and Hobbs, 2002). In our study, knowledge of CUD
risk factors was relatively high (mean 18.1 1.9; range 0 - 25, where 0 is low knowledge
and 25 is very good knowledge) and, higher in females compared to males. However,
there were no differences between the ethnic groups with respect to knowledge of CHD
risk factors. Interestingly, good knowledge of CUD risk factors did not translate into
action as FBCA participants were less likely to be physically active, whereas AA
participants with high knowledge of CHD risk factors were more likely to have high BMI
(an indication of sedentary lifestyle). This is in agreement with the report of Shepherd
(1998) that showed individuals in 5 European countries (France, Germany, Italy, Sweden,
United Kingdom) to have considerable degree of indifference to CHD, despite the
possession of a reasonable level of knowledge of CHD risk factors and, even among
individuals with CHD.
Family History of CHD
There is evidence to indicate that a family history of premature CUD (definite
myocardial infarction or sudden death before 55 years of age in father or other male first-
degree relative, or before 65 years of age in mother or other female first-degree relative)
is an independent risk factor for coronary events even when other risk factors are absent
(Benson et al., 1999; Li et al., 2000; Williams et al., 2001). Coronary heart disease tends
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to cluster in families and a positive family history of premature CHD counts as a risk
factor (NCEP: ATP III, 2001). Children of parents with heart disease are more likely to
develop the condition themselves, probably due to shared socio-cultural environment,
exposures to similar behavioral habits and genetics (NCEP: ATP III, 2001). In our study,
the reported presence of a family history of CHD was higher in FBCA (39.4%)
participants compared to AA (31.1%) and USBCA (25.8%) participants, although the
differences were not significant. Maybe the variation in this parameter could be due to
the information about family health issues not being discussed or shared with siblings. In
our study we observed that the percentage of the USBCA (51.6%) participants who
reported that they did not know their family history of CHD was higher compared to the
FBCA (30.3%) and AA (32.8%) participants. However, a positive family history of CHD
captures the underlying complexities of gene-gene and gene-environment interactions by
identifying families with combinations of risk factor, both measured and unmeasured,
that lead to disease expression (Hunt et al., 2003). Our results showed males who had a
positive family history of CHD were smokers an indication that this knowledge did not
influence their smoking habits. Also, USBCA participants with a positive family history
of CHD were more likely to have elevated TC, LDL-C and hs-CRP. Thus, targeted
screening and intensive intervention (Hunt et al., 2003) in this population may prevent
the early onset of cardiovascular evens in the future. There is a very limited data on the
relationship between family history of CHD and different ethnic groups or the effects on
behavioral/environmental parameters.
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Health Insurance and Visitations to Healthcare Professionals
Health Insurance is the key that provides access to high quality health care and
consequently to better health", so states a recent Institute of Medicine (IOM) report
(IOM, 2002). Nearly 30 million working adults are uninsured. The uninsured receive too
little medical care and receive it too late, are generally sicker and die earlier and receive
poorer care during visitations to the hospital or doctor (IOM, 2002). Our study results
showed that more FBCA (71.2%) participants had medical insurance coverage compared
to USBCA (69.4%) and AA (67.2%) participants, however, the USBCA participants
(85.5%) were more likely to visit a Healthcare Professional (HCP) during the past year
compared to FBCA (80.3%) and AA (73.8%) participants. Since most of the FBCA
participants were international students, then registration under the university's health
plan was compulsory. The differences in visitations to the HCP may mirror differences in
beliefs, attitude and values of how each group perceives illness and disease or possibly
mistrust of the health care system, which lead to less willingness to use the health care
system (LaVeist et al., 2000a,b). Our result is in contrast to the report of Singh and
Siahpush (2002) which indicated that the percentage of US-born non-Hispanic Blacks
(40.2%) who had insurance coverage was higher compared to foreign-born non-Hispanic
Blacks (34.5%).
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Research Question 2: Are FBCA adults less likely to have behavioral risk factors for
CHD as compared to USBCA and AA adults?
Dietary Intakes
Krauss et al. (2000) have indicated that populations consuming diets high in
fruits, vegetables, whole grains and unsaturated fatty acids may be at lower risk for many
of the chronic degenerative conditions, such as CHD, obesity, hypertension and diabetes.
There is evidence from animal experiments, observational studies, clinical trials and
metabolic studies conducted in different populations showing strong and consistent
relationship between dietary fats and CVD, especially CUD (Kris-Etherton et al., 2001).
The American Heart Association recommends a diet low in saturated fat, trans fat,
cholesterol and sodium. It should also be high in vegetables, fruits, whole grains,
legumes, fat-free or low-fat dairy products, and dietary fiber (AHA Statistical Update,
2002). The total fat (saturated, trans, monounsaturated, polyunsaturated) intake should be
less than 30% of total daily calories. Saturated fat and trans fat should not exceed 10% of
total daily calories for healthy individuals.
In general, the findings of our study have showed that the foreign-born Afro
Caribbean (FBCA) individuals had a better diet profile compared to their US-born
counterparts. The dietary findings included the observations that the FBCA participants
compared to the USBCA and AA participants consumed significantly less total fat,
saturated fat, percent energy from fat, fat servings, dietary cholesterol and sodium and
more percent energy from carbohydrate and vegetables. A similar trend was seen for the
FBCA males compared with the USBCA and AA males. For the FBCA females, only the
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mean dietary cholesterol intake was significantly lower compared to the USBCA and AA
females.
Reports from the BRFSS 2000 (CDC/NCHS, 2000) survey showed that 81% of
males and 73% of females consumed fewer than 5 servings of fruits and vegetables each
day. This report also states that more than 60% of young adults eat too much fat (fat
provided more than 30% of total energy intake) whereas less than 20% ate the
recommended 5 or more servings of fruits and vegetables each day. Our study showed
similar trends as 70% of the males and 53% of the females consumed too much energy
from fat (fat provided more than 30% of total energy intake) of whereas less than 20%
and 30% of males and females, respectively, consumed less than 2 servings of fruits and
vegetables daily. Also, the percentages of participants exceeding dietary
recommendations for percent energy from fat, saturated fat, cholesterol and sodium and
not meeting these recommendations for fruit consumption were higher for USBCA and
AA participants compared to the FBCA participants. Thus, based on these dietary
findings, the USBCA and AA participants may be at greater risk of CHD events in the
future, since evidence from animal experiments, observational studies, clinical trials and
metabolic studies conducted in different populations have showed strong and consistent
relationships between dietary fats and CVD, especially CHD (Kris-Etherton et al., 2001).
In our study, high diet score (better diet) correlated positively with high-density
lipoprotein cholesterol (HDL-C) in AA participants, indicating the close relationship
between diet and dyslipidemia. Our study is in agreement with other studies showing a
relationship between diet, dyslipidemia and CHD (Kruass et al., 2000; Willett, 1998).
Also, low vegetable and fiber consumption in USBCA participants was associated with
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high TC, whereas high dietary cholesterol consumption by the AA participants was
associated with low HDL-C levels. These findings are in agreement with the Framingham
Heart Study (Wilson et al., 1998), the Multiple Risk Factor Intervention Trial (MRFIT)
(Stamler et al., 1986), and the Lipid Research Clinics (LRC) trial (Lipid Research Clinics
Program 1984a,b) which showed a direct relationship between LDL-C (or TC) and the
rate of new onset of CHD in men and women who were initially free of CHD. Also, there
is strong epidemiological evidence indicating that low levels of HDL-C increase CHD
mortality and morbidity (Wilson et al., 1998; Gordon et al, 1989; NCEP: ATP III, 2001).
In our study, the fat, dietary cholesterol, vegetable and sodium components of the
diet were the major differences between the ethnic groups. In England, Sharma et al
(1999) have shown that foreign-born Afro Caribbeans eat less fat compared to the United
Kingdom-born (UK-born) Afro Caribbeans and the general UK population. This may be
due to the influence of the social environment on the food selection process (Anderson,
2003) a concept not investigated in this study and, an important area of research in the
future. Understanding the social context of food choice may be as important as
identifying the food sources of the major nutrients in food (Anderson, 2003). This is
because food provides a means to demonstrate cultural identity and is also symbolic of
many areas of the participants' origin, religious background and beliefs structures
(Anderson, 2003). Bonow and Eckel (2003), have suggested support for a "heart-healthy"
balanced diet. They suggested that this diet should consist of a wide variety of fruits and
vegetables, whole grains, legumes, lean meat, poultry and fish, with the percentage
intakes of total fat accounting for less than 30% and, saturated and trans fatty acids less
than 10% of the total calories, respectively. Advise from the American Heart Association
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(AHA statistical Update, 2004) is in agreement with this suggestion. The AHA
recommends a diet low in saturated fat, trans fat, cholesterol and sodium. It should also
be high in vegetables, fruits, whole grains, legumes, fat-free or low-fat dairy products,
and dietary fiber. The total fat (saturated, trans, monounsaturated, polyunsaturated) intake
should be less than 30% of total daily calories. Saturated fat and trans fat should not
exceed 10% of total daily calories for healthy individuals.
Poor nutrition and physical inactivity together are the second leading preventable
cause of death in the US. Poor nutrition and physical inactivity are responsible for an
estimated 300,000 deaths each year and are causally related to a variety of chronic
diseases and conditions, including overweight and obesity, high blood pressure,
hyperglycemia and diabetes, hypercholesterolemia, CHD, stroke, osteoarthritis and some
cancers (FLDH, 2001). A healthy diet is important for preventing heart disease and stroke
(Wood et al., 1998; AHA Statistical Update, 2002).
Physical Activity/Inactivity
The mean physical activity index (PAI), work activity index (WAI), sports
activity index (SAI) and leisure-time time activity index (LTAI) scores of the participants
were generally low and did not differ significantly between the ethnic groups or the
gender-ethnic male and female subgroups. More USBCA and AA participants did not
play a sport (indication of sporting activities) and watched TV often/very often
(indication of leisure-time physical inactivity) compared to FBCA although the
differences did not reach statistical significance. There is evidence indicating that
physical inactivity is a major risk factor for CHD (National Cholesterol Education
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Program [NCEP]: Adult Treatment Panel [ATP] III, 2001; Fletcher et al., 1996; US
Surgeon General Report, 1996). The relative risk of CHD associated with physical
inactivity ranges from 1.5 to 2.4, an increase in risk comparable to that observed for high
blood pressure, high blood cholesterol or cigarette smoking (AHA Statistical Update,
2002; Pate et al., 1995). Individuals who are less active have a 30-50% greater risk of
developing high blood pressure compared to those who are more active (AHA Statistical
Update, 2002; Haskell et al., 1992).
In our study, the mean PAI was moderate (7.8 1.4; range 3.0 - 15.0, where 3.0
is low PAI and 15.0 is high PAI scores) and did not differ significantly between the
ethnic groups. The USBCA participants who were physically inactive were more likely to
have elevated TC and LDL-C and total cholesterol/high-density lipoproten cholesterol
(TC/HDL-C) ratio, observations that were in the direction showing an association
between physical inactivity and CHD (NCEP: ATP III, 2001; Fletcher et al., 1994; US
Surgeon General Report, 1996). Also, the USBCA participants who were physically
inactive were more likely to have elevated hs-CRP levels suggesting that physical activity
may reduce hs-CRP levels. Indeed there is evidence to this effect (Smith et al., 1999; Tisi
et al., 1997). Watching television often/very often was positively associated with DBP in
FBCA participants and elevated TC/HDL-C in AA participants, demonstrating the
importance of increased physical activity on risk factors for CHD in this and other
population.
182
Anthropometry
Evidence from the Framingham Heart Study has indicated that obesity is strongly
predictive of CHD and, that risk for cardiovascular disease is increased when abdominal
obesity is present. In our study, overweight was defined as body mass index (BMI) 25.0-
29.9 kgm 2 and obesity BMI 30.0 kgm2 . Central obesity was defined as waist
circumference (WC) > 35 inches (88 centimeters) in women and 40 inches (102
centimeters) in men (World Health Organization [WHO], 1997; National Heart, Lung
and Blood Institute [NHLBI], 1998; NCEP: ATP III, 2001). The mean BMI (24.8 4.0)
and WC (32.6 4.1) score of FBCA participants were lower compared to the USBCA
(26.2 4.8, 33.5 + 4.6) andAA (26.7 6.6, 33.5 5.2) participants. Also, the
percentages of FBCA participants who were obese (7.6%) and had increased abdominal
girth (10.6%) were lower compared to USBCA (17.7%, 16.1%) and AA (23.0%, 16.4%)
participants. Similar findings have been documented by the studies of Singh and
Siahpush (2002). Using data from the National Longitudinal Mortality Study (1979
through 1989), they showed that the mean BMI score of foreign-born non-Hispanic Black
(25.6) adults was lower compared to the US-born non-Hispanic Black (27.1) adults. This
same study showed that foreign-born non-Hispanic Blacks (25.2%) were less likely
to be overweight compared to their US-born (3 8.4%) counterparts. Our study has
also been corroborated by a report from the National Academy of Sciences (Harris, 1999)
reporting that foreign-born young adults were less likely than their US-born young adult
counterparts to be obese (17.0% versus 26.7%).
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We observed positive associations between BMI/WC and, systolic/diastolic blood
pressures (SfDBP), TC, LDL-C in USBCA, S/DBP in AA participants and DBP in FBCA
participants. Also, BMI/WC was negatively associated with HDL-C in FBCA, USBCA
and AA participants. These findings are consistent and in the direction of reports showing
relationships between BMI and these parameters that are associated with CHD (NCEP:
ATP III, 2001; AHA Statistical Update, 2004; Koenig et al., 1999; Rhode et al., 1999).
Our study is also in agreement with the report of Folsom et al (1989) which demonstrated
that central or abdominal obesity was negatively correlated with HDL-C in both Blacks
and Whites. The positive association between BMI/WC and TC, LDL-C in the USBCA
participants compared to the FBCA participants could be due to the higher percentages of
the USBCA participants who were overweight and obese or who had poorer diets
compared to the FBCA participants. It is suggested that although body fat is
metabolically active it cannot by itself cause CUD but may be an index of underlying
metabolic disturbances and that could directly impinge on atherogenesis and CHD
(Zoratti, 1998). Body fat also plays a leading role in increasing the flux of free fatty acids
(FFA) carried to the liver from abdominal adipocytes (Marin et al., 1992) with the
possibility of the excess FFA interacting with the secretions of lipoproteins (McKeigue et
al., 1991) and possibly influencing TC and LDL-C levels.
A positive association between BMI and hs-CRP was also observed in males,
females and all three ethnic groups. Our results are similar to that of Saito et al (2003)
who suggested that body fat may directly influence hs-CRP levels, since adipocytes are
known to secrete interleukin-6, the primary hepatic stimulant of hs-CRP (Visser et al.,
1999; Yudkin et al., 1999) and, may of also synthesize and secrete hs-CRP (Pepys And
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Hirschfield, 2003). Our study is also similar to the National Health and Nutrition
Examination Survey (NHANES II) study (Wilson et al., 1998) that showed a positive
association between BMI and hs-CRP levels, with the occurrence of elevated hs-CRP
found to be twice as likely in obese men and six times more likely in obese females.
Other studies (Yudkin et al., 1999; Festa et al., 2000; Heald et al., 2003) have also found
similar associations between hs-CRP and BMI. Also, BMI was positively associated with
TC/HDL-C in the males and all three ethnic groups but did not achieve significance for
the AA participants. Scranton et al (2004) have also demonstrated a positive association
between increased weight or failure to exercise and TC/HDL-C ratio. They demonstrated
that physicians who gained weight (BMI 25.0 kg/m2) were twice as likely to have a
TC/HDL-C ratio 5.0 compared with physicians who maintained normal weight (BMI <
25.0 kg/i 2). Also, physicians who stopped exercising were 40% more likely to have
TC/HDL-C ratio 5.0.
Additionally, the positive association between BMI and cigarette smoking in
USBCA and BMI and PAI in AA participants compared to FBCA participants may
suggest that USBCA and AA participants may gain weight by other measures, such as the
type and quality of their diets and possibly, time spent watching television (TV). We
observed significant differences between the ethnic groups with respect to dietary habits.
Although there was no significant difference in the amount of time spent watching TV
between the ethnic groups, the percentages of USBCA and AA participants who watched
TV was higher compared to FBCA participants. Positive associations between obesity
and time spent watching TV, have also been reported by other investigators (Dietz and
Gortmaker, 1985; Gortmaker et al., 1990; Tucker and Bagwell, 1991; Buchowski and
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Sun, 1996). Although we did not detect any consistent association between BMI and the
physical activity index, this could indicate that we may not have adequately identified all
the activities that contribute to energy expenditure in this population. The physical
activity questionnaire used in this study did not include any questions about housework
(Pomerleau et al., 1999), an import source of energy expenditure for students especially
women in this population. Thus, more research is needed in assessing physical activity in
this population. These findings are in agreement with reports showing that obesity
especially central obesity is a risk factor for many chronic diseases including
cardiovascular disease (CVD) (Willett, et al., 1995) and possibly death (Folsom et al,
1993). Obesity is of public health importance affecting not only the individuals in the US
population but also individuals in the developing world (Eckel, 1997). Knowledge of, and
awareness of the complications of obesity may help motivate individuals in their weight
management efforts (Williamson et al., 2000). This is important since Afro Caribbean
and African American women with fuller figures are more acceptable to their male
counterparts whereas, non-Hispanic White females with fuller figures maybe despised by
their male counterparts (Anderson et al., 2002). Also, in a study of elderly women in the
US, African Americans were more likely than white women to report that they were
satisfied with their weight and less likely to diet (Stevens et al., 1994).
Cigarette Smoking
There is evidence to support the claim that cigarette smoking is a contributor to
the risk for CHD and other forms of CVD (Kannel et al., 1980; Colditz et al., 1988;
LaCroix, 1991; McBride, 1992; Jonas et al., 1992; Pyiria et al., 1994). This relationship
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is dose related and smoke cessation will reduce the risk for CVD events within months of
quitting (US Surgeon General Report, 1990).
In our study, more USBCA (4.8%) and AA (6.6%) individuals smoked cigarettes
compared to the FBCA (0.0%) individuals. A similar trend for cigarette smoking was
seen in the report of Singh and Siahpush (2002). They reported that the percentage of
foreign-born Blacks (10.4%) who was current smokers was lower compared to US-born
Blacks (29.3%), whereas in our report FBCA participants were all nonsmokers. The AA
participants were generally older than the FBCA and USBCA participants and, a positive
association was observed between age and cigarette smoking in the AA participants. In
the US, as many as 30% of all deaths due to CHD are attributable to cigarette smoking or,
being exposed to environmental tobacco smoke at home or work, with the risk being
dose-related (AHA Statistical Update, 2004). Cigarette smoking also acts synergistically
with other risk factors, thus substantially increasing the risk of CHD (Ockene and Miller,
1997). Our study demonstrated a positive association between cigarette smoking and hs-
CRP levels in USBCA participants. Our results agree with other reports showing that
cigarette smoking, which seems to promote arterial inflammation and predispose to major
coronary events, was associated with higher hs-CRP levels (Tracy et al., 1997b) and,
possibly risk of CHD.
Alcohol Consumption
Although there is a complex relationship between alcohol consumption and CHD,
with moderate consumption of alcohol showing reduction in CHD, risky drinking has
been associated with health risks (Pearson, 1996). Compared to the USBCA (29.0%) and
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FBCA (24.2%) participants, AA (50.8%) participants consumed more alcoholic
beverages each month. Our findings are in agreement with those of Hicks et al (2003).
Using data from NHANES III, they showed that the percentages of African Americans
from the North (Northeast, Midwest or West census regions) (56.8%) or South census
regions (47.5%) who consumed more than 12 g alcoholic beverages per day to be higher
than that of Black immigrants (39.7%). Of interest 72% of individuals less than 21 years
old were consuming alcoholic beverages with 34% consuming in excess of one drink per
month. This could be due to the easy availability of alcoholic beverages on the university
campus or, younger individuals may consume alcoholic beverages purchased by older
persons.
In our study, we observed a positive association between alcohol consumption
and triglyceride (TG) levels in males compared to females indicating an association
between risky drinking with health risk (Pearson, 1996). There is epidemiological
evidence indicating a positive relationship between serum triglyceride (TG) levels and
incidence of CHD (Austin et al., 1998; Assmann et al., 1998a; NCEP: ATP III, 2001). In
our study, we also observed a negative association between alcohol consumption and
systolic blood pressure (SBP) levels in USBCA participants but not FBCA and AA
participants. Moderate alcohol consumption has been shown to be associated with
reduction in CHD risk (Pearson, 1996).
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Research Question 3: Are FBCA adults less likely to have bio-physiological risk
factors for CUD as compared to USBCA and AA adults?
Blood Pressure
A recent report (7 th Report of the Joint National Committee on Prevention,
Detection, Evaluation and Treatment of High Blood Pressure [JNC] VII, 2003) has
classified normal BP as systolic BP < 120 mm Hg and diastolic BP < 80 mm.
Hypertension is the most potent risk factor for stroke. It is also a major risk factor for
CHD, kidney failure and heart failure (JNC VI, 1997). The percentages of FBCA (25.8%;
29.0%) participants with elevated SBP and DBP were higher compared to the USBCA
(13.3%; 26.7%) but lower than values for the AA (26.7%; 50.0%) participants,
respectively, although these differences were not significant. In the report by Hicks et al
(2003), hypertension was defined as S/BBP ? 140/90 mm Hg and they reported the
percentage of Black immigrants with hypertension (48%) to be lower than African
Americans in the northern (72%) and Southern (80%) census regions, respectively,
whereas Singh and Siahpush (2002) reported a much lower prevalence of hypertension in
foreign-born non-Hispanic Blacks (17%) compared to US-born non-Hispanic Blacks
(25%), using self-reported data on hypertension. However, like our study these
differences were not statistically significant. However, significantly lower rates of
hypertension were reported for Caribbean and African Blacks compared to US Blacks in
the International Collaborative Study of Hypertension in Blacks (ICSHIB) (Cooper et al.,
1997a). Possible reasons for these different results may be due to different
methodologies, or the fact that majority of our participants were young students. The
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FBCA participants are in the process of adjusting to a new environment and higher blood
pressure values may reflect this acclimatization process (Singh and Siahpush, 2002). In
our study, BMI was found to be associated positively with S/DBP in males and females,
DBP in FBCA participants and, S/DBP in USBCA and AA participants indicating that
obesity is a powerful determinant for the development of hypertension and CUD (JNC
VII, 2003). In our study, a positive association was observed between S/DBP and hs-CRP
in females and between DBP and TC/HDL-C ratio in males. This is in agreement with
other studies (Koenig et al., 1999; Rhode et al., 1999) showing positive associations
between S/DBP and CVD risk factors, including hs-CRP. In the Koenig et al (1999)
study, they investigated and followed, for 8.2 years, 936 men between the ages of 45 to
64 years, who participated in the first Monitoring Trends and Determinants in
Cardiovascular Disease (MONICA) Augsburg study, in Germany, between 1984 and
1985. They demonstrated that hs-CRP levels varied significantly with age, BMI, TC,
smoking status, blood pressure and diabetes and, slightly with alcohol consumption,
education, leisure-time physical activity and work activity. In the Rohde et al (1999), they
investigated 1172 apparently healthy middle-aged (40-84 years) men who participated in
the Physician Health Study. They showed significant positive associations (all p values <
0.05) between hs-CRP levels and age, number of cigarettes smoked each day, BMI,
S/DBP, TC, triglyceride (TG), lipoprotein (a) [Lp (a)], apolipoprotein B (apo B), tissue-
type plasminogen activator antigen, total homocysteine and fibrinogen.
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Blood Glucose
Impaired fasting blood glucose levels (110-125 mg/dL) is an indicator of insulin
resistance and is generally accompanied by other metabolic risk factors (Tripathy et al.,
2000; NCEP: ATP III, 2001). Some individuals with impaired fasting blood glucose will
eventually develop type 2 diabetes (Lindahl et al., 1999), which further enhances the risk
for CHD. Type 2 diabetes is the epitome of the metabolic syndrome, characterized by
abdominal obesity, atherogenic dyslipidemia (elevated triglyceride, small low-density
lipoprotein cholesterol particles, low high-density lipoprotein cholesterol), elevated blood
pressure, insulin resistance, pro-thrombotic and pro-inflammatory conditions (NCEP:
ATP III, 2001). This disorder is associated with increased risk of CHD and occurs in 24%
of the US adult population (Ford et al., 2002). Over 600,000 individuals are diagnosed
with DM each year. Diabetes accounts for over 200,000 deaths and $18.9 million in
ambulatory visits annually (Center of Disease Control (CDC) Diabetes Factsheets, 2000).
In this study, the mean fasting blood glucose (FBG) levels of the three ethnic
groups were normal (< 110 mg/dL) and did not differ significantly. However, impaired
fasting blood glucose (110-125 mg/dL) levels were detected in 6.1%, 6.5% and 6.6% of
FBCA, USBCA and AA participant, respectively. These individuals were indeed
unaware of their condition and may indicate a subset of this young adult population at
risk for diabetes mellitus and CHD. There is evidence indicating that over 16 million (12
million diagnosed) Americans, nearly 6% of the US population, have diabetes mellitus,
with 50% (5.9 million) of these individuals unaware of their condition (CDC Diabetes
Factsheets, 2000).
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Symptoms associated with the metabolic syndrome (MS) were observed in 4.2%
of this young adult population. This is much lower than that reported by Ford et al
(2002). A low percentage of participants in the present study met the criteria for the MS:
1.5%, 1.6% and 3.2% of FBCA, USBCA and AA participants, respectively. This
indicates that a small subset of individuals are showing early signs of CHD risk and, may
indeed develop CHD in the future if behavioral and other risk factors are not addressed.
This is the first report that addressed the differentials in the metabolic syndrome of
foreign-born and US-born individuals.
In our study, higher perceived stress (PS) was associated with fasting blood
glucose (FBG) levels in AA participants, whereas cigarette smoking was positively
associated with FBG levels in females, indicating the harmful effects of PS and cigarette
smoking on health outcomes. There is evidence showing that the effect of stress on the
hypothalamic-pituitary-adrenal (HPA) axis, which plays a central role in the homeostatic
process, is the increased production of glucocorticoids (cortisol, catecholamines), which
have been shown to have diabetogenic effects (Dalman et al., 1993; Rosmond, 2005) and,
in fact contribute to the entire spectrum of the metabolic syndrome, including central
obesity, hyperglycemia, dyslipidemia and other risk factors for CHD (Bj rntorp, 1993;
Rosmond, 2004).
Total Cholesterol and Low-density Lipoprotein Cholesterol
There is strong epidemiological evidence demonstrating that CHD is positively
correlated with TC and LDL-C (Gordon et al., 1989, Wilson et al., 1998, NCEP: ATP III,
2001; AHA Statistical Update, 2004). In our study, the percentages of males with TC
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levels above 200 mg/dL and LDL-C above 130 mg/dL were 27.5% and 30.8%,
respectively, whereas in the females, the situation was reversed with TC levels above 200
mg/dL and LDL-C above 130 mg/dL being 34.7% and 27.6%, respectively. The
American Heart Association has reported similar results (AHA Statistical Update, 2004).
The report showed the percentages of male African Americans with TC levels above 200
mg/dL and LDL-C above 130 mg/dL were 37% and 46%, respectively, whereas for the
females, the values were 46% and 42%, respectively.
The percentage of FBCA (25.8%) participants with elevated TC was lower than
the USBCA (37.1%) and AA (31.1%) participants, whereas the percentage of FBCA
(27.3%) with elevated LDL-C lower than USBCA (35.5%) but not the AA (24.6%)
participants. This is the first report that addressed the differentials in the lipid profile of
foreign-born and US-born individuals. In our study, we observed a strong and positive
relationship between TC, LDL-C levels and the TC/HDL-C ratio in the male and female
groups and the three ethnic groups, indicating the strong relationship between
dyslipidemia and risk for CHD (Wilson et al., 1998, NCEP: ATP III, 2001; AHA
Statistical Update, 2004). Scranton et al (2004) have also demonstrated an association
between dyslipidemia and the TC/HDL-C ratio. There is evidence indicating that the total
cholesterol/HDL-Cholesterol ratio (TC/HDL-C) is a powerful predictor for CHD risk
(Kinosian et al., 1995; Criqui and Golomb, 1998).
Triglyceride and High-density Lipoprotein Cholesterol
There is strong epidemiological evidence indicating that low levels of HDL-C
increase CHD mortality and morbidity (Wilson et al., 1998; Gordon et al., 1989; NCEP:
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ATP III, 2001). Many case-controlled and prospective studies have shown that HDL-C,
TG or both are better predictors of individuals with or without CHD than TC or LDL-C
(Nikkila et al., 1990; Simons et al., 1991; Stampfer et al., 1991; Romm et al., 1991;
Genest et al., 1991; Buring et al., 1992).
In our study, the TG levels were similar between the gender and ethnic groups.
However, the percentage of males (35.2%) with low HDL-C (<40 mg/dL) was
significantly higher compared to the females (8.2), whereas, there were no significant
differences between the percentages of the ethnic groups with low HDL-C levels. The
AHA have reported similar trends (AHA Statistical Update, 2004) They reported that low
HDL-C levels were present in 24% of African American males and 13% of females.
There is evidence indicating that a 1% decrease in HDL-C is associated with a 2-3%
increase in CHD risk (Gordon et al., 1989) whereas high HDL-C levels have been
associated with longevity and are indeed protective against CHD (NCEP: ATP II, 2001;
Toth, 2004). For example, in the Framingham study (Castelli et al., 1986) low HDL-C
levels (below 40 mg/dL) have been shown to increase sharply the risk of CHD and, this
relationship was independent of TG levels as demonstrated by The Prospective
Cardiovascular Munster Study (Assman and Schulte, 1992).
In our study, we observed a strong and positive relationship between TG levels
and hs-CRP in males. It is suggested that a possible pathway through which dyslipidemnia
influence CHD maybe through inflammation, now considered a risk factor for CHD
(ATP III, 2001; Ross, 1999). Also, there were strong and positive associations between
TG and TC/HDL-C ratio in males and USBCA participants and, strong and negative
associations between HDL-C and the TC/HDL-C ratio in males and females and the three
194
ethnic groups. It is suggested that a possible mechanism for the cardio-protective effects
of HDL-C could be through a reverse cholesterol transport pathway, or inhibition of lipid
peroxidation (Mackness and Durrington, 1995), cellular adhesion (Barter, 1997) and/or
platelet activation (Sugatani et al., 1996).
Research Question 4: Are FBCA adults less likely to have emerging risk factors for
CHD as compared to USBCA and AA adults?
C-reactive Protein
Lipid deposition in the vascular system has been thought to be the major cause of
CHD, and thus aggressive cholesterol testing has been used as a tool to identify
individuals at increased risk for CHD. Yet 50% of all myocardial infarctions and strokes
occur in individuals with normal or slightly elevated TC (Kannel, 1995) but elevated hs-
CRP levels (Rifai and Ridker, 2001; Ridker, 2004). There are reports showing an
association between hs-CRP and low-grade inflammation, an important determinant of
atherothrombosis, a leading cause of morbidity and mortality in the world (NCEP: ATP
III, 2001; Libby et al., 2002; Zeltser et al., 2004). Measurement of hs-CRP is now
considered a sensitive marker of chronic low-grade vascular inflammation, which has
been implicated in the pathogenesis of atherosclerosis (Koenig et al., 1999). There is
evidence indicating that serum hs-CRP levels are increased many years in advance of the
first coronary and cerebrovascular events in healthy (Ridker et al., 1997; Ridker et al.,
1998b; Koenig et al., 1999) and high-risk individuals (Tracy et al., 1997b; Kuller et al,
1996). In two of these studies (Ridker et al., 1998a, 2000), hs-CRP was shown to be a
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powerful indicator of future cardiovascular events even among subgroups of women with
no history of hyperlipidemia, hypertension, smoking, diabetes or family history of CHD.
There is additional evidence demonstrating that individuals with elevated hs-CRP
were 4 times as likely to have a cardiovascular event as those with low hs-CRP.
Additionally, in the Women' Health Study (Ridker et al., 2002), risk of CVD was
markedly elevated in women with elevated hs-CRP and normal LDL-C (< 130 mg/dL)
indicating that hs-CRP provides risk prediction better than LDL-C alone, that it identifies
high risk individuals who would not be considered to be at high risk on the based on
LDL-C or other traditional risk factors, and that hs-CRP adds substantial predictive
information to traditional risk evaluation (Ridker, 2004). Most of the information about
hs-CRP in ethnic groups originated from Europe where hs-CRP levels of Afro
Caribbeans were generally lower than UK-born individuals (Heald et al., 2003).
However, studies in the US (Wener et al., 2000; Wong et al., 2001) have shown that hs-
CRP levels are normally higher in Blacks than Whites. However, there is no published
data on hs-CRP differentials in foreign-born and US-born individuals.
In our study, the mean hs-CRP levels in FBCA were lower compared to USBCA
and significantly lower compared to the AA participants. Also, the percentage of FBCA
with elevated hs-CRP was lower than USBCA and significantly lower than the AA
participants. Thus, USBCA and AA participants may be showing early signs of sub-
clinical inflammation and, maybe at risk of early cardiovascular events compared to
FBCA participants. Although no firm guidelines on treatment for elevated hs-CRP
currently exists, there is evidence suggesting that hs-CRP adds predictive information to
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the other established CHD risk factors, such as TC and LDL-C (Ridker et al., 2002;
Albert et al., 2003).
Total Cholesterol/High-density Lipoprotein Cholesterol Ratio
There is evidence indicating that the TC/HDL-C is a powerful predictor for CHD
risk (Kinosian et al., 1995; Criqui and Golomb, 1998). A TC/HDL-C ratio of 3.5 (males
and females) is associated with a lower risk for CHD whereas TC/HDL-C ratios of 5.0
are associated with higher risk for CHD (Sonnenberg et al., 1996; Kannel, 1983).
In our study, the mean TC/HDL-C ratio of the USBCA participants was higher
but not significantly than values in the FBCA and AA participants. Also, more USBCA
participants (19.4%) had elevated TC/HDL-C ( 5.0) ratio compared to the FBCA
(13.6%) and AA (13.1%) participants. Thus, based on the TC/HDL-C ratio alone, the
USBCA participants maybe at very high risk for early CHD events compared to FBCA
and AA participants. This is because Konosian et al (1995) and Grover et al (1995), using
data from the Framingham Heart Study and the Lipid Research Clinics Population
Prevalence Study, showed that the TC/HDL-C ratio is a better predictor of CHD risk,
even when compared with newer risk factors for CHD, such as Lp(a), homocysteine,
fibrinogen and tissue plasminogen activator antigen. Gotto et al (2000), using data from
the Air Force/Texas Coronary Atherosclerosis Prevention Study indicated that even in
individuals with average cholesterol levels, baseline TC/HDL-C levels were significant
predictors of subsequent major coronary event while TC and LDL-C levels were not.
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Additional Findings
Behavioral/Environmental
Individuals with low numbers of risk factors for CHD have low prevalence of
CHD (Stamler et al., 1999). Low prevalence of CUD is related to healthy behavioral
activities such as healthy diet, not smoking, consumption of moderate amount of alcohol
and maintaining healthy body weight (Stampfer et al., 2000). These behavioral risks/risk
factors impose a significant burden on our health care system and, are indeed the most
important and modifiable causes of mortality and morbidity from CHD and stroke
(Mokdad et al., 2004). This is demonstrated in the Nurses', Health Study (Stampfer et al.,
2000) which reported that females who ate a healthy diet, did not smoke, had moderate
alcohol consumption and exercise regularly had an 84% reduction in cardiovascular
events. Behavioral risks tend to cluster in individuals and populations (Niggs et al., 2002,
Orleans et al., 1999; Solomon and Kington, 2002) and disease risk and health care costs
are greatest for individuals with multiple behavioral risks (Orleans, 2004).
In general, the findings of our study have showed that the foreign-bom Afro
Caribbean (FBCA) individuals had a better behavioral/environmental (healthy diet as
measured by the diet score, lower percentages not watching television, proxy for leisure-
time inactivity, obese, smoking and drinking alcoholic beverages) profile compared to
their US-bom counterparts. Multiple behavioral risks are indeed common (Ford et al.,
2001; Berrigan et al., 2003; Coups et al., 2004; Pronk et al., 2004) even in our relatively
young adult population.
Comparisons of our results with other reports on behavioral risk factors are
difficult due to differences in methodology, variables and study population. In our study,
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the percentage of individuals (14.5%) with none of the 5 behavioral/environmental risk
factors (unhealthy diet, watching television often/very often, obese, cigarette smoking,
excess alcohol consumptions) was higher than that reported by Pronk et al (2004)
(10.8%), whereas the percentage of individuals (15.9%) with 3 behavioral risk factors
was lower than the percentage of adults (26.9%) who did not met ? 3 behavioral
guidelines in the same report. Data from the Pronk et al (2004) study compared whether
participants between the ages 18 to 64 years, from a large Midwestern health plan in the
US, met the recommended guidelines for behavioral factors such as high diet quality,
being physically active, having healthy weight, not smoking and no/or moderate alcohol
consumption. Other studies (Coups et al., 2004; Fine et al., 2004; Ford et al., 2001;
Berrigan et al., 2003) reporting on 4 behavioral risk factors have demonstrated the high
prevalence of multiple behavioral risk factors for CHD in the US, and the challenge this
may present for heath care professionals and policy planners. Coups et al (2004)
investigated physical inactivity, overweight, cigarette smoking and risky drinking
(consumption of 5 alcoholic beverages in a single day), whereas Fine et al (2004)
reported on overweight, physical inactivity, cigarette smoking and risky drinking both
using data from the National Health Interview Survey (2001). Coups et al (2004) reported
that 11.0% of the participants had none or 3 behavioral risk factors, respectively
whereas Fine et al (2004) reported that 10.0% of the participants had none of the
behavioral risk factors but that 17.0% had 3 behavioral risk factors. Ford et al (2001)
investigated healthy lifestyle factors such as not smoking, adequate fruit and vegetable
intakes, adequate physical activity and normal body weight in adults 21 years whereas
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Berrigan et al (2003) investigated patterns of health behavior by characterizing adherence
to public health recommendations for behavior related to exercise, tobacco, alcohol,
dietary fat and fruit and vegetable intakes both using data from the NHANES III database
for their studies. Ford et al (2001) showed that only 6.8% of the US population engaged
in all 4 healthy lifestyle behaviors whereas Berrigan et al (2003) showed that adherence
to recommendations concerning 5 health behaviors ranged from 34% to 74% (exercise,
40.6%; tobacco use, 68.1%; alcohol use, 73.9%; percent energy from fat, 34.4%; fruit and
vegetable consumption, 35.1%), respectively.
Most of the data on the clustering of behavioral activities are general in nature
(Coups et al., 2004; Pronk et al., 2004; Berrigan et al., 2003; Ford et al., 2001; Fine et al.,
2004) and have not reported on differences between ethnic subgroups. Also, most of
these reports have included BMI, a proxy for sedentary lifestyle (Pronk et al., 2004;
Coups et al., 2004; Ford et al., 2001; Fine et al., 2004), fruits, vegetables, dietary fat
(Berrigan et al., 2003) or fruits and vegetables (Ford et al., 2001). Additionally, the
percentage of males (24.2%) with > 3 behavioral/environmental risk factors was
significantly (p< 0.01) higher than females (8.2%). The percentage of the FBCA (6.1%)
participants with 3 behavioral/environmental risk factors was significantly (p< 0.05)
lower than that of the USBCA (22.6%) and AA participants (19.7%). Similarly, the
percentage of the FBCA (3.2%) males with 3 behavioral/environmental risk factors was
significantly (p< 0.01) lower than the USBCA (36.7%) and AA (33.3%) males. Our study
is in agreement with other studies (Coups et al., 2004; Fine et al., 2004; Pronk et al.,
2004; Ford et al., 2001; Berrigan et al., 2003) demonstrating the high prevalence of
multiple behavioral/environmental risk factors in the US, and indeed this population, and
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the challenge this may present for primary care and public health systems (Fine et al.,
2004).
Strengths of Study
This is the first study of its kind presenting socio-demographic,
behavioral/environmental, bio-physiological and emerging risk profiles for foreign and
US-born Afro Caribbeans in South Florida. Although the Afro Caribbeans are considered
part of the African American ethnic mosaic, they have different attitudes and behaviors
towards health and healthcare and indeed are growing faster than other well-established
ethnic groups, such as Cubans (Logan and Deane, 2003). There are over 1.5 million Afro
Caribbean individuals living in the US with over 500,000 living in the tri-state counties
of Miami-Dade, Broward and Palm Beach Counties (US Census, 2000). Individuals from
the Caribbean Region are the fastest growing ancestry group in Broward, Palm Beach and
Miami-Dade Counties in South Florida (US Census, 2000). For the year 1990 to 2000,
the Caribbean population grew by 173% (from 55,197 to 150,476) in Broward County,
142% (from 20,441 to 49402) in Palm Beach County and 45% (from 105,477 to 153,255)
in Miami-Date County (US Census, 2000). In spite of this increase in the foreign-born
population of the US, there are relatively few studies investigating differentials in health,
nutrition and mortality patterns between foreign-born and US-born individuals, especially
Afro Caribbean Americans. The importance of this study is based on the realization that
the US population is diversifying. Thus, distinctions based on national origins will
become more visible and, therefore, healthcare policy planners and healthcare
professionals must be aware of differences between the various ethnic groups. This will
201
help in the formulation of culturally sensitive strategies and programs to improve health
access and health outcomes in this and other populations. Also, with budget limitation for
healthcare, properly identifying ethnic groups at increased risk for CHD can help in
targeting this scarce resource more efficiently and effectively.
In the comparison of risk factors for CHD in this young and apparently healthy
Black population, we demonstrated that some individuals had multiple risk factors for
CHD. Indeed, differences in behavioral/environmental and emerging risk factors for
CHD between FBCA, USBCA and AA participants were the major findings of this
project. There were differences in socio-demographic and physiologic profiles between
the ethnic groups, but these did not attain statistical significance, possibly due to small
sample sizes. Data from the AHA Statistical Update, 2004 showed higher CVD events in
males compared to females at younger ages. If these trends continue or if these risk
factors for CHD remain unattended, then these can fuel increases in CVD events in the
near future. The participants, in answering the self-administered questionnaires and
receiving information on their health profile were more aware of their health status and
this may provoke them to address health issues of concern to them. We also investigated
the clustering of behavioral/environmental and metabolic risk/risk factors that provided
more information about the health status of this population than would have been
possible if the report was based on only a single factor (Pronk et al., 2004). The
comprehensive behavioral risk measure and the established metabolic risk measure
should be used more frequently, especially in the field of health promotion, disease
prevention and health policy determinants.
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Limitations of the Study
The self-report nature of some aspects of the data collection process such as
alcohol and cigarette use, in our young adult population, maybe reported with less
accuracy (Dufour, 2001) and raises the possibility of recall bias. However, our results
showed that a majority of the participants was knowledgeable about cardiovascular
disease and, the test-retest results of our questionnaires showed high correlation. Thus,
like Coups et al (2004) we were not aware of any evidence of systematic biases
associated with recall of information in our study. To reduce information bias in this
study, one investigator, using standardized and validated instruments collected and
analyzed the data. To reduce self-reporting biases, assurances of confidentiality were
given to the participants in order to encourage truthfulness. Accuracy of their responses
on the questionnaires was encouraged as the participants were informed that a health
profile would be given. Thus, for the health profile to be helpful, the accuracy of the
information given is of vital importance. To minimize data extraction bias, all data was
entered into SPSS, Version 12.0 by the Principal Investigator only and, the data checked
for anomalies in order to ensure consistency in data extraction. Our research design was
cross-sectional and, we may not be able to generalize our results beyond these ethnic-
cultural groups from South Florida. The FBCA and USBCA populations comprise
different groups such as Jamaicans, Haitians, Trinidadians, Barbadians and others from
the English-speaking Caribbean. These different groups of individuals may have different
socio-economic backgrounds and behavioral habits. Thus, future research should
investigate risk factors for CHD in the different Caribbean groups living in the Caribbean
and compare these risk factors with US-born counterparts over time.
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Summary
Our study is corroborated by large studies such as the studies of Stephen et al
(1994), Fang et al (1996; 1997) and Singh and Siahpush (2002). Stephen et al (1994),
using data from the National Center for Health Statistics, have reported that foreign-born
persons were generally healthier than the US-born population, although the health
advantage varied by length of residence in the US. They also stated that in every measure
of health status, and with regard to almost every socio-demographic variable, the most
recent immigrants were healthier than foreign-born individuals who have lived in the US
10 years or more as well as healthier than the US-born population, although the
differences were not as striking as between recent immigrants and the native-born
population. There are some suggestions for this so-called "immigrant effect". It is
suggested that (a) recent migrants may have been healthier than earlier migrants at the
time of migration (Stephen et al., 1994), or physically fitter and more driven than those
who remain in their country of origin (Singh and Siahpush, 2002), (b) earlier migrants
may have been as healthy as recent migrant but that the health status of these earlier
migrants may have deteriorated with increased duration of residence in the US (Stephen
et al (1994) and, (c) these findings may reflect a combination of the above or other
factors such as behavioral, psychological and environmental conditions known to
influence health status, morbidity and mortality (Singh and Siahpush, 2002). This suggest
that recent immigrants may have acquired behaviors that expose them to risk of chronic
diseases in their new environment or that access to health care or visitation to health care
professions may have been limited. In our study, although more FBCA (71.2%)
participants had medical insurance compared to USBCA (69.4%) and AA (67.2%)
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participants, USBCA (85.5%) participants were more likely to visit with healthcare
professionals during the past year compared to FBCA (80.3%) and AA (73.8%)
participants. A study from the National Academy of Sciences (National Academies of
Sciences, Hernandez, 1999: access at http://www.nap.edu) has reported on the protective
effect of immigrant status. This report demonstrated that foreign-born young adults
experienced more favorable physical and emotional health and less involvement in risky
behaviors than US-born young adults of foreign-born parents and US-born young adults
of US-born parents. The report also stated that the protective quality of immigrant status
was not related to the family or neighborhood context of immigrant children. Thus, it is
suggested that future research should concentrate on uncovering the mechanism(s) behind
the health protective effect(s) of foreign birth. Fang et al. (1997) showed 46%-51% lower
mortality among black migrants compared to US-born black counterparts in New York
City. In an earlier study, Fang et al. (1996) showed that Caribbean-born Blacks in New
York City had substantially lower all-cause and cardiovascular mortality rates compared
to Blacks born in the southern and northern region of the US. In this same study, Fang et
al. (1996) have intimated that the risk of cardiovascular disease of foreign-born
individual increases with length of residence in the US. Singh & Siahpush (2002), using
data from the National Longitudinal Mortality Study (1979 through 1989), a data set for
the examination of socio-demographic and occupational factors associated with all-cause
and cause-specific mortality in the US, found that immigrants tended to have more
favorable health-enhancing behavioral habits than their US-born counterparts. They also
showed that non-Hispanic black migrants compared to their US-born non-Hispanic black
counterparts were less likely to smoke cigarettes (10.4% vs. 29.3%), less likely to be
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overweight (25.2% vs. 38.4%), and less likely to be hypertensive (16.8% vs. 25.5%) but
more likely to have no medical insurance (40.2% vs. 34.5%). Our results are also in
contrast to the report of Singh and Siahpush (2002) which indicated the percentage of
US-born non-Hispanic Blacks (40.2%) who had medical insurance coverage was higher
compared to foreign-born non-Hispanic Blacks (34.5%). The Fang et al (1996) and Singh
and Siahpush (2002) reports did not inform if the differences they observed were
significant. Also, Cairney and Ostbye (1999) showed that prevalence of excess body
weights increased with time since migration to Canada. Prevalence of excess body
weights increased from 33.5% and 17.1% (0-4 years since immigration) to 52.6% and
42.1% (10 or more years since immigration) in males and females, respectively.
Prevalence of excess body weights in male and female Canadians were 59.3% and
37.4%, respectively. Additionally, in England, Sharma et al (1999) have also shown that
as the length of residence of the foreign-born Afro Caribbean population increases, their
eating habits approximates that of the eating habits of the native-born population.
There is a suggestion that ethnic groups within one location may adopt certain
behaviors, whereas in another location this same ethnic group may behave differently
(Yusuf et al., 2001) indicating a geographical transition of risks (Abbotts et al., 2004) for
CHD. Differences in demographic profiles, environmental factors, early childhood
programminig influences as well as differences in gene frequency or expression can
influence variations in CVD between different populations (Yusuf et al., 2001) and
indeed between different ethnic groups and ethnic subgroups within the same population.
For example, in the Ni-Hon-San study of Japanese migrants, low TC and CHD rates were
seen in Japanese men in Japan whereas intermediate and high TC levels and CHD rates
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were seen in Honolulu and San Francisco, respectively (Kagan et al., 1974). In England,
comparison of Afro Caribbeans, South Asians and Europeans showed marked differences
in central obesity, glucose intolerance hyperinsulinemia nd elevated dyslipidemia, despite
having similar blood pressure, BMI and TC (McKeigue et al., 1991). Additionally, a
study of individuals of West African Ancestry in Africa (Cameroon), the Caribbean
(Jamaica) and England (Manchester) showed the prevalence of diabetes mellitus and
hypertension was lowest in rural Cameroon and highest in Manchester (Cooper et al.,
1997/1997a; Mbanga et al., 1999; Cruickshank et al., 2001). Thus, behavioral activities
and culture rather than differences in genetics and clinical factors between foreign-born
and US-born individuals may in part be explanatory for differences in CHD mortality
between foreign- and US-born individuals as reported by Stephen et al (1994), Fang et al
(1996) and Singh and Siahpush (2002).
Conclusion and Recommendations
Reports from several authors have demonstrated that foreign-born Black
individuals have lower mortality and morbidity from CHD (Stephen et al., 1994; Fang et
al., 1996; Singh and Siahpush, 2002; Hicks et al., 2003) and suggested that this maybe
due to better health profiles compared to their US-born counterparts (Stephen et al., 1994;
Singh and Siahpush, 2002; Hicks et al., 2003). In most of these reports (Fang et al., 1996;
Stephen et al., 1994; Singh and Siahpush, 2002) reported differences between the
foreign-born and their US-born counterparts were noted but whether these differences
were statistically significant was not published. However, Hick et al (2003) reported
statistically significant differences in the measured parameters they investigated.
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Our study provided baseline information on socio-demographic,
behavioral/environmental, bio-physiological and emerging risk factors for CHD in three
subgroups of a predominantly Black population in South Florida. In general, the findings
of this study showed that the foreign-born Afro Caribbean (FBCA) individuals had a
better behavioral health profile compared to their US-born counterparts. The FBCA had
better behavioral (healthy diet as measured by the diet score, watching television [proxy
for leisure-time inactivity], lower percentage being obese, lower percentages not smoking
or drinking alcoholic beverages) profiles. The dietary findings included the observations
that the FBCA participants compared to the USBCA and AA participants consumed
significantly less total fat, saturated fat, percent energy from fat, fat servings, dietary
cholesterol and sodium and more percent energy fromn carbohydrate and vegetables. A
similar trend was seen for the FBCA males compared with the USBCA and AA males.
For the FBCA females, only the mean dietary cholesterol intake was significant. Of
interest, the mean total fat, saturated fat and dietary cholesterol intakes of the FBCA
participants were significantly (p< 0.05) lower than the intakes reported for the African
American population by the NHANES III study (Popkins et al., 2001) whereas the
intakes of these nutrients for the USBCA and AA participants approximate that of the
NHANES III values. Also, the percentages of participants exceeding dietary
recommendations for percent energy from fat, saturated fat, cholesterol and sodium and
not meeting these recommendations for fruit consumption were higher for USBCA and
AA participants compared to the FBCA participants, with the differences being more
pronounced in the male ethnic subgroups. The fat, dietary cholesterol, vegetable and
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sodium components of the diet are the major differences between the groups and indeed
modifiable and subject to appropriate interventions.
Over the last decade the US Government (Healthy People 2010) and the
American Heart Association (AHA Statistical Update, 2004) have set recommendations
for improving the dietary intakes of the US population. The recommendations are to
reduce total fat, especially saturated fat, dietary sodium and increase fruits, vegetables
and fiber intakes. Although the knowledge of CHD risk factors was high in this
population, the USBCA and AA participants in this study were apparently not following
these recommendations. Maybe the messages were not culturally sensitive or specific to
this ethnic group or, as reported by Anderson (2003) there may be differences in the
social environment in which food is selected and consumed, areas not investigated in this
study. Understanding the social context of food choice may be as important as identifying
the food sources of the major nutrients in food (Anderson, 2003). This is because food
provides a means to demonstrate cultural identity and is also symbolic of many areas of
the participants' origin, religious background and beliefs structures (Anderson, 2003).
We also observed that more USBCA and AA participants were obese compared to the
FBCA participants. Other authors (Stephen et al., 1994; Singh and Siahpush, 2002; Hicks
et al., 2003) also found that more US-born individuals were indeed obese compared to
their foreign-born counterparts. The USBCA and AA participants may be at increased
risk of CHD based on our findings that the percentages of USBCA and AA participants
with behavioral and biophysical risk factors for CHD were higher than FBCA
participants. These behavioral and biophysical risk factors for CHD have been associated
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with risk for CHD in numerous reports (NCEP: ATP III, 2001; AHA Statistical Update,
2004; Pearson et al., 2002).
These findings will become more noteworthy as the population of foreign-born
individuals especially Afro Caribbeans increases. The need for culturally sensitive
messages and programs to address health disparities by ethnically trained health care
professionals will become even more important. It is also important that the health care
establishment evaluates and understands the health needs, concerns and behavioral
propensities of this and other ethnic groups.
According to the US Census Brief Report (2001), the term, "Black or African
American" describes individuals having origins in any of the Black racial groups of
Africa and, includes individuals who reported their race as "Black, African American,
Negro, Afro American, Nigerian or Haitian," on the 2000 census survey. Such broad
categorization of individuals does not take into consideration the existence of
subgroups/cultures within this black population. These subgroups/cultures maybe
composed of varying numbers of foreign-born individuals. Also, individuals of this black
population may share some socio-demographic and genetic characteristics. Thus,
differences in attitude, knowledge and behaviors leading to differences in some of the
risk factors for CHD within the subcultures of this Black population (Kleier, 2003). Thus,
it may be of vital importance to health policy planners and health care providers in the
US, to monitor the health status of immigrants, especially as the population of
immigrants increases (Stephen et al., 1994). The challenge of preventing CHD in this
population lies in identifying and addressing the components of CUD most relevant to
each ethnic group (Yusuf et al., 2001) especially dietary habits, one of the major
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differences between FBCA and the US-born counterparts. Poor dietary habit, one of the
components of behavioral profile, is the cause of over $33 billion in medical cost and
over $9 billion in lost productivity due to CHD, cancer, stroke and diabetes mellitus
(AHA Statistical Update, 2004).
Research is required to elucidate the various mechanisms for the differences in
health behaviors between foreign- and US-born counterparts. Additionally research
should examine screening for multiple behavioral and metabolic risk/risk factors in other
racial/ethnic-cultural groups and subgroups with respect to geography (geographical
transition of risks) and other behavioral factors such as sleep (Pronk et al., 2004),
working at home/housework and visitations to healthcare professionals. Also, research on
the behavioral activities of immigrants in the US versus their activities in their country of
birth may help us better understand the geographical transition of behavioral and other
risk factors for CHD in this and other ethnic populations. It is suggested that we should
also investigate individuals who adhere to multiple health behavior recommendations as
this might help us to understand the mechanisms that influence such behaviors (Berrigan
et al., 2003). This might be helpful in the design of programs that will encourage
healthier behaviors in this and other populations.
Focus should be placed on the ethnic and cultural differences in a population to
better understand the variations in health indicators among different ethnic and cultural
groups of the same race. This focus can provide healthcare professionals and policy
planners with the opportunity to develop culturally sensitive nutrition/health programs
and strategies for the improvement of health outcomes.
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Florida International University
College of Health and Urban Affairs
Comparison of Coronary Heart Disease Risk Factors in
Caribbean-American and African-American Adults in South
Florida
Are You:
> Aged 18 - 40 Years Old?
> Caribbean National?
> Caribbean-American?
> African-American?
> Not taking anti-inflammatory drugs (Aspirin, Motrin, Advil)?
> Then You Can Participate in a Research Study
You will be asked to: You will Receive:
> Sign an informed consent > Meal voucher
form. > Free study-related
> Answer a dietary dietary assessment
questionnaire. Free study-related
> Answer a cardiovascular heart disease
risk questionnaire. assessment
> Answer a knowledge of Free study-related
heart disease risk assessment of heart
questionnaire. disease knowledge
> Answer a stress Free study-related
assessment questionnaire. stress assessment
SGive 1tablespoon of blood.
For more information Call:
Errol Davis at 305-348-6427
Email: edavisO2@fiu.edu
Room HLS 430
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IJ IRB A roVd
t Date:
No.: 00D3 n
FLORIDA INTERNATIONAL UNIVERSITY
Miami's public research university
INFORMED CONSENT
Comparison of Coronary Heart Disease Risk Factors in Caribbean-American and
African-American Adults in South Florida
PURPOSE
You are being invited to freely participate in this study to look at risk factors for coronary
heart disease ong Caribbean-Americans and African-Arericans. You will be one of
one hundred and eighty individuals who will be involved in this study. The entire study
will require 45-60 minutes of your time.
PROCEDURES
o You will be asked to complete five questionnaires that ask about (a) yo urelf and
your family history of coronary heart disease and diabetes, (b) your food intake,(c) your physical activity, (d) your perceived stress and (e) your knowledge of
coronary disease risk factors.
o Your weight height and waist circumference will be measured
o Your blood pressure will be taken
o One tablespoon (approximately 15 mL) of blood will be taken, from your arm, by
a licensed Phlebotomist, using s d procedures. This is necessary to measure
your coronary heart disease risk. Some of your blood will be stored at -70 oC, in
one of our freezers, for future analysis of C-reactive protein (a marker for
cardiovascular disease and inflammation) and other biochemical substances as
needed.
RISKS
There is no cost to you for being in this study. You may feel a slight discomfort lasting
less than a minute, due to the withdrawal of blood. However, with the use of sterile
equipment and, standard procedures administered by a well-trained phlebotomy
technician, the risk of soreness or ion is very small.
REIMBURSEMENT
You will receive a meal voucher ($3.20 value) which will be honored by the Pollo
Tropical Restaurant, within a one month period, at Florida International University.
College of Health and Urban AffairsSchool of Health
Dp ent of Dietetics and NutritionUniversity Park, HLS 450 - Miami, FL 33199 -Tel: (305) 348-2878 'Fax: (305) 348-1996
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CONFIDENTIALITY
Your answers and other personal information on the survey forms will be kept strictly private.
You will be given an identification number known ONLY to the people doing the study. All
survey forms and other information taken from you will be kept in locked files that will be used
only by the people doing the study.
OTHER INFORMATION
You are free to withdraw your consent and refuse further participation in this study at any time
with no problems. You may ask questions about any materials and tests being used. We will
provide answers to your satisfaction.
If you have more questions about this study, you may contact Dr. Fatma Huffman at (305) 348-
3788 or Mr. Errol Davis at (305) 348-6427. If you have any questions about your rights, you may
call the Chairperson of the Institutional Review Board at Florida International University, Dr.
Bernard Gerstman at (305) 348-3115. You will receive a copy of this Informed Consent form
once you and the researcher have signed it.
I have read and understood the information above.
Participant's Name Participant's Signature
Date
I have explained the study to the satisfaction of the participant and have provided a copy of this
Informed Consent Form.
Signature of Principal Investigator Date
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Florida International University
Socio-demographic Questionnaire
Dear Participant: Please answer the following questions about your lifestyle habits and please
write or place a check (1) in the appropriate spaces.
Pin # Date:
Last Name:_ 
___________ First Name:
1 - Gender: 1 Male 2 Female
2- Age: 1 ___ less than 21 years
2 ___ 21-30 years
3 ___ 31-40 years
3 - Race and ethnic background
1 __ African American
2 __ Caribbean National/American
4- Please state your place of birth
5 - How long have you lived in the United States of America?
1 __ less than 1 year 4 6-10 years
2 __ 1-3 years 5 __ Other (specify)
3 __ 4 - 5 years 6 All my life
6 - Marital Status
1 __ Single (never married) 2 Married
3 _ Separated or Divorced 4 Widowed
7 - At present, are you attending school? Yes No
If yes, 1 __ full time
2 __ part-time
3 __ not attending school
8 - Education (completed)
1 __ 6th grade (Caribbean) 2 _ 8t grade (US)
3 __ High School (Caribbean) 4 High School (US)
5 _ College (Caribbean) 6 College (US)
7 __ Graduate Studies (Caribbean) 8 __ Graduate Studies (US)
9 __ Other (Specify) 
_
9 - Do you have medical insurance?
1 ___No 2 Yes
If yes, please specify
A __Medicare
B ___Medicaid
C __Private Provider Organization
D __Home Management Organization E __ Other (Specify)
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10 - How often do you visit a Health Care Professional for medical examination?
1 once per year 2 ___ twice per year
3 ___ three times per year 4 ___ 4 times per year
5 __ never/no visit in past year
11 - Are you employed?
1 __ Yes 2 _No
If yes, current occupation
12 - Household Income
1 _ Less than $10,000 4 _ $30,000-$39,000
2 __ $10,000-$19,999 5 more than $40,000
3 $20,000-$29,999
13 - Monthly Expenditure on Food
1 _ Less than $100 4 __ $300-$400
2 __ $100-$200 5 $400-$500
3 __ $200-$300 6 __ More than $500
14 - How many individuals live in your household?
1 Children less than 5 years 2 Children 5-20 years
3 ___Adults 21-64 years 4 ____Adults 65 years and older
15 - Family history of heart disease (check first correct answer):
1 __ two relatives with heart disease before 60 years of age
2 __ one relative with heart disease before 60 years of age
3 __ two relatives with heart disease after 60 years of age
4 __ one relative with heart disease after 60 years of age
5 __ you have no family history of heart disease
6 __ you do not know your family history of heart disease
16 - Personal history of heart disease:
1 __ you have had or have been diagnosed to have heart disease
2 _ you have never had heart disease
17 - Family history of diabetes (check first correct answer):
1 __ you have two relatives with diabetes
2 __ you have one relative with diabetes
3 __ you have no family history of diabetes
4 __ you do not know your family history of diabetes
18 - Personal History of diabetes
1 __ you have diabetes that began before the age of 20
2 __ you have diabetes that began between the ages 20-60
3 _ you do not have diabetes
Please answer the other attached questionnaires
THANK YOU.
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Florida International University
Cohen Perceived Stress Scale
Pin #
The questions in this scale ask you about your feeling and thoughts and perceived level of stress
during the past month. Please circle a number for each question according to the following scale.
0 = Never 1 = Almost Never 2 = Sometimes 3 = Fairly Often 4 = Very Often
1. In the last month, how often have you been upset [0] [1] [2] [3] [4]
because of something that happened unexpectedly?
2. In the last month, how often have you felt that [0] [1] [2] [3] [4]
you were unable to control the important things
in your life?
3. In the last month, how often have you felt [0] [1] [2] [3] [4]
nervous and "stress"?
*4. In the last month, how often have you dealt [0] [1] [2] [3] [4]
successfully with irritating life hassles?
*5. In the last month, how often have you felt [0] [1] [2] [3] [4]
that you were effectively coping with important
changes that were occurring in your life?
*6. In the last month, how often have you felt [0] [1] [2] [3] [4]
confident about your ability to handle your
personal problems?
*7. In the last month, how often have you felt [0] [1] [2] [3] [4]
things were going your way?
8. In the last month, how often have you found [0] [1] [2] [3] [4]
that you could not cope with all the things that you
had to do?
*9. In the last month, how often have you been able [0] [1] [2] [3] [4]
to control irritations in your life?
*10. In the last month, how often have you felt that [0] [1] [2] [3] [4]
you were on top of things?
11. In the last month, how often have you been [0] [1] [2] [3] [4]
angered because of things that happened that
were outside of your control?
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12. In the last month, how often have you found [0] [1] [2] [3] [4]
yourself thinking about things that you have
to accomplish?
*13. In the last month, how often have you been [0] [1] [2] [3] [4]
able to control the way you spend your time?
14. In the last month, how often have you felt [0] [1] [2] [3] [4]
that difficulties were piling up so high that
you could not overcome them?
Note: * Scored in the reverse direction.
Used with permission of the publisher from Cohen S, Kamack T, Mermelstein R. A Global
Measure of Perceived Stress. J Health and Social Behav 1983; 24: 385-396.
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Florida International University
Knowledge of Cardiovascular Risk Factors Questionnaire
Dear Participant: Please circle True (T) or False (F) to the following questions to test your
knowledge of heart disease and its risk factors.
Pin #:
1 - T F The risk factors for heart disease that you can do something about are: high
blood pressure, high blood cholesterol, smoking, obesity and physical inactivity.
2 - T F A stroke is often the first symptom of high blood pressure,
and a heart attack is often the symptom of high blood
cholesterol.
3 - T F A blood pressure greater than or equal to 140/90 mm Hg is
generally considered to be high.
4 - T F High blood pressure affects the same number of African-
Americans and Caribbean-Americans as it does non-Hispanic
Whites.
5 - T F The best ways to treat and control high blood pressure are
to control your weight, exercise, eat less salt (sodium), restrict
your intake of alcohol, and take your high blood pressure
medicine, if prescribed by your doctor.
6 - T F A blood cholesterol level of 240 mg/dL is desirable for
adults.
7 - T F The most effective dietary way to lower the level of your
blood cholesterol is to eat food low in cholesterol.
8 - T F Lowering blood cholesterol levels can help people who
have already had a heart attack.
9 - T F Only children from families at high risk of heart disease
need to have their blood cholesterol levels checked.
10- T F Smoking is a major risk factor for 4 of the 5 leading causes
of death including heart attack, stroke, cancer and lung diseases
such as emphysema and bronchitis.
11 - T F If you have had a heart attack, quitting smoking can help
reduce your chances of having a second attack.
12 - T F Someone who has smoked for 30 to 40 years probably will
not be able to quit smoking.
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13 - T F The best way to lose weight is to increase physical activity
and eat fewer calories.
14 - T F Heart disease is the leading killer of men and women in the
United States.
15 - T F High blood cholesterol is one of the risk factors for heart
disease that you can do something about.
16 - T F To lower your blood cholesterol level you must stop eating
meat altogether.
17 - T F Any blood cholesterol level below 240 mng/dL is desirable
for adults.
18 - T F Fish oil supplements are recommended to lower blood
cholesterol.
19 - T F To lower your blood cholesterol level you should eat less
saturated fat, total fat and cholesterol and, lose weight if
your are overweight.
20 - T F Saturated fat raises your blood cholesterol level more than
anything else in your diet.
21 - T F All vegetable oils help lower blood cholesterol levels.
22 - T F Lowering blood cholesterol levels can help people who
have already had a heart attack.
23 - T F All children need to have their blood cholesterol levels
checked.
24 - T F Women do not need to worry about high blood cholesterol
and heart disease.
25 - T F Reading food labels can help you eat the heart healthy way.
National Heart, Lung and Blood Institute Publication, Nos. 93-2724 and 95-3794
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RESPONDENT ID
NUMBER TODAY'S DAT E
0RE FFeb
G 00 bQGDQ(1D Mar o®®20000UEST1 NNAII{E
00(1 C 000001)C)0 OAp! 00)2001
0 0 0 (D(DcCO May GD 2002 0
0 0 0000 O Jun C 2003 0
000000000 a Jul 2004 0
000D 0000( O Aug 20050
00000000® O Sep 20060
0000000D Q Oct 20070
8 0 0 00 0Nov 820080-
ON) 0 0 0 ODec 0 20090
This form is about the foods you usually eat. SEX AGE WEIGHT HEIGHT .
It will take about 15 - 25 minutes to complete. o Male pounds ft. in. -
" Please answer each question as best you can. Female
Estimate if you aren't sure. "
®Q ®®O -
" Use only a No. 2 pencil. If female, are you 0 0 O -
pregnant or 0D 2D CD 
-D(D* Fill In the circles completely, and erase breast feeding?
completely If you make any changes. 4® on®
Q No D( (1 e
Please print your name in this box. 0 Yes (D -
O Not female 
-
9 -9
This form Is about your usual eating habits In the past year or so. This Includes all meals or snacks, at home or ..-
In a restaurant or carry-ouL There are two kinds of questions for each food. 
-
HOW OFTEN, on average, did you eat the food during the past year?
*Please DO NOT SKIP any foods. Mark "Never" if you didn't eat it. 
-
HOW MUCH did you usually eat of the food?
*Sometimes we ask how many you eat, such as 1 egg, 2 eggs, etc., ON THE DAYS YOU EAT IT
*Sometimes we ask "how much" as A, B, C or D. LOOK AT THE ENCLOSED PICTURES. For each food,
pick the picture (bowls or plates) that looks the most like the serving size you usually eat (If you don't have
pictures: A=1/4 cup, B=l/2 cup, C=1 cup, D= 2 cups.)
EXAMPLE: This person drank apple juice twice a week, and had one glass each time. Once a week he ate a -g
"C"-sized serving of rice (about 1 cup). -
IO'VOFTEN IN THE PASTFEAR """
A < HOWMUCH H TME ...
OF FOOD a~r ows r T[ Nr E TWICE T Es TmIEs S ~Er !GE PORTIN$Z -ETYP PO POOD .fir e bAY PICTURES FO AO-b -
YEAR MONTH MOr EK WEK WaK, WEE _K
How many
Apple juice o o 0 0 0 0 gIasses @ 000
each time 1
Ri¬c 0 0 0 C 0 6 _ 0 0 0 OW No ra 0 0 0 0 -
PLEAsE DO o NOT WOE IHS AEA
sE0ESmooooeoosoO6oonoo 
-9274
k -ref 02000 BDOS Phone (510)-704-514 www.nutr onquestcom
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HOW OFTEN IN THE PASTYEAR HOW M/C ACH TIMEI A FEW 2-3 3-4 s-s 
-1
TYPE OF FOOD E TIMES ONCE TIMES ONCE TWICE TIMES TIMES EVER SEE PORTICYI 27E
per per per per per per per DAY PICTURES FOR A-B-G D
.. _ _ _YEAR MONTH MONTH WEEK WEEK WEEK WEEK
How often do you eat each of the following foods all year round?
Eggs, including egg biscuits or Egg How many
McMuffins (Not egg substitutes) O O O O O 0 0 0 0 eggs O O O O
each time 1 2 3 4
Bacon or breakfast sausage, including How many
sausage biscuit 0 0 0 0 0 pieces 2 0 0
Cooked cereals like oatmeal, cream of Which
wheat or grits 0 00 0 0 0 0 0 0 bowl B O 0
Cold cereals like Coin Flakes, Which
Cheerios, Special K, fiber cereals 0 0 0 0 0 0 0 0 bowl 0 0 C
Which cereal do you eat most often? MARK ONLY ONE: O Bran Buds, Raisin Bran, Fruit-n-Fiber, other fiber cereals
0 Product 19, Just Right, Total 0 Other cold cereal, like Corn Flakes, Cheerios, Special K
Cheese, sliced cheese or cheese 0 0 0 0How many O 0 0 0
spread, including on sandwiches. slices I 2 3
Yogurt (not frozen yogurt) 0 0 O O O O 0 0 O How much 01 0 0 O
How often do you eat each of the following fruits?
Bananas O O 0 0 0 0 0 0 How many 0 0 0 0each time 1 2 3
Apples or pears 0 0 0 0 0 0 0 0 0 Iow many 0 0 0 0
- 2 1 2 3
Oranges, tangerines, not including juice 0 O O O O O O O O How many 0 0 0 0
IZ 1 2 2
Applesauce, fruit cocktail, or any o 0 0 0 0 a o 0 0 0 0 O
canned fruit How much A C
Any other fruit, like grapes, melon,
strawberries, peaches, applesauce 0 0 0 0 0 C 0 0 0 How much 0 0 0 0
_ _ 
_ _A B .c a
s.2
as
s .
sea
s..
saes
se262
PLEASE DO NOT WRITE IN THIS AREA
9274 oQo _,DOOQOE o Eo oooomEoE|
HOW OFTEN IN THE PAST YEAR
EW -El________
.. OFFFEDA  3-4 I-6 HOW MUCH EACH TIME
TYPE OF FOOD NEVER TIMES ONCE TIMES ONCE TWICE TIMES TIMES EVER SEE PORTION SIZEper per per per per per per DAY PICTURES FOR A-B-C-DYEAR MONTH MONTH WEEK WEEK WEEK WEEK
MEATS
Do you ever eat chicken, meat or fish? O Yes O No IF NO, SKIP TO NEXT PAGE
Hamburgers, cheeseburgers, meat loaf, O O O O O O O O How much O O a O
at home or in a restaurant meat 118 b. 1/1b. I1 l. 314 lb.
Tacos, burritos, enchiladas, tamales O 0 0 O O O 0 0 0 How much O O O O
A 6 C D
Beef steaks, roasts, pot roast, or infrozen dinners or sandwiches QO O O O O O How much O O O O
fe A B C D
Pork, including chops, roasts,
or dinner ham O O O O O O O O O How much O O O OA 8 C D
When you eat
beef or pork, do you O Avoid eating the fat O Sometimes eat the fat O Often eat the fat O I don't eat meat
Mixed dishes with meat or chicken,
like stew, corned beef hash, chicken O O O O O O U 0 ) How much O O O O
& dumplings, or in frozen meals A 8 c 0
Fried chicken, at home or in a restaurant O o O O O O O O O I mum a O o C)pieces I 2 3 4
Chicken or turkey not fried, such as
baked, grilIed,;orons ches t C C C C O C C C How much n  C O
When you eat chicken, do you O Avoid eating the skin O Sometimes eat the skin O Often eat the skin O N/A
F ried ao O o 0 0 0 0 O O O How much O o 
iareauatA B C 0
Any other fish or shellfish not fried, C 0 0 C C C) Howmuch C C C O
including tuna A s C m
Hot dogs, or sausage like Polish, Italian
orChorfzo O 0 0 o O o 0 0 How many O O 4
Boloney, sliced ham, turkey lunch O O C C C C How many O O O C
meat, other lunch meat slices 1 2 3 4
Wher you eatlidi meats, are they ) usually lowfat O Sometimes O Rarely ow-fat O N/A
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HOW OFTEN IN THE PAST YEAR
TYPE OF FOOD AFEW 2-3 4 1 HOW MijC EACH TIME
NEVER TIMES ONCE TIMES ONCE TWICE TIMES TIMES JVERY SEE PORTION SIZE .NEER pr per per per per per IDY1PTURES FOR A-B-G-DMOTWEKEKWE EKYEAR MNH MOH WEEK WEEK WEEK WEEK A
How often do you eat each of the following vegetables, including fresh,frozen, canned or in stir fry, at home or in a restaurant?
French fries, fried potatoes or hash
browns O O O O O O O O O How much O O O O
A B C 0White potatoes not fried, incl. boiled,
baked, mashed & potato salad O O O O O O O O O How much O O O O
A B C DSweet potatoes, yams, or sweet potato w 0 0
pie 
.-
A B C DRice, or dishes made with rice 0 0 0 0 0 0 0 0 0 Howmuch 0 0 0 0
Baked beans, chili with beans, pintos, A B C
any other dried beans 0 0 O O O O O O O How much O O O O -
A B C 0Refriedbeans O O O O O O O O How much O O O O
A B C DGreen beans or green peas 0 0 O O O O O O O How much O O O O -
A B C DBroccoli O O O O O O O How much O O O O ..
A a C 0Carrots, or stews or mixed vegetables
containing carrots O O O O O O O O O How much o O O O
A B C D
Spinach, or greens like collards O O O O O O O O O How much 0 0 ...
A a C D
Cole slaw, cabbage O O O 0 0 0 0 0 O Howmuch 0 0 0 O -
A a C 0
Green-sa.td 0. O o C O Howmuch o O O O
A a C Do F
Raw tomatoes, including in salad 0 0 C 0 0 0 0 0 0 How much 0 0 0 -
114 112 1 2
Catsup, sasa 4 il eppers O O 0 fow 0 0 0 0
Salad dressing or mnayonnaise 
"-(Not lowfat) 0 0 0 0 0 0 0 0 0 How many 0 C C -
At 4~t g~a1r ~Q O O O O O O O O O Fsas :k a, tbbked green pe prsr 0o 0uc 000 0em0Q0 0
onjo s 
-Vegetable soup, vegetable beef, 
--
chicken vegetable, or tomato soup . O 0 0 0 0 0 0 hch 0 C) 0 -
bw4 c a
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PLEASE DO NOT WRITE IN THIS AREA
Sc 00000OO oOOomUeOfI -
.HOW OFTEN IN THE PAST YEAR
P DA FEW 1 _f34 3- HOW MUCH EACH TIME
TYPE OF FOOD NEVER ONCE TIMES ONCE Ewc TIES TIMES EVERS SEE PORTION SIZE .per Per Per per per Per per DAY PICTURES FOR A-B-C-DYEAR MONT MONTH WEEK WEEK WEEK WEEK
Pasta, breads, spreads, snacks
Spaghetti, lasagna, or other pasta with
tomato sauce O O O O O O O O O How much O O O O ..
A B C 0Cheese dishes without tomato sauce, ""
like macaroni and cheese O O O O O O O O O How much O O O O
A a C D 
_
Pizza, including carry-out O O O O 0 O O O O How many 0 0 O 0 .
slices 1 2 3 4
Biscuits ,muffins O O O O O O O Howmany 0 0
each time 1 2 3 4
Rolls, hamburger buns, English O O O O O O O 0 0 How many o O O O -
muffins, bagels each time 12 1 2 3
Whitebread or toast, incuding How manyFrech, ltaliaior inandwiches O O O 0 O O O O O slices 0 0 m y
-, ' - 2 3 4
Dark bread like rye or whole wheat,
including in sandwiches Hslices ny 2
Totillas 0 0 O O 0 O O O O How mapy 0 O O -
each time 2 3 4
Margarine on bread, potatoes ortm
vegetablespats (Tsp.) 1 2 3 4
Peanuts or peanut butter O O O O O O O O How many O O O O
TBSP. 1 2 a 4
StT kcsl tato dips, nchips; 0 0 O O O O O O O Now much 0 0 0ppant6 Wrzes A. ' C 0 -
Doughnuts, cake, pastry, pie O O O O O O O O O How many 0  0 O 0 .pieces 1 2 s 4
p0 0 0 0 t-ootto t)) 0 ilow many 0 1 0 "
Ice cream, frozen yogurt, ice cream bars 0 0 0 0 0 0 0 0 0 How much 0 0 0 0 -.
y o~1Na ot es OC arIly bowat 0 N/A -
Chocolate candy, candy bars O O O O 0 0 O O' O How many m m m (
bars a,,a n . ro
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HOW OFTEN IN THE PAST YEAR - HOW MUCH E A TIME
I AFEW I 2-3 3- 5- HO MUH___~TYPE OF BEVERAGE E IMES ONCE TIMES ONCE TWICE TIMES TIMES VERY SEE PORTION SIZE
.per per per per -per per per DAY PICTURES FOR A-B-C-D
YEAR MONTH MONTH WEEK WEEK WEEK WEEK
How often do you drink the following beverages?
" Real orange or grapefruit juice, Welch's How many
grape juice, Minutemaid juices, Juicy O O O O O O O O O glasses each O O O O
"- Juice
. H-awaijan.Punch, Sunny-Delight, Hi-C, How many
Tang, or Ocean Spray juices O O O O O O O O O glasses each O O O O
" How many
- Kool Aid, Capri Sun or Knudsen juices O O O O O O O O O glasses each O O O O
time 4
-ntn i ast t 0silksakikfe 00 0 Haw many 0  0 0
ia o~ale'takie - m- t or glasses oE 2 3 <
- 4~isipti~jeriskrisre 'cans
- Glasses of milk (any kind) O O O O O O O O O Hw smay 0 0 0 0
- ____________________________glaSseS 1 2 3 4
u. sses tilk O Nloon-fat ik don't drink milk or soy milk
. Xia iI 0 duced fat 2%6 milk O Rice milk
.. 0ow-,at 1% milk O Soy milk
Cream, Half-and-Half or non-dairy ow TBSP. on e 0 0 0
creamer in coffee or tea 0hosdays 1 2 3- 6+
~red dnik m 0 0 0 0~ a 0 0 0
- _ ui~ i~ 6d~ nnkf - t)Ot. 1s 2J O:- .. 5+.O
-Beer 000000000 On 0 0bottles or 1 2 3-4 5+
- cans
quor or mixed drinks 0 O O O O 0 O dHow many 0 0 O 0
r.2
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During the past year, have you taken ariy vitamins or minerals regularly, at least once a month?
O No, not regularly O Yes, fairly regularly
(IF YES) WHAT DID YOU TAKE FAIRLY REGULARLY? 
.-
VITAMIN TYPE HOW OFTEN FOR HOW MANY YEARS?
A FEW 1-3 4-6
DAYS DAYS DAYS LESS
DIDN'T per per per EVERY THAN 1 2 3-4 5-9 10+
TAKE MONTH WEEK WEEK DAY 1 YR. YEAR YEARS YEARS YEARS YEARS -
Multiple Vitamins. Did you take.. ~ ~ - - ----------- -
Regular Once-A-Day, Centrum, or Thera type 0 0 0 O 0 O 0 0 0 0 0Stress-tabs or B-Complex type 0 0 0 0 0 0 0 0 0 0 0 -Antioxidant combination type 0 0 0 0 0 0 0 0 0 0 0 .Single Vitamins (not part of multiple vitamins)
Vitamin A (not beta-carotene) 0 0 0 0 0 0 0 0 0 0 0 -Beta-carotene O 0 0 0 a 0 0 0 0 0 0 -VitaminC 0 0 0 0 O0
Vitamin E 0 0 0 00 
-
O
Folic acid, folate 0 0 0 O 0 O O o -Calcium or Tums, alone or combined with vit. D or
magnesium O 0 0 0 0 0 0 0 0 0 0Zinc 0 0 O 0 O O O 0 O O -
Iron 0 0 00 0 0 0 0Selenium 0 000 o 0 0 00
Vitamin D, alone or combined with calcium 0 O O 0 0 0 0 0 0 0 0 ...
f you took vitamin C or vitamin E:
How many milligrams of vitamin C did you usually take, on the days you took it? 
.. "
o 100 0 250 O 500 O 750 O 1000 O 1500 0 2000 O 3000+ O don't know -How many IUs of vitamin E did you usually take, on the days you took it? 
-
O 100 O 200 0 300 0 400 0 600 O 800 0.1000 O 2000+ O don't know -
How often do you use fat or oil in cooking? ...O Less than once per week O A few times per week O Once a day O Twice a day o 3+ per day -
What kinds of fat or oil do you usually use in cooking? MARK ONLY ONE OR TWO 
-O Don't know, or Pam O Butter/margarine blend 0 Lard, fatback, bacon fat ..
O Stick margarine O Low-fat margarine 0 Crisco .-
O Soft tub margarine 0 Com oil, vegetable oil ..
O Butter O Olive oil or canola oil -".
Did you ever drink more beer, wine or liquor than you do now? O Yes O No
Do you smoke cigarettes now? O Yes O No ..
IF YES, On the average about how many cigarettes a day do you smoke now? 
-
O 1-5 O 6-14 O 15-24 O 25-34 O 35 or more .-
What-Is your ethnic group? (MARK ONE OR MORE) 
..O Hispanic or Latino O Black or African American O American Indian or Alaska Native "
O White, not Hispanic 0 Asian 0 Native Hawaiian or Other Pacific Islander -
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Please think. Are there any foods you did not see on this questionnaire which you ate at least once
per week, even in small quantities, or that you ate frequently in a particular season. Please
indicate in the spaces below. Thank you.
How Many Times a Day, Week or a Month Would You Say You Ate the Particular Food Item?
Please See Portion Size Pictures for A-B-C-D.
Serving Size How Often
A B C D Day Week Month
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Baecke Questionnaire of Habitual Physical Activity
lease circle or write the appropriate response
I. What is your main occupation? 1-3-5
2. At work, I sit (never/seldom/sometimes/often/always) 1-2-3-4-5
3. At work, I stand (never/seldom/sometimes/often/always) 1-2-3-4-5
4. At work, I walk (never/seldom/sometimes/often/always) 1-2-3-4-5
5. At work, I lift heavy loads (never/seldom/sometimes/often/very often) _ 1-2-3-4-5
6. After work, I am tired (very often/often/sometimes/seldom/never) _ 5-4-3-2-1
7. At work, I sweat (very often/often/sometimes/seldom/never) ___ 5-4-3-2-1
8. In comparison with others my own age, I think my work is physically much
heavier/heavier/as heavy/lighter/much lighter 5-4-3-2-1
9. Do you play sport?
Yes/No ____
If yes:
" which sport do you play most frequently? __ Intensity 0.76 - 1.26 - 1.76
" How much hours per week? _____ < 1/1-2/2-3/3-4/> 4 Time 0.5 - 1.5 - 2.5 - 3.5 -4.5
" How many months per year? < 1/1-3/4-6/7-9/> 9
Proportion 0.04 - 0.17 - 0.42 - 0.67 - 0.92
If you play a second sport:
* Which sport do you play most frequently? Intensity 0.76 - 1.26 - 1.76
* How much hours per week? < 1/1-2/2-3/3-4/> 4 Time 0.5 - 1.5 - 2.5 - 3.5 - 4.5
* How many months per year? ____ < 1/1-3/4-6/7-9/> 9
Proportion 0.04 - 0.17 - 0.42 - 0.67 - 0.92
10. In comparison with others my own age, I think my physical activity during leisure is
much more/more/the same/less/much less 5-4-3-2-1
11. During leisure time, I sweat
very often/often/sometimes/seldom/never __5-4-3-2-1
12. During leisure time, I play sport
never/seldom/sometimes/often/very often _ 1-2-3'4-5
13. During leisure time, I watch television
never/seldom/sometimes/often/very often 1-2-3-4-5
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14. During leisure time
I walk never/seldom/sometimes/often/very often ___________ 1-2-3-4-5
15. During leisure, I cycle
never/seldom/sometimes/often/very often 1-2-3-4-5
16. How many minutes do you walk and/or cycle per day to and from work, school, and
shopping? <5/5 - 15/15 - 30/30 - 45/>45 1-2-3-4-5
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INSTRUCTIONS
The Baecke Questionnaire is self-explanatory.
CALCULATIONS
Scoring of the questionnaire was describe by Baecke et al (1982) as follows:
Work activity index (WAI) = mean score from the occupational Likert scale questions 1-8.
Note: Score categories for question 1 are:
1 = 'Low level' occupations such as office or clerical work, driving, teaching or studying
2 = 'Middle level' occupations such as factory work, plumbing or carpentry
3 = 'High level' occupations such as dock work or construction work.
Sports activity index (SAI) = mean score of questions 9-12.
Note: Score for question 9 = sum of (proportion of year of participation x intensity code x time
[duration] for all activities. The intensity, duration and proportion codes can be found on the
questionnaire.
'Low level sport' = billiards, sailing, bowling, golf.
'Middle level sport' = badminton, cycling, dancing, swimming, tennis.
'High level sport' = boxing, basketball, football, rugby, rowing.
Non-sports leisure-time activity index (LTAI) =mean score of questions 13-16.
Total score = WAI + SAI + LTAL
Note: For questions 2 and 13, the Likert scale response is subtracted from six. Since the
questionnaire scores have no inherent unit of measure (e.g., kcal/unit time), they were designed to
be categorized into quartiles for general classification of activity levels.
EXAMPLE
Hypothetical responses to the Baecke Questionnaire (Question [Response]: 1 (3); 2 (4); 3 (3); 4
(5); 5 (2); 6 (2); 7 (1); 8 (3); 9 (cycling, 3-4 hours/week, 4-6 months/year and, volleyball, 1-2
hours/week, 1-3 months/year); 10 (4); 11 (4); 12 (4); 13 (3); 14 (3); 15 (5); 16 (1):
WAI (questions 1-8)=(3+[6-4]+3+4+2+2+ 1 +3)+8=2.5
SA (questions 9-12) = (2* + 4 + 4 + 4)+ 4 = 3.5
" *Calculation for 9: (0.42 x 1.76 x 3.5)+ (0.17 x 1.26 x 1.5) = 2.9
" The value of 2.9 is scored as a 2.0 according to the following scale:
" 0 (no sport reported)= 1; 0.01 < 4= 2; 4 < 8 = 3; 8 < 12= 4; > 12= 5.
LTAI (questions 13-16) = ([6-3] + 3 + 5 + 1) + 4 = 3.0
Total score = 2.5 + 3.5 + 3.0 = 9.0
Used with permission of the publisher from Baecke JA, Burma J, Frijters JER. A Short
Questionnaire for the Measurement of Habitual Physical Activity in Epidemiological Studies. Am
J Clin Nutr 1982; 36: 936-942.
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Florida International University
Document to Collect Measured Parameters
Pin #
Weight _______ lb Height in
Weight ______ kg Height cm BMI
Waist circumference in Waist circumference cm
Blood Pressure: 1 Blood Pressure: 2
Systolic mm Hg Systolic mm Hg Average mm HgDiastolic 
_____mm Hg Diastolic mm Hg Average mmH
Blood Lipids
Total Cholesterol mg/dL
High-density Lipoprotein Cholesterol mg/dL
Triglyceride mg/dL
Low-density Lipoprotein Cholesterol mg/dL
Blood Glucose mg/dL
High-sensitivity C-reactive Protein mg/L
Cholesterol/HDL-C
VLDL mg/dL
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Glossary of Health and Cultural Terms
Acculturation: As a group that stays in the (United StatesUS for a period of time, they
become more like the dominant culture because of changes that occur due to the repeated
exposure to influence from another culture. The extent of this transformation is related to
age, education and opportunities for interaction with another culture. Individuals within
groups will be found to lie all along the continuum representing various levels of change.
Age-adjusted Rates: Used mainly to compare the rates of two or more communities,
population groups or the country as a whole, over time. A standard population year
(2000) is used so that these rates are not affected by changes or differences in the age
composition of the population.
Angina (angina pectoris): A pain or discomfort in the chest that occurs when some part
of the heart does not receive enough blood. Angina is a common symptom of coronary
heart disease.
Atherosclerosis: Hardening of the arteries in which cholesterol and other substances in
the blood are deposited in the walls of arteries, including coronary arteries that supply
blood to the heart.
Bias: Any systematic error in the design, conduct or analysis of a study that results in a
mistaken estimate of an exposure's effect on the risk of disease.
Body Mass Index (BMI): A mathematical formula to assess body weight relative to
height. This measure correlates highly with body fat. It is calculates as weight in
kilograms divided by the square of the height in meters (kg/m2). Because it is easily
calculated, BMI is the measurement of choice as an indicator of healthy weight,
overweight and obesity.
Blood Pressure: The force of blood pushing against the walls of the arteries. Blood
pressures less than 120/80 are considered normal.
Cardiovascular Disease (CVD): Includes a variety of diseases of the heart and blood
vessels, coronary heart disease (coronary artery disease, ischemic heart disease), stroke
(brain attack), high blood pressure (hypertension), rheumatic heart disease, congestive
heart failure and peripheral artery disease (ICD/10 codes 100-199, Q20-Q28).
Centers for Disease Control and Prevention/National Center for Health Statistics
(CDC/NCHS): A division of the US Department of Health and Human Services
(USDHHS). The CDC conducts the Behavioral Risk Factor Surveillance System
(BRFSS, ongoing). The NCHS conducted the National Health Examination Survey
(NHES) and the National Health and Nutrition Examination Surveys (NHANES) I(1971-
74), I (1976-80) & III (1988-94). The NCHS also conducts these ongoing studies
(among others): The National Health Interview Survey (NHIS), The National Home and
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Hospice Care Survey, The National Hospital Ambulatory Medical Care Survey and The
national Hospital Discharge Survey.
Coronary Heart Disease (CHD): A condition in which the flow of blood to the heart
muscle is reduced. If enough oxygen-carrying blood cannot reach the heart muscle, one
will feel pain in the chest or sometimes in the left arm or shoulder (angina). When the
blood supply is cut off completely, the result is a heart attack. This includes ICD/10
codes 120-125.
Culture: The values, norms, traditions, customs, arts, history folklore and institutions
that are developed, learned and shared by a group of people and passed down from one
generation to the next. Culture is not static. It is an ongoing process within which
individuals are constantly trying out new ideas and behaviors to better meet their goals
and objectives. Culture is not monolithic. People within a racial/ethnic group are
heterogenous. Put another way culture is a group which shared experiences, language and
values that permit people to communicate in ways not shared by those outside the culture.
Under certain circumstances, such a group may go beyond racial or ethnic categories.
Culturally Appropriate: An unbiased attitude and organizational policy that values
cultural diversity in the population served. Reflects an understanding of diverse attitudes,
beliefs, behaviors, practices, habits and communication pattems that could be attributed
to age, gender, race, ethnicity, religion, socio-economic status, physical or mental ability,
or generational and acculturational status. It includes an awareness that cultural
differences may affect health, health outcomes and the effectiveness of health care
delivery.
Cultural Sensitivity: The recognition that cultural differences as well as similarities
exist, that both are valued, and there is no right or wrong cultural difference. They are
just different.
Death Rate: Sometimes reported as "crude" death rate reflects the frequency with which
death occurs within some specified interval of time in a population. However, age-
specific or sex-specific rates are more meaningful and informative. This is because it
allows one to look at well-defined sub-groups of the total population.
Ethnicity: Belonging to a common group, often linked by race, nationality and language
with a common cultural heritage or derivation. Ethnicity is also a construct that
encompasses both genetic and cultural differences.
Health: A state of physical, mental and social well-being and merely the absence of
disease and infirmity.
Health Outcomes: The results or consequences of a process of care. Health outcomes
may include satisfaction with care as well as the use of health care resources. This
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includes clinical outcomes such as changes in health status and changes in the length and
quality of life as a result of detecting or treating disease.
Health Literacy: The degree to which individuals have the capacity to obtain, process
and understand basic health information and services needed to make appropriate
healthdecisions.
Health Promotion: Any planned combination of educational, political, regulatory and
organizational supports for actions and conditions of living conducive to the health of
individuals, groups and communities.
Incidence: An estimate of the number of new cases of a disease that develop in a
population in a one-year period.
Morbidity: Incidence and prevalence rates are both measures of morbidity, that is,
measures of various effects of disease on a population.
Mortality: The total number of deaths from a given disease in a population during a
specific interval of time, usually a year.
National Heart, Lung and Blood Institute (NHLBI): An institute in the National
Institutes of Health in the USDHHS. The NHLBI conducts the Atherosclerosis Risk in
Communities (ARIC) study (ongoing since 1985), The Cardiovascular Health Study
(CHS, ongoing since 1988), The Framingham Heart Study (FHS, ongoing since 1948),
The Honolulu Heart Program (HHP, 1965-97) and the Strong Heart Study (SHS, 1989-
92; 1991-98). The NHLBI publishes the reports of the Joint National Committee on
Prevention, Detection, Evaluation and Treatment of High Blood Pressure, JNC VII, the
most recent.
Prevalence: An estimate of the total number of cases of a disease existing in a population
at a specific point in time. Prevalence is sometimes expressed as a percentage of
population.
Primary Prevention: Health care services, medical tests, counseling and health
education and other actions designed to prevent the onset of a targeted condition. Routine
immunization of healthy individuals is an example of primary prevention.
Race: A socially defined population that is derived from distinguishable physical
characteristics that are genetically transmitted.
Risk Factor: A characteristic that has been demonstrated statistically to be associated
with a particular injury.
Secondary Prevention: Measures such as health care services designed to identify or
treat individuals who have a disease or risk factors of a disease but who are yet to
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experience symptoms of the disease. Cholesterol and high blood pressure screenings are
examples of secondary prevention.
Target Population: The group of individuals (usually those at high risk) whom program
interventions are designed to reach.
Tertiary Prevention: Preventive health care services that are part of the treatment and
management of individuals with clinical illness. Example of tertiary prevention include
cholesterol reduction in persons with CHD and insulin therapy to prevent complications
of diabetes mellitus.
The definitions were adapted from:
American Heart Association. 2004 Heart and Stroke Statistical Update. Dallas, TX.
Healthy People 2010. With Understanding and Improving Health and Objectives for
Improving Health. (November 2000) (1st and 2 "d ed) Washington, DC: US Government
Printing Office, US Department of Health and Human Services.
Healthy People 2010. Heart Disease and Stroke. (November 2000) (1 s ed) Washington,
DC: US Government Printing Office, US Department of Health and Human Services.
Bronner Y. Cultural Sensitivity and Nutrition Counseling. Topics in Clinical Nutrition
1994; 9(2): 13-19.
Anand SS. Using Ethnicity as a Clssification Variable in Health Research: Perpetuating
the
Myth of Biological Determinism, Serving Socio-political Agendas, or Making Valuable
Contributions to Medical Sciences? Et Health 1999; 4(4): 241-244.
Susuf 5, Reddy S, Ounpuu 5, Anand S. Global Burden of Cardiovascular Diseases Part 1:
General Considerations, the Epidemiologic Transition, Risk Factors, and Impact of
Urbanization. Circulation 2001; 104: 2746-2753.
Maitland, TE. The Health and Nutritional Status of Multiethnic Perimenopausal Women.
Ph.D Thesis, Florida International University, 2001.
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